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Previous ep idem i ological studie s i ndicated t ha t cigarette
smoking- f emal es are at inc r ea s e d risk of de veloping cervica l
cancer . However . be cause o f the conf ound ing variablp:s of these
studi es , an d since other s tudies have given confl i c t i ng
r esu l ts, co nvi ncing evidence is lacking. Furthe rmore, t he
molecula r r o l e of cof actors , such as hormones, i n t he
multistage carcinogenic proc ess is st ill un clea r .
To e x ami ne the role of h uma n papillomavirus (HPVI a nd
c iga r ett e smoking i n the carcinogenesis o f c e r vi c a l cancer , I
s t udi e d two HPV16 i mmor t a lized en docervica l cell lines
previously establishe d in t hi s lab, HEN- 16 a nd HEN-16-2 . Both
lines were treated with ciga r ette s moke co nden s a t e le SC) at
15 , 100, 125 ~g/nl. Af ter 6-12 mon ths ' t r eatmen t with CSC,
101 c ells of trea ted and un t r eat ed i mmortalized ce l ls wi t h
equal pa s s a ges were in jected into fema le nude mi ce. Four t o
six we e ks l a t e r , on l y csc - t.reatec c e ll s but not csc-unt r e e ted
i mmort a lized c e l l s f ormed palpable tumors, wh i c h we r e
su bs e quently used to derive t umor cell lines, HEN-16T and HEN-
Furthe r cha racteri zatfon o f the immorta lized ce l l line s
an d csc- t.re n e rc rmec ce ll lines indicated that the e sC- t reated
tumorigenic cells a l displayed distinct morphologies in
monolayer and organotypic (raft ) cultures ; b } proliferated
f a ste r in DMEM, a medium c ont a i ning phys Lo Ioq Lc .i I calcium
levels; c) showed in vitro anchorage- independency; d)
contained and expressed s imilar levels of HPVl 6; e) exp ressed
similar levels of some cellular genes a s so ciated with en hanced
malignancy, c -myc, H-ras, p53, WAFl, GADD45 , GADDI53, and
fibronectin, compared with immortalized cells . However, f)
HEN-16T and HEN-l6-2T expressed higher l ev e l s o f B-myb and
PCNA; an d g) ob ta ined enhanced c e s i s tence t o grow th inhibition
b y tans forming growth rector-Br (TGF- ~l) and re tinoic acid
(RA ) . On the other hand, the two immortalized cell lines
displayed higher levels of p53 , B-/I1yb , PCNA and lower levels
of Wa ft and f ibronectin , compared with primary endocervical
cells.
In addition , two novel cDNAs, des ignated PA.4 and PA9,
wh i c h were specif ica ll y e xpressed at h igher l e vels i n
immortalized cel ls and primary endocervical cells ,
respec tively, were identified and cloned us ing d if ferentia l
d i sp l a y assay" . Further characterization of these t wo novel
cDNAs will be very helpful for us t o fully understand the
molecu l a r pathogenesis o f cervical cancer .
In summary, th is s t ud y p r-ov Lded the first in vi t r o
e vidence that c .tqe r c t te s moke c a n enhanc e t he r isk of
develop ing ce rv ical in HPV-infected patients .
Furth e r more , the in vitro system wi l l be very useful to
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I n 1954 , Armitage a nd Dol l studi ed t h e age an d i ncidence
of 17 common types of cancers and con c luded t h a t
carc i nogenesis wa s at le ast a six or seven s tage proce s s
(Ar mitage a nd Doll, 1 954). This l ead to the con c e pt o f
mul t istage carc f n cce ne s Is o f cance rs . since t he n , t his
concep t ha s be en p rove n clear ly and i mpro v ed significantly by
ep i d e mio logical a nd mo l ec ula r ge netic studies . As shown i n
Fi gu r e I, mu ltistage carcino g e nes is can be divide d i n t o fo ur
steps : In1 tiat l on , promot i o n , ma lignant prog ress i on a n d
metas tas i s . However, in s ome case s, n o t al l of t h ese s t e ps can
be ident if ied cl e a r ly . The i nitiation s tep i s b elieved to be
ca us e d usually by genot oxlc agent s , especially p hy s ical
factors , s uch as ul t r aviole t (UV) light and irradia t i on,
chemical c a rcinog ens a nd viru s es, wh i ch c a use gene tic cha ng e s
in a sing l e cel l . After init i a tion , the c ell st i ll may ha v e
t he normal p henotype. However, when t he cell b e come s exposed
to some tumor promoting reagents and exp erience s f ur ther
genet ic a lter at ions , such as mutat ion, activat i on or
inactivation or o ncoge n es an d t us or suppressor genes , a s i ngle
cell acquires some heritable f orm of growth advantage and
Fig ure 1 Mul ti stage carcinogenesi s of cance r . The sYJIbols
r epresent : 0 , no r. al c e lls; 0 , nor. a l cell s with qenetic
changes; . , premalignant cells; . , maliqna n t cel l s . See
the text to r details .
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11 \ METASTASESFurther geeet techanges
Mela, lalic « II,
expands to form a clonal malignant tumor. Finally, ad d itional
changes allow the outgrowth of clones with metasta tic
potential t o o the r tissues. He re, I will discuss how
i nd i vidu a l fac tors function in t he mUltistage carcinogenes is
of human cancer.
1.1 .1 Physical f a ctors
UV l ight and i oni z i ng radiation are recognized as the t wo
mos t impo r t ant p h ys i c a l causative factors i n t he development
of cancer (Adam and Cox, 1991 ) .
UV light ha s wavelengths between 200 run and 400 nm and i s
compo sed of fN -A (20 0 -280 n m) , tN-B 1280-320 nm) a nd uv-c
(32 0 - 400 rim}, each ha v i nq d ifferent effe c ts on the e kt n and
eye . Generally , the shorter the wavelength, t h e more
destructive t he radia t i on. Thus, UV-A h a s t he most damagi ng
effects on human cells. Since almost all t h e UV-A is abs orbed
by the oxygen and ozone of t he atmosphere , it i s a minor
fa c t or . However , a considerable amoun t of UV-B penetrates t he
atmosphere, especially in the Arctic a n d Antarctic reg ions
wh e r e a severe seasona l depletion 0 f ozone layer is observed .
Si nce the spectrum of UV- B i s ve ry clos e t o the a bsorption
spectrum of DNA , it can be ea sily absorbed by DNT\ molecules
an d cause da mage to DNA. The damaged DNA is normally
re paired b y the DNA repair sys tem i n the cells. However , whe n
the r e pa i r s ys t em i s a lso i mpai r ed , UV-B may ca use f urther
ge netic ch anges and , fi na lly , induce ca nce r . UV light is
believed t o be one of the major ca uses o f malignant melanoma
and o t her f orms of skin c an ce rs (St e r n an d Lan g , 198 8) .
Ionizing radi at ion co ns i sts of e l ec tromagn e tic r adiation,
s uc h a s X- and y-rays , and subatomi c pa rt i cles , such as alpha
pa r t i cle s , elect r on s, neut r ons , and pro t on s . Epidemiologica l
s t ud i e s i ndicate that ioni zing radiation i s believed to be one
of the c ausative fact ors for the development of l eukemia and
skin, bo ne , breast , lung, t hyroi d , s t omach , colon, bladder,
esophagus, and live r c anc e r (BEI R IV, 1988 ) . rur tbermore,
ce llular and molecu la r b i ological s tud ies have c onf i rmed t ha t
ioniz i ng radiation c a n be invol ve d i n t he init i a tion and
promot i on p r oc ess o f multi s t a ge c arc i no gen e s is of ca nc e r by
causing c e ll inac tiv a tion, chromos ome damage and mutat ion o f
gen es , such as r as , directly o r by i n t e racting with wat e r t o
fo r m hydroxyl radicals t ha t ca n dama ge DNA (Adam an d Cox ,
1991 ) .
1 . 1 . 2 Chemical factors
Epidemiologica l an d an i ma l to xicologica l s tudi e s ha ve led
to the ge nera l accep t ance that chemical ca rci nog ens are on e o f
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the mos t import an t ca usative fa ctors for t h e d ev e lopment of
human ca ncer. Tab le 1 lists some of the chemical c a r cinogen s
that can cause human c ancers .
From t he Tabl e 1 we notice tha t a specific chem ica l
ca uses only certain types of t umors . For examp l e , arsenic and
its compounds can induce skin, l ung and live r cancer; however ,
chlorambucil on ly causes l e u kemi a . The mechanism fo r this
c a rcinogen-specific is unk nown .
One of the most convincing pieces o f ev idence that
i mplica t e chemical carcinogens in mult istage carcino genesis
c ame f rom s tud ies on the fo r mat i on of mouse skin t urnor s
(Be r e nb l um and Shubik, 1949; Balmain and Brown , 1966 ). In
t hes e experiments, a s ingle chemica l ca rcinogen, such as MNNG
or NMU, was first appl ied to the skin of mouse . This resulted
in the initiation of an un kno wn number of cells which would
persist for a very long time without showi ng any apparen t
c hanges i f they were left without further treatment . However ,
if a second class of ch emi cal agent , a tumor promo ter, su ch as
t e tradecanoyl phorbol l 3- ac e t a t e (TPA) , was applied a t the
same time or even a yea r later, benign tumors cal led
papil lomas appeared. A small port ion of t hese papillomas
deve l ope d i n t o fully malignant tumors with or without fu r ther
applications o f tumor' promoters . Further molecular biological
studies indicated t ha t the t umors were derived from the clonal
expansion of cells bearing the .ras proto-oncogene which had
been activated by mutation after treatme nt with the first
chemical carcinogen (Ba l mi n and Brown, 1988). Therefore,
chemical carcinogens are believed to be involved in the
initiation and promotion of cancers by activating proto-
oncogenes or Lnec t IvatLnq tumor suppressor genes.
1 .1 . 3 Viral factors
Viruses have been implicated in the etiology of up to 20'1.
of all cancers in the world (Vousden and Farrel, 1994). Thus,
studying the relat ionship between viruses and h uman cancers
has become one of the most extensively studied areas in cancer
research .
Until now, only five viruses , including three DNA
viruses, Epstein-Barr virus (EBV), hepatitis B virus (HBV),
human papillomavirus (HPV) and two RNA viruses , human T-ce ll
l eu kemi a virus I (HTLV I) and human immunodef iciency virus
(HIV) are well known to be the facto rs associated with
several human cancers.
EBV is a member o f human herpe sv i r us family, which
inf ects about 90% of the wor ld population (Keitf and Liebowiz ,
1990). Previous studies indicate that EBV may be the ca usative
agent of two human neoplasms , Burkitt's lymp homa (BL) a nd
nasopharyngeal carcinoma (NPC) (Keiff and Liebowiz, 1990 ). The
epidemiolog ical association of EBV with BL was furthe r
sup ported by the ability of EBV to i mmortali ze human
lymp hocytes in c ulture (Hammerschmidt and Sugden, 1989) .
Howeve r , un til now, t he mol ecular mechan ism for EBV in the
etiology of BL and NPC is stil l not clearly de fine d due to the
l a r g e 18 0 kbp si ze of t he EBV ge nome and the l a c k of ce ll
eu r ture systems for virus propagat ion (Vousden and Farrel ,
1994) .
HPVs are a l arge group o f epitheliotropic papovaviruses
which i n f ec t a wide variety of cu taneous and mucosal ep ithe lia
including those in the skin, mout h, cervi x , vu lva , larynx and
respi ratory tract (Howley, 1991 ) . Of the 70 t ypes o f HPVs that
have been i de nt i f i e d so far, mos t are re l ated to benign
geni tal or skin warts . Onl y a f e w of t hem, especia lly HPV16
and la, are i nvolved in t he development of human cancers, such
as cervica l , anal and l a r yngeal c arcinomas (de Vi lliers, 199 4) .
The association of HPVs with ce rv i cal ca ncer , the second most
common female ma l i gna nc y 1n the world , has be e n extens ively
s tud i ed (for re ce nt r ev i ews see zur Haus en, 1994; zur Haus e n
and de Villiers , 1994a,b) . This will be di s cu s s ed in more
deta i l i n section 1 .2 and 1 .3.
Hep a t it i s B virus (HBV) i s a 3 .2 kb partially doub le
stranded and pa r tia lly s ingle stranded c i r c ular DNA v i rus. I t
is a member o f the hepatitis viruses and infects at least 300
million people i n the world (Bea s l e y and Hwang, 1991) .
Epidemiological studies indicate that HBV is a major risk
factor for the development of hepatocellular carcinoma (HCC l
(Be a s l e y et a1. , 1981). Despite the close association between
HBV rncrcence and hepatocel lular carcinoma, the exact
mechanisms by which HBV contributes to malignant progression
remain to be elucidated. I t has been repo rted that HBV can
integrate into the human DNA genome and persist for life . This
integration is thought to allow HBV to escape the immune
response and initiate the subsequent development of HCC
(Be a s l e y et a L, , 198 1) . In add ition, integration of HBV near
some genes, such as c-myc, cyclin A or retinoic acid receptor
p may cause the deregulation of the genes, which is related to
the multistage carcinogenesis of Hec (Nagaya et a 1., 1 9B1 ).
Furthermore , HBV X protein can interact with t he p53 tumor
suppressor gene and inactivate t he t r ans activating function of
the gene (Feitelson et a1. , 1993) . All of the above
observations i ndi cat e t hat HBV may initiate the ca rcinogenesis
of hepatocellular carcinoma by interacting with some cellular
gene products.
HTLV-1 is a retrovirus which infects from O.025~, ( i n t he
U.S.A.) to 30% (in Japan) , of the human population of
1 0
d ifferent countries dur ing th€dr life time tc enn and Chen,
199 0) . Epidemiol og i cal studi es link this r etrovi r us t o a type
of cancer ca lled adult T cel! leukemia rATL) . Since only 2\ of
t he people who are i n f e c t e d by HTLV- I develop ATL and HTLV- I
c an only i mmor t alize peri phe ral blood l ymptJocytes. HTLV-I ha s
been o nl y r eg a r de d a s the i nitia t ing ag ent i n t h e
carcinogenesis of ATL (Hol!sb e r g and Ha tle r , 1993 ) . Ot h e r
cha nge s such a s chromoson.al rearrangements or somatic
mut a t i on s are ne cessary for t he fu ll transfor mation of
p rima ry lymp hocy t e s (Holls be r and Hafle r , 1993).
HIV i s anothe r re t r ov ar us and i s linked to ac qui r ed
immunod eficiency s yndro me (AIDS I (Gallo and Montagnier. 19 88 ) .
The hallmark o f AIDS i s t be gradual l o s s o f T4 c e ll
l ympho c yt e s an d t he s ub sequent de ve l opment of
immunod eficien t s t a te . The ab senc e o f T cells leads t o t he
expans ion of polyclonal B cell p opu l a tions and. finally, t he
forma t ion o f l ymphomas . Molecular ge netics stud i e s h ave sho wn
that rea rrangeme nt and ectfvat.tcn o f t he c-m}'C l oc us is one o f
t h e majo r pathomechanisms in the de velopment of l ymp homa s
(Kno wles et aL , 1988) . Ben i gn hyp e rplastic l ymph node s
ob tained from patients infect ed by AIDS co nta in ed an intact c -
myc gene locus a nd oligocl onal IgH, whereas frequent
monoclonal c -my c gene r earrangement and ol1goclona l 19H gene
rear r angement ha ve be en observed in l ympho i d ne op l asms
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(Knowles et a L, , 1988), suggesting that infect ion of HIV is
only an initiating agent in the multistep process in AI DS
patients and that the alteration of other c e llular genes such
as c-myc may also contr ibute to this process. In addition , a
higher incidence of several types of tumors, such as recta l,
cervical , oral, test icular cancers, has also been described
ir l AIDS patients , suggesting the poss ible role of this virus
i n the oncogenesis of these cancers due t o immunosuppress ion
(E-r au , 1994 ).
In summary, all these DNA vi r us e s and RNA v iruses can be
regarded to be necessary but not suf ficient agents in the
multistep carcinogenesis of cancers . Othe r changes
cr.i t ical in tumor progression and metastasis .
1 . 1 . 4 Callular f a c tor s
Molecular genetic ucudt ea indicate that deve lopment of
cancer is largely a consequence of abnormal expression
function of specific cellular genes (So lomon e t a L, , 1991) .
Specific cellular genes are either activated or inactivated i n
the process of mUltistage carcinogenesis. Genes Who s e
activation or abnormal function of the gene product can induce
neoplastic transformation of nonmalignant cells are call ed
oncogenes . On t he contrary, genes for which inactivation of
the gene product can induce neoplastic transformation of
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benign ce i i e a re called tumor suppress or gen es .
Until now, a t l e as t 50 d i fferen t oncoge n es have be en
i de nti f i ed t hat i nduce chan ge s neces sary f or ma l i gnar. t cel l
gro wth. Table 2 lis t s o nc oge ne s amplified in some of t he most
co mmon tumors .
A c e r tai n kind o f cancer i s us uall y caused by
deregu lat i on of se ve ra l o f the o nco genes i n this table ,
sugge s ting t hat mul tiple gene t ic alterations are requ ired fo r
invo l ve d in the mU l tistage carcinogenesis o f the cancer.
Whil e oncogenes p r e vt ous Ly were regarded as the maj or
ce llula r fa c to r i n human cancers , with the d ev e l opmen t of
mol ecu l a r gen etics within t he past 10 years , an i n c r e as i ng
number of reports ha ve sh own altera t i ons i n t umor suppresso r
ge ne s I So l omon et a l . , 19911 . 'rbus , it is no w believed that
mutation and deletion of ch romosomes f or t umo r s up p r e s s or
gen e s plays a c entral r o le in t he gen es i s and progression o f
human cancers (Weinbe r g , 1989 ; Lev in , 199 31. Table 3 sh ows the
co r relat ion be t ween human cance r s and de l e tion o f chromos omes
or tumor s uppres s or ge nes.
Compari ng iable 2 with rebae 3, one basically c an
perce ive t hat both onco genes an d tumo r suppressor genes may be
i nvo lve d i n a specific type o f ca ncer . For example, i n colon
ca nc e r , both t he activation o f e rca t , L-myc , N- myc , H-ra s and
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Table 2 : Oncoqenes amplified in hurnan cancers.
Cancer Oncogenes
Bladder H- r a s , K-ras , int-2
Brain erbBl, s is
Breast erbB2, n-c-ee , c- myc , in t-2
Cervica l c- myc, H-ras , erbB2
Col o r e c t a l a-rae, x-a-e e, c-myb, c - myc
Ga s t ric erbBl, hst, c-myc, c - myc, N-ras, y es
Lung erbB1 , c- myc , r.-myc , N-myc, n-z a s ,
x - eas
Melanoma H-ras
Neuroblastoma c-myc , N-myc
Ovarian erbB2, K-ras
Panc reas x-r-as , c-myc
Prostate c-myc
Stomach c-ave, in t -2, hst
Testicular c -myc
... Cole and KeIeker , 1981 ; Cooper , 199 0; Dav ies ant Vousden ,
199 3 ; Mitra et al .. 199<1 .
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Table 3 . Delet ion of' chr omosomes and l os s o f' human tumor
suppr e s s or glaReS i n human canceee-
Tumor/site Chromosome Loss of tumor
deletion su ppressor gene

















Ip ,6q, 9q ?
Neur obl a s t oma l p, 1 4q
Neurofibromatosis l7 ql1 Nfl
22ql2 Nrz
Osteosa rcoma 13q14 Rb
17p13 p53
Prostate IIp, 1 6q
Stomach lq, 12q
Wilms llp13 " Tlllp15 H19
*We i nbe r g , 1989 ; Solomon et a L, , 199 1; Levin , 1993 ; Yokoya et
al., 19 93 .
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K-ras oncogenes and the inactivation of APe, Rb, p5J and VHl,
t umor suppr essor genes wer e found . However , ho w are these
oncogenes an d tumor suppressor gen es i nvo l ved in the
o ncoge n e s i s of a certain ca ncer? Is their fu nction altered
s IrnuLt a naous Ly or subsequently duri ng the p r oce s s o f
carcinogene sis? Studies on the multistep carctno cenes ts o f
colon c a nc e r have shed some light on this ques t i on s .
Figure 2 shows the ge ne t i c c hanges occurring duri ng
evolut ion of a typ ical colon carcinoma (Fe aron and
Volgelstein , 1990 ). While t he tumor suppressor ge ne , APC,
inactivated b y somatic mutations at t he earl iest s t a ge s o f
colo n carcinogenesis , H- r a s activation and DCC l oss were only
found in mos t of the late adenomas . Inac tiva tion of p5 3 i s
detected only in the f ull carcinoma (Figure 2). This model
c lear ly il lustrates that alterations of oncogenes and t umor
s uppressor genes may
carc inogenesis . However , there
at dif fere nt stages o f
a lso some examp l e s of
activation of certain oncogenes an d i na c tiva t i on of certain
t umor su pp resso r genes occurring a t t h e s ame stage o f
ca rcinogenesis (Mc Don a l d and Ford, 1991 ) . Thu s , coo pe ration
betwe en oncogenes, such a s H- r a s and c -myc, or be t ween
oncoqenes and t umor suppressor gen es, such as i nac t i vation of
Rb and activation of c -myc , may a l s o be nec essary for t he
mul tistep carcinogenesis of cancer .
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Figure AlteratioDs ass ociated. with mUltistage
carcinogenesis of c ol on cancer . Act ivation of specif ic
oncogenes and inactivation of specific tumo r suppressor gen e s
are s t at i s t i ca lly associated with 4. of the 6 s t eps in tumor





1 . 2 . Gene r al features of HPVs
Human papi l lomaviruses a re smal l , naked, i co sah edr al
double-s tranded circ ular DNA of about 8 , 000 bps . TheY be l ong
t o the sub-family papillovirinae (Howl e y, 1991 ) .
Until now, approx ima tely 70 t ype s of HPVs have been
i d e n t ifie d based on a comparison o f the DNA sequences of E6,
E7 , and L1 open readi ng f rames (ORFs ). Ov e r 30 types are
associated with anogenital lesion s (de Villiers, 1994 ). These
HPVs c an be fur the r c l a s si fi ed as either high risk, such as
HPV 16, 18 , 31, 33 , 39 and 52, or low risk, such as HE'V 6 and
11, based on t he re lative tende nc y o f t he l esions t o progress
i n to genita l carcinomas (de Villiers, 1989) . Generally, high
r isk BPVs are frequently f ound i n high gr ad e cerv i c al
i n t r a epithe lia l neoplasia (CI N) , which has a higher tendency
f o r malignant c onversion . I n con tras t , low risk HE'Vs
commonly f ound in be nign genita l condylomas and nasa l and
la ryngeal papi llomas, which have a lower tendency for
malignant conv ers i on (Sh ah and Howl ey , 199 0 ).
The 8,000 bp genome of HPVs i s gene ra lly organized into
t h r ee distinct regions: early reg i on (E ), late r egio n (Lj , and
long control region (Le R) es shown in Figure 3 . The early
reg ion i s composed of 6 ORFs , des ignated E1, E2, E4, E5, E6,
E7 , wh Lcl , are involved i n viral DNA replication and
t ranscription and cellular transformation and maturation . The
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Pigure 3 . Gen?aUc organizati on of HPV16 (Ada pted frOlll Munget
et a1. . 1992 ) . All papillomaviruses contain a double -stranded
circular DNA genome of approx imately 8 kb . The major
transcript ional promoter for HPV16 is de s ignated P97.
Transc r iption occurs only i n a c l ockwise man ner . Nucleotide
positions are i ndicated in the inner circle . The early ORFs
deduced from the DNAsequence are designated 51 to 57, and the
late ORFs are designated Ll and L2. The viral long control
region CLCR) contains DNA elements that regulate HPV
transcription and replication by interacting with vira l and
cellular transcription fac t ors a nd replication factors. Short
vertical lines in the LCR represent the l o c ation s of the E2
b i ndi n g sites. ACCN.GGT. Note that ove r l ap between some of the






late region i s composed of two ORFs, de s i gn a ted Ll and J~2,
which encode the viral capsid proteins. The LCR, a l s o called
the noncoding r egion (NCR) or ups tream regulatory region
(ORR) , is found between the 3' end of the late region and 5'
end of the ear l y region and provides binding si tes fo r
s ev eral cellular and viral transcription a nd replication
factors (Howley , 1991 ; Hoppe -Seyler and Butt, 1994 ).
The basic features and f unct i ons of each ORF and t he ir
prote ins are listed i n Table 4 , and they wi ll b e fur ther
discussed i n s ucceeding sect ions .
1 . 3 . Molecular oncogenesis of primary cervical ce l l s
1. 3 . 1 An in vivo a nd in vi t ro model of multistage oncoqsnesill
of cervical cells
As stated abo ve , the d evelopment of cancer is a
muLtistage process, in wh i ch mult i p l e genetic changes arc
required for the full t r an s f or ma t i on o f no r mal c ells . This
mul t i s t a g e nature of c ancer also clearly can be ob served in
t he oncogenesis of human cervica l ce lls both in vi vc and in
vitro. Figure <I il l us t r ate s a mode l of the in vivo a nd in
vitro oncogenesis of cervica l ca nc er . In this model , high risk
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Table 4 Basic features andfunctions of HPV ORFs and proteins•
QRF
Protein5! ze Feate es Functions(' 0. )
E1 68-7Z 1. Consel'Ved hil1y we ll among HPVs 1. Increase immortaliZiltloo c;ap;llc:ltyof Hf'V gen~
Z. Bindsto minimal replication Of'igin 2. Requi'"ed together with £2 for vlr. 1replication
3 . lnt erKt,wlth E2 pr otein
4. Usually tan be dtleted In HPV-eontaining
,."Inomo>
EZ 48 1. Cont;tin, DNAbIndlng aI'Idu ansa etlvatitlg 1. Transactiwt lll or r epress HPV IIlllP'nsiort
demol.
Z. Forms o;kners 2 . ReqJired together,.,.;th E1 for vinl r~ic.tlon
3. htlffilctswithEl protein
~
4 . Usually dele ted In HPV· eontalnlng CU"d nornas
E4 16-10 1.Significant divergence amongHPVs 1. Vlfal maturation
2 . Most abundan t pro tein In HPV-ln teeted cells 2 . Collapse o t ker atin cyt oslrele ton
3."'t_Uwlth eyt~er.tlns
4. U:p' essed in ditferentii ting keriiltinoc:ytes
1. u.... ly del.l~ or lIsrupted In~~ 1 . Weak onc;~is
C¥lCff$
2:. Enhanced EGF-med ated mitogenic Sl1lal
transduc tion
E6 18·19 1. Produces unspticed £6 and£6* andE6" , 1. Required together with E7 for Irnmorta~zatlon
Internally spliced rnRNA and transformation
2 . In_blndinllproteio 2. Tr _ ti v.at ion
3. h terxts with cellulatprotein such as pS3
2 4
Figure 4 . In vivo and. in vil:ro model s of the multistage
oncogenesis of cervical cancer . Each ste p will be des c r ibed in
d e t a il i n t he t ext.
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HPVs are r egarded as the initiating age nt for t h e de ve l opme n t
of c er vica l ca ncer. The pr e s e n ce of HPV is responsible for eIN
I low grade lesions i n vivo an d an e xt en de d life span i n cell
cul ture (in vi t ro) . Furt her modi f i ca tion s of c e llu l a r genes
result in CIN II and III h i gh grade l es i on s i n vivo or
i mmorta lization in vitro. Howeve r, t hese eve nts are not enough
to t r ans f o r m the normal cervical cells i nto invas i ve tumors .
Other f actors, su ch as hormones and smoking are required to
ma ke further changes in othe r cellular genes to transform some
of the h i gh g rade neoplas i as or immortali7.ed cells to form
invasive tumors . I will discuss t his process in detail in the
next section .
1 .3 .2 Role o f HPV in oncogenesis of cervical cells
Cervical cancer is the second mos t common cancer am'lnq
women i n the wor ld (Howle y , 198 8) . It was r ecognized as a
s e x ually t r ansmi t t ed disease mor e t han a centur y ago a n d since
t hen numerous infectious agents have been suggested to playa
causative role in ce rvical cancer Ifo r revi ew s ee zur Hausen
and de Villiers , 1994 ) . In 1 976, zu r Hausen firs t p r op os e d a
h yp ot he s i s t hat links human pa pillomaviruses to cerv ical
carcinoma . Ove r the subsequ ent 20 ye ars , a l ar ge body of
epidemiological and molecu lar biologi ca l evidenc e h a s
accumula t ed to fi rmly s upport a r ole for HPVs i n t he
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development of cervical c ancer ( f o r reviews see Howley , 1 9 88:
zur Hausen, 1 9 91,1 9 94; zu r Hausen an d de Vi ll iers, 1994a,b;
Garland e t a1 ., 1992; Davies and Vousden , 19 :J3: Lowyet a1.,
1 994; Ponten et a1. , 1995 ) . Here, I briefl y discuss the in
vi vo and in vitro evidence that s upport the role of HPV in the
etiology of cervical cancer .
1 . 3 . 2 .1 I n vivo e v i dence
The in vivo data link ing HPV wit h carcinoma of the cervix
are as f ollows:
1) HPV DNA, especially high risk HPVs such as HPV16 and
HPV18 , c an be detected in over 90% o f cervical ca rci n oma
biopsies (zu r Hausen , 1991).
2 ) HPV DNA of th e s ame types can be detected bo th in
primary cervical cancer and met astatic lesions (Lowy et a 1.,
1 994) .
3) In morphologically benign l es i o ns , t h e viral geno me of
HPV is usual ly maintained in an episomal sta t e while i n
malignant les ions an d high grade i ntraepithelial n eoplas i a i t
is often i n t e gr a ted i nto the hos t ce ll ch ro mosomal DNA .
Integra t io n generally occurs wi t hin t he E1 or E2 ORFs, l e a vi ng
t he ORFs of the transforming on c og ene s , E6 and E7 , intact and
act ive ly t r anscribed in HPV-positlve ca nce r ce lls (Cu l l en,
1991) . Only a small perce nt age of ma lign a nt tumo rs h a r bor
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ep isoma l DNA lCu llen , 19911 .
4) The interval between primary in f e ction of HPV and t h e
app earance of cer v i ca l can ce r i s usually s everal decades. I n
addition , only a small percentage o f women with clinically
appa r ent HP V infec tion will eventuall y develop cer vical
carcinoma, suggesting t hat HPV i s n e c ess a r y but no t sUfficient
for malignant p rogression l zur Hausen, 1994 1 Ponten et a l .,
1995 ) .
1 .3 .2 .2 In d t r o evide nce
Most of t h e ev idenc e f or the r ole of HPV in t he
oncogenesi s o f ce rv i c al cancer comes f rom the in vi tro
s t ud i es , wh i ch are sumrnar1t. e d i n the fo llowing :
1) Transfect i on with the high ri s k HPVs, such as HPV1 6
and HPV1S , or t hei r transformi ng qen es , E6 and E7, can
i ni t ia t e i mmortalization o f ectocervical and endocer vi cal
ce ll s (Pi ris i et a1., 1987 ; Woodworth et a1., 1988; Tsut s urn i
et a L. , 1 9 921. The £6 and £7 ORF s of HPV16 and HPVl a are
su f fi cien t t o immortalize c e r vi c al ce l l s i n vitro IHawl e y -
Nel son e t a1. , 1989; Kaur et al . , 198 9, Ts utsumi et a l. ,
1992 ). The E7 gene of HPV16 an d HPV18, when pla ced u nder the
co n trol o f a s t rong p ro mot e r, can i mmorta lize human c ervi c a l
ep ithelia l cell s with lo w eff i cienc y (Halber t et a l. , 1991 ) ;
the E6 ge ne of HPV a lone c a n no t immor talize human c er vi c al
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cells , but can enh ance t he efficiency of illllllortalization b y
t he 81 gen e (Ha l ber t e t al., 1991) or immortalize human
mamma ry epi t he lia I cells (Ba n d et a l ., 1990) . Other genes of
HPV, su ch a s El , E2, Eol, E5 , can n ot immortalize cervical
cells (pi ri s i et aI. , 1 987) . However , disruption of El or 82
can enhance the immortalization capacity of t he HPV genome
(Durst et a l. , 19 81 ; Munger et al. , 1 989; Sang et al. , 1992 ) .
2 ) The E6 an d E7 oncoproteins o f HPVs are responsible for
the immort alization of ge nital cells by HPVs , s ince continued
expression of the E6 and E7 i s nec essary for t he infin i te
pro liferati on o f cerv i ca l carcinoma ce l l s (Munger et a L . •
1989a; Mansur and Androply, 1 993) .
3) The i mmor t ali ze d cel l s usua l l y co ntain i nt eg r a t ed HPV
DNA, express vi r al transcripts, are defect ive i n the ir abili ty
to termin a lly differentiate and resemble moderate or hi gh
grade eIN (Woodworth et aL, , 1990; sun et al , , 1992).
4 ) Th e E7 prot e i n from high r i sk HPVs can bin d to t he
tumor suppressor gene, Rb (Dyson e t al ., 198 9 ) , a n d t he E6
protein c an bind to p53 and accelerate i t s degradat ion
(We r ness et aI. , 1989; Munger et al., 198 9b; Sc heffner et al .,
1990 ) . Inactivation of t he t umor suppressor genes, Rb and p 5 3 ,
by HPV is necess ary bu t not sufficient fo r the i mmor t a li zatio n
and tumorigenici ty of p r imar y cervical cells in vitro (Chen et
al , , 1993; Jewe rs et a l . , 1 9 92). P 5 3 is usu a l ly wi l d -type in
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HPV-positive cervica l carcinoma ce ll l ines and mu t at ed in HPV-
neg a t iv e c e rvical carcinoma cell lines (Pa r k et a1. , 1 9941.
51 Although i n vitro E6-E7 - immortalized cervical ce lls
nonmalignant i n nu de mi ce (Hawl e y - Ne lson e t al . , 1989,
Watanab1e et al . , 1989), additional trans tection wi t h the v-
us oncogene or wi t h He rp es Simplex virus can con ver t them t o
tumo rigenic cells (Durs t at a L ; , 1990; DiPaol o et aI., 1987,
199 0, 1994 ) . Furthermore, co -trans tection o f HPV 16 a nd 18
with an oncogene, such as c- myc or H-ras, c an trans form rodent
cells and p rimar y human f ibrob l as t s and ker atinocytes i n vitro
IDi Pao10 e t a I. , 1989; Durst et a L, , 1990; PeI , 19931,
suggesting HFVs may cooperate wi th on cogenes in t he
onc ogenes i s of cancer .
1.3 .3 Ch romosome abno rmali ties a s cause o r ce rvical canceee
cy t og e ne t ic aM l ysis o f c e r v i c a l tumors h a s sh own th a t
ch romos ome s 1, 3, 11, and 17 ar e o f t en abnormal l: e ys sier ,
1999) , and that t ra nsformat ion i s a s sociated with non-random
abnormalities o f chromosomes I, 11, 19 , and 2 0 (Di Pa olo et
aI. , 1993). I n addition , aneuplo i dy is otten obs e r ved in HPV-
i mmor t alized cells (Smith an d Peri ra -S mith, 199 0) . Recent
s tudi es i ndic at e that E1, but not E6, 1s respon sible f or t he
chromosomal instabi lities i n HPV- po s i t i ve ce lls (Hash ida an d
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raeumctc, 1991 ) . Thus , ch r omosoma l loss , duplication, o r
re arrange ment mi ght lead to in activat ion o f some tumor
suppressor genes s uch as p53 , DeC or ac t ivation of c e ll ula r
oncogenes such c-syc , which su ggests a ro le of
abno rmalities i n the mechanism of onco genes is of cervical
ca ncers (referred t o Section 1. 1. 4 ) .
1.3.4 Ce11ular genes i nvolved in multistagQ on cogenesi!l of
ce rvical cells
1. 3 . 4 . 1 Cellular gen e s ragulat ed by HW e
As we know f rom Table 4, the HPV E6 and E7 pro duc ts are
zinc bi n d i ng p roteins, i mp lying that they may modul a t e
cel lu lar g e ne express ion by binding to t heir promoter regl ons .
In add i tion, t h e E6 an d E7 proteins a lso co ntain p eot ei n-
protein b i n ding a nd t ransact lvating domain s, wh i ch may be also
ve ry impo rtant r oz t he transforming act i v ity of HPVs.
The amino t ermi n al half o f the E7 protein contai ns
reg ions o f similarity with the t r ansforming prot e i n s of the
DNA tumo r vi rus e s , a denovi rus Ela and SV4 0 large T an tige n ,
implying t hat these p r oteins may act b y a common mechan i sm
(Ph e lps e t a1. , 1986) . As e xpected , prev i o us i n vitro stud ies
demonstrated tha t al l t he t hree p r ot eins ca n rorm a comp l e x
wi t h a t umor su p pressor gen e produc t , Rb , which is a nega t i v e
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regula tor of c e ll g row th (Munger et a L, , 19 92) . Since pRb
i nduces G1 growth i nh i b i tio n by binding and inactivating the
t r e ns c - s oc icn factor , E2F, b i nd i n g of E7 to t he
h yp op ho sphor yl a t e d form of Rb results in t he r ele a s e of E2F
from pRb. This permits t he ac tiva tion by E2F of oncogenes such
as c -myc , c-fos, or B-myb, and cons equently the p ro gression of
t h e cell into S phase o f the c e ll c yc l e (Sch e Uner e t a L, ,
199 4) . In ad dition, E7 has been sho wn to i nte r act wi th other
cellular p r ot e i ns , such as p l07, p130 , h i s ton e H1 kinase ,
p33 "IOl, cycl in A and B- myb ITornma s i no et a L, , 1993 ; Ar r oyo et
al ., 1993 ; Dav i e s et a1. , 19~3 ; Lam e t a L. , 1994) . The
ac tivation, such as f or B-myb, or inactivation, such a s for
Rb, of these proteins by t he E7 protein must play an importan t
r ole i n the oncoge nesis o f cervical cells .
Unlike E7, E6 does not display sequence similarity wi th
the transto r mi ng proteins o f other DNA tumor viruses . However,
a c l e a r func tional similarity is found in that HPV E6,
adenovirus E1b and SV40 l a r ge T ant igen a l l target another
tum or suppressor gene protein, p53 (Munge r et a L, , 1992 ) .
Interaction o f t he HPV E6 prote i n with p53 through a c e llu l ar
protein, E6-AP , results in the r apid degradation of the p53
p r o t ein (Scheffner et a 1. , 1990 ; HUiBregtse et al . , 1991 ) ,
ab ro gation of the transact!vating a ct!vi t y o f p53 (Le ch ne r et
a L, , 1992) and loss of t he p 53-med i a t e d cellula r r e spons e to
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DNA damage (Kessis e t a l ., 1993; Hickman et a L. , 1994), which
are r e spons i b l e for the subsequent accumulation of ge netic
changes aseoc t ated with cervical tumorigenesis. Furthermo re ,
E6 has recently been shown to interact with at least seven
other cellular proteins, designated pp212, pp182 , pl OO, pSI,
p15 , p53 and p33 (Keen et a L, , 1994) . The ro le of t he
interaction of E6 with these proteins ne eds to be f ur t he r
characterized .
In addition, cellular genes that are up - or down-
regulated by p53, such a s Rb and pl01, may be a lso important
in the etiology of cervical cancer. However , the roles of
these gene products in the oncogenesis of cervical cancer have
not been well characterized.
1 . 3 . 4 .2 Ce l l ular gonos regulating HPV express i on
From the abo v e discussion, it can be concluded that the
exp ression of HPV plays a central role in t he oncogenesis of
HPV-associated c ervical carcinoma . Therefore, i t is of
particular i nterest to understand the r e gu l a t or y mech an i s m
resulting in the activation of HPVoncogene exp r e s s i on in t his
carcLnoqenes i e process .
The 500 -1000 bp LCR of IIPVs is known t o fun c tio n
transcriptional r egu l a t o r y e lement in a lmost all the HPV-
containing cells . I t is the major determinant o f the
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differential i mmo r t a liz a t i on activities of some HPVs such as
HPV16 and HPVla tacne nceuk et aI., 1991). Pr ev i ous studies
indicated t hat, in addition to t h e binding of E1 and E2 to
t he LCR, cellular proteins a r e the main f ac tors that
participate in the transcriptional cont ro l of HPV oncogene
expression (zur Hausen, 1994) . A numbe r of cellular
transcription factors have been identified that bind to t he
LCR r eg ions of HPVl 6 (API, Nfl , oct-f , TEF- 1, Spl , a nd GR) and
asvia (API, Nfl , Oct -I, KRF-l, Spl, GR, YY1) (For review see
Hoppe -Seyler and But z , 199 4) . The binding of these
transcri ption f actors can either activate (e .g . API , NFl , and
GR) or repress (e.g. Oct - l and YY1), the transcrip tion of
HPVs. I n ad d ition, other proteins. such as nuclea r factor for
i n te r l eu ki n 6 express ion (NF- IL6 ) and TGF- 13 I, have also been
shown to su ppress HPV expression (Bran et OIL , 1990 , 1992 ; Kyo
et a L, , 1993) . The regulation of HPV by these factors will be
discussed further in s ection 1.3. I.
Several observations have indicated the po s s ib l e ro le of
deregu l ation of the HPV LCR in t he carcinogenesis of primary
cervica l cells. For ex amp l e , Ma y et OIL (1994) f ound that
deletions or mutations in the HPVl6 promoter r egion r esulted
i n the loss of a YY1 bind i ng site in so me cervical tumors
containing ep i somal HPV DNA. Chloramph e nicol acetyl
t r ans f e r a s e (CAT) assa ys on the promoter activity o f HPV16 in
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cervical cancer-derived HT3, Si Ha and CaSH cells s howed that
the CAT ac tivity i ncreased 5- to 6-fold under the co ntrol of
t his partially mutated or deleted LCR. Since YY1 was shown to
serve as a negative regulator of HPV expression , deletions or
mutations within HPV promoter may alter the regulation o f £6
and E7 expression , allowing escape from the repression by YYl.
Loss of so me parts of ch r omo some 11 have been reported in
several c ervical ca rcinomas (Te ys sler , 1989). In addition, it
h a s been shown by several researchers t hat transfer of
chromosome 11 i nt o cervica l carcinoma cell lines can suppress
t h e i r t umorigenicity (Se x on et a L, , 1986) , i nd icating that a
s uppressor gene may exis t on chromosome 11 . The inactivation
of this gene might cause c e rv i c a l ca nce r. The tumor sup presso r
gene was proposed to act through the inhibit ion of HPV
expression by binding the LCR (Sche gge t and van der xc o r c ea ,
1994 ) •
1.3 .4 .3 Cellular ge nGS n ot interacting with UP\'
From the above discussion, i t seems t hat HPV has become
t he mos t impo rtant facto r in the etiology o f cervical ca ncer.
However, the long latency between HPV i nfection and tumor
emergence (zur Ha us en , 1991), non-malignant characteristics of
HPV-immortali zed cells (Hawley- Nelson et a l ., 1989), and the
exis tence of cell lines derived f ro m cervical ca rc i nomas
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(C33A, H3T) or cervical carcinoma specimens devoid of HPV
(Park. et al., 1994), all suggest that HPV is not sufficient
for the full transformation of primary cervical cells and that
deregulation of cellular genes other than HPV may be also
involved in the multistage carcinogenesis of cervical cells.
One cellular gene that is not related to HPV is a tumor
suppressor gene DeC. The DCC gene product i s a c e ll surface
protein which may be responsible for cell-cell communication
(Gao et al ., 1993). The inaction of DeC by mutations or
de ltions has been reported t o be responsible for several human
cancers inclUding colon, breast and lung cancer (Gao et al . ,
1993 ; Thompson et a1., 1993 ). Cytogenetic analysis of the HPV-
IS-imm ortalized keratinocyte cells exposed to nitrosometh1urea
(NMU) detected a deletion of part of the long arm of
chromosome IS, which harbors DeC. Further analysis indicated
that the expression of DeC in NMU-transformed cells was
greatly decreased (Klingelhuz et a L, , 1993 ), indicating that
i na c t i va tio n of DeC expression may be important in the NMU-
induced carcinogenesis . However, the role of Dee in the
oncogenesis of primary cervical cell has not been clearly
identified.
By checking 22 protooncogenes for amplification in 50
primary, untreated squamous cell carcinomas of uterine cervix,
Mitra et a L, (1994) observed that amplification of erbB2
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(HER2!n eu l was f ound in 14% o f t he c ases. In addition , 2
t umor s with er bB2 amplification s ho wed a dditiona l r estriction
fragments, su ggesting t hat the amplification o f erbB2 may play
an i mpo r t an t role i n tumor igenesis .
In addit ion, deregulation of several other gene products ,
s uch a s the proliferation cell nuc lea r a nt igen (pe NAl,
fibronectin , i n t eg rin and the TGF-a. receptor , in immortalized
ce lls has also been repor ted (Ll et a l. , 1992; Hodivala e t
aI. , 19 94 ; Kar a ki t s os et a L, , 1994; Noda et a1. , 1994; Shin at
a l. , 1 994). Studying t he regu la tion of t he s e ce l l u l ar gene s ,
eapec.ia Ll y i n HpV- negat i ve cells , wil l be very helpful f o r us
to fully understand the multi stage oncogenesis of c e r vi c a l
1 . 3 . 5 Role of co-factors i n multistage carcinogenesis of
cervical cells in vi vo and in vitro
Several co -factors have been i den t i f i ed by
epidemiological and molecular b iological ap proaches .
1 . 3 . 5. 1. Hormones
Pr e vi ous epidemiologica l s t ud i es i nd ica t ed that chronic
o f ore I contracept i ve pills whlch contain steroid
ho r mon e s is an importan t risk f ac t or for the d evelopment of
c e r v ica l cancers IHllde s he i rn et al . , 199 0 ) . In experimental
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s t ud ies, t he ste ro i d hormones , dexamethasone and proges teron e ,
ha ve been sh own to be es sential f o r t he expression o f HPV16 i n
primary cervical cells IMitt a l et a1. ,1993) . Most i mpor tantly ,
thes e ho rmon es have a lso been s ho wn t o en ha nce the express i on
o f HPV16 from t hr e e GREs of t he enhancer a nd t o e nha nce the
i mmortali zation and trans fo rma tion ef f i ciencies of h igh r i s k
HPVs (Pater et a l ., 19 BB; Cr ook e t al . , 19BB: Pater et a L, ,
199 0 ; Pa t er e t a L, , 19 94; Mittal et a L, , 19 93 ) . Thu s,
co oper a tion of HPV and hormon es may plays an important ro l e in
t he onc o genesis o f primary cerv i c a l c e lls .
1 .3 .5 . 2 Other i nfectious a gen t s
Va r ious sexually transmit t e d age nts , i ncluding herpes
simplex v irus (HSV) , c ytome ga l ovirus (CMV) and HIV ha ve been
r e garde d a s t he co -factor s i n c e rvical cancer (Herri ngton ,
199 5 ) . Recent ex perimenta l s tudies i nd icate tha t HSV 6 not
onl y i nfected genital epith e lial ce lls, but a lso up regulated
t he expression o f HPV (DiPao l o e t a I, 1994), and t r an sformed
HPV- inunor talized human genital ce lls into tum ors (DiPaolo et
a I , 199 0 ), sugges t i n g t hat HSV has a potential r o le i n the
tum origene sis o f cervica l cells . Several repor ts also s ho w
that squamous Intraepithelial l e s i ons o f t he cervix
progressed more rapidly i nto cervical cancers i n HIV-infected
women (Ma i man et a 1., 1990 ) , suggesting t ha t HIV may ac t
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co-factor and promote the malignant progression o f ce rvica l
Ies I one , Further i n vi ere studies a lso indicate that t he HIV-l
regulatory pro tei n, ta t, i n combi na tion with the E2 p r otein o f
HPV16, can t r a ns act i vate t he HPV 16 P97 promoter in c e r v i c a l
ca r c i noma cells. tat c an a l s o r everse E2- med i a t e d repression
o f t he HPV16 prom oter (Ver no n et a l., 1993) .
1 . 3 . 5 . 3 Immune response
In i mmunoc ompe t e nt i ndi vi du a l s the cell -mediated inunune
response influences the pe rsistence or regression of HPV
inf e ctions . When HPVs infect t he cells, the host usually
infil trates the lesions with i n flamma t o ry cells, including
macrophages, cytotoxic T- l ympho c yt e s , and na tu ral killer
cells . The se cells can secrete a variety o f regulators known
as cytok ines an d l yrnpho ki n e s , including TN'F a and p, TGF-p,
interleukin (IL l 1 , 2, 3, 4, 5, 6, 7 and B a nd i nte r f e r on
(I N'F) ex, p and y, which can repress the growth o f HPV-in fe c ted
cells and HPV express ion. The refore , t he i n fil t r at i on o f
macr ophages, T-lymphocy tes , and natu r a l killer cells is often
obs e r v e d t o be f o llowed b y regres s ion of HPV infe c t ion
(Fierlbe ck et a L, , 19891. However , a d isorder o f the immune
response should lead t o pe r s i ste n c e o r progress ion of vira l
Infect.L o n , Therefore , depres sion of immune response has been
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regarded as a co -factor for the oncogenesis o f cervical cells.
Se v e r al in vivo an d i n vitro experiments have been
ca r r i e d out to understand t h e ro l e of the immune r es po ns e in
t he carc inogenes is o f cervical cancer.
Se ve ra l in vivo s t udies de monstrated an as s ctatLon
betwee n i mpa i red i mmune function and the de ve lopment o f
cervical c an cers. Firstly, p a tie nt s with histologically proven
i nvasiv e squamous c e l l carcinoma of the c e r vix h ave becn
obs e rved to have i nunune defec ts characterized by a decrease i n
T cel l numbers and CD4+ helper cells , and impaired fu nction of
Lang e r ha ns ' s cells , compared with healthy controls (Ca s tello
et al . , 1986) . Secondly, women who have be en immunosuppresscd
and have HPV i n f ection have be e n ob s er ved to develop i n vas ive
ce r vica l c a nc e r rapidl y (Si l l man et al . , 1984) . Thi rdly, t he
i ncidenc e of i nvas i ve cervical can cer increases with advancing
age , i nd i c a t i ng t ha t immune s e nesce nce , which i ncr e a s e s with
age may c on t ribute to this ca ncer (Mand e l b l at t , 1993 ) .
Finally , women who are i nfec ted by both HIV and HPV ha ve a
markedly increased incidence of cervical cancer . Women with
con c urrent HPV an d HIV i nfect i o n are 42 time s more likely to
have e I N than women without either virus (Fe i ngol d et a l , ,
1990 ) .
The fo llowing in vi t r o e>:periments studied mainly the
basic me c ha n i sm under lying t he immune response t o vira l
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infection u sing molecular biological approaches. Firstly, it
has been show n that TNF-a: , TGF- [J, I L- l and IFN-y can r ep re s s
HPV ex pression at the transcriptional l evel in HPV-
immortalized cells (Woodwor t h et a L. , 1992 ; Bra un et a l. ,
1990; Kyo et al., 1994). However , i n some tumor cell lines ,
i nsensitivity to TNF-a and TGF- ~l has also been observed
(Braun et al., 1990 , 1992; Rosl et a L, , 1994) , indicating th at
escape f rom t h e i mmune response may be a mecha nism for the
tumorigenesis of cervical ce l ls . Secondly, cocu1tivation
experiments with activated macrophages r e vea l ed that
nonmalignant f i b r ob l a s t - He l a hybrid cells re s pon d to
macrophages by suppressing HPV gene exp ress ion . Howeve r , this
r e sp ons e was not de tectable in malignant f ib roblast -Hela
cells, indicating that the c rucial s tep in malignant
conversion involved a disruption of an immune response pathway
that no rmal ly suppresses HPV transcript ion i n immortalized
cells(Rosl et al. , 1994) . Thirdly, reduced exp r ession of c lass
MHC class I genes in HPV16-positive cervical c arcinoma cell
lines was observed (Cronune et e i , 1993) , i ndicating that
insufficient presentation of antigenic domai ns of viral
oncoproteins due to diminished expression of MHC class I
molecules may be a cause for malignant progr e s s i on in vi vc ,
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1 .3 .6 Tobacco smoke a nd ce rvi ca l c ancer
Ep i d emi o l ogi c al investigations and animal studies over
the past several de cades have c learly delin e at ed that tobacco ,
particularly cigarette smoking, is one of the major cause o f
human ca ncers including lung , oral cavity, pharynx, larynx,
e s opha gus , urinary bladder, renal pelvis an d pa nc reas (IARe ,
1986) . Th e mos t i mpor t an t of these is l ung cancer.
Experimenta l studies have shown that toba cco smoke co n ta ins
more than 6000 chemicals which include toxic agents, such as
nicotine , ammon i a, formic acid and carbon mon ox ide;
carc i nogens, such as benzene, benzo [a )pyren e , N-n itroso
compounds , f or ma l dehyd e , 2- n i t r op r opa ne and vinyl ch loride ;
and twno r promoter agents, su ch as phe nol. The role of some o f
these carcinogens in the carcinogenes is have been c learly
demon st r ated (for r ev i ew see Hoffmann and wynd e r , 1986 ) .
An a s s ociat i on be t ween c igarette smoking and cervica l
canc e r was f irs t noted i n 196£ (Na guib et al. , 196 6) . In 1977,
a speci fic hyp o t hes i s regarding t h e c ausi t ive role o f
ciga ret te smoking in cervical p roposed
(W inkelstein , 1977) . Since then , i nc r easing epidemiological
inves t igat ions h av e b een car ri ed ou t. The e v i den c e that
s upp orts the hyp o t hesis is as f o l l ows : 1 ) The r elat i v e risk
fo r the de ve l opment of invasive cervical c an ce r i s h i ghe r i n
cigare t t e -sm ok ers t ha n in non - s moker s . Wit h an i ncreas e in the
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number or ci ga r e tte s smoke d per day b y smokers, the r e l a ti ve
r isk fa c tor a lso increased (Brint on , 1990 ) . 2 ) Accumulation o f
tobacco metabolites in cervica l fluids has be e n obse rved in
c i gar et t e smokers (Sasson et a1. , 1995 ; McCann et a L, , 1992) .
3 1 Some chemicals c ontained in c igarette smoke , s uch as
b en ac le l py rene an d NMU, have been shown to cause malignant
transfor mation o f human HPV-immorta li zed keratinocytes cells
from the foreskin and mouth (Li e t al . , 1992 ; Garrett e t a L. ,
1993 ; Klingelhutz et a1., 1993 ) . However , t he re a re some
r esults t ha t a rgue against the role of c i ga rette smoking i n
cervical cancer : 1) No association be tween smok ing and
cervical found by Layde( 1999) . 2 ) Some o t he r
fac t ors , su ch as the number of sexual partners , which may a l so
contribute to cervical cance r, c a n confound the statistics of
the assoc iat ion between cigarette smok i ng and cervica l cancer
(El u f - Ne t o , 1994; Ph i lips an d Smith, 1994) . 3) There is no
d irect evidence which proves that c igarette smok e causes
cerv ica l cancer a s demonstra t e d for o t he r cancers (Masui et
a l . , 1986 ). Therefore, the r ol e of c i ga r et t e smoking i n the
carcinogenesis o f ce rvica l cancer is undete r mined . Further in
vitro exper iments are r e quired be fore maki n g conc l usions .
1.4 Objective oC this study
Fr om the above discussion, it can be concluded that HPV
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an d s ome co - fac t ors a re ve ry i mpo r t an t i n the mul ti s t ep
ca rci nogene s i s of ce rvic a l cells . Howeve r, t he r e a r e few i n
vi r r c systems that de monstrate t he mul t istage n a t ure o t the
developmen t o f c ance r . I n addi t ion , t he mecha nism underlyi nQ
the co oper a tive and sequential role of HPV a nd co - facto r s in
t he onc oge ne sis o f ce r vica l i s s till poo r l y under stood .
Unde r s t an d i ng t he co mp l ex i nte r ac tion be t ween h os t cells and
HPV i s critically esse nt i a l i n cervical c anc e r research .
The obj ec tive s o f my s t ud y were t o fu r ther the
underst a nding ot t he molecul ar mecha ni sm o f the cooperation o f
HPV a nd cigarette smoking in t he onc ogen e s i s o f ce rvi ca l
cells . For t his purpos e, I fi rs t e s tablish ed an i n vitro
s ystem, i n which pri mar y human endocervica l c e l ls (HEN) were
immor t a lized by HPV and subsequent ly t ransformed i nto tumo rs
by treating the immortali zed c e l ls wi th esc, t o mimic the
mult i s t ag e onc o genes i s o f cer vi ca l cells in vi vo. Th en, the
IlIOr pho logy , g r owt h ch a racte ristics , vi r a l an d cellu la r gen e s
exp r ession , and r es p ons e to c yto ki nes o r re tinoic ac i d (RA)
were stUdied i n pr ima ry cells an d ilMlor t a l i zed a nd esc-
transformed t umor c e ll lines. I n a ddit i on , a ne w me thod ca lled
mRNA differential di splay was empl oyed t o identify novel ge nes





KGM and DMEM were purchas ed f r om GIBr,O -BRL and l eN
respectively . GIECO- BRL was the supplier f or feta l calf serum
(FCS) , goat serum and trypsin-ethylenediamine tetraacet1c acid
(tr yP sln - EDTAI. Penicillin-strept omycin and Collagen t yp e I
were obtained from leN and Collaborative Biomedica l Produc ts ,
respectively. Primary endocervical tissues for preparation o f
endocervical cells were kindly prov ided by Dr . M. Para! of the
Grace Hospital, St. Jo hn ' s , Newfoundland. HEN- 16 and HEN- 16- 2
were established by Dr . K. 'rs ueumi . Ca Ski and SiHa c e ll lines
ha ve been cultured in this lab .
Restriction endonuclease were ordered from GIBCO-BRL wi t h
their respective lOX reaction buffers . Superscript reverse
transcriptase with lOX buffer and 0.1 M OTT was also purchased
from GIBCO-BRL. Pr omega was the supplier of T4 kinase , Taq
polymerase and rRNasin ribonuclease i nh i bi t or. DNase I (RNase
free l was obtained from Boehringer Mannhe im.
a [31PjdCTP , y[ 32P1ATP, and a jl 5S IdATP were purchased from
Amersham . Ni ck columns obtained from Phe rmac La
Biotechnology . GIBCO-BRL was the supplier for Random Primer
DNA Labelling System and BioNiek Labelling Sys tem.
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GIBCO-BRL supplied TGF-p l and all the markers . i nclud i ng
th e 1 kb an d 100 bp DNA ladders and the 0 . 24,,:, 9 .5 kb RNA
l a d de r , while Sigma Ch e mi ca l Co. supplied TNF- a and RA. Low
me lting point aga rose , aqarose, acrylamide, N, N l -
methy1enebisacrylamid, urea, 10 roM dNTP (dGTP, dATP, dTTP and
dCTP j and dextran were all purchased from GIBCO-BRL . Baker
Inc , Bio-Rad, Carnation, and Pharmacia were t h e suppliers of
2- mercaptoethanol , N, N, N', N ' -te t r a - me t h y l e t h y 1en e d iami n e
(TEME:Dl , skim milk powde r , and dextran sulphate , respectively.
Wiza rd PCR Preps DNA Puri fi cation Sys tem and t he f - mo l
DNA Sequencing System were purchased from Pxorneqa , GIBCO-BRL,
Invitrogen, Pharmacia Biotechnology, and Uni ted States
Bi o c hemical Co . supplied the In Si t u Hybridization and
D-etection System, TA Cloning Kit ve r s i on 2 .0, QuickPrep mRNA
Pu r ific a tion Kit, an d Sequenase Vers ion 2 .0 Sequencing Ki t ,
respec t i ve ly.
HPV16 DNA was kind gi ft from Dr. H. zu r Hausen . JE /MCP-l
plasmid was pu rchased from American Type Culture Collection
(ATCC). Plasmids for B- myb, fibronectin, GADD45 and GADDI53 ,
p53 , and Wafl/Cip l were kindly p rovided by Drs . A. Sala
(Thomas J efferson University, USA), J .R. Smith (Na tion a l
Cance r I n s t itu t e , USA), J. Fornace , Jr. (National Cancer
Institute, USA), S . Benchimol (Ont a r i o Cance r Ins titute,
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Canada) , and W. Har per (Ba yl or Colle ge of Med i c ine , USA),
r espectively . Pr olife ra t ing ce ll nuclear ant igen (PCNAI 4 0- mer
probe was pu r chased from Oncogene Scien ces. All other
synthetic oligon ucleotides used fo r p rimers and p robes
ordered f ro m Gen era l Synthesis and Diagnostic , 'ro rc-ro , DAKO
Co ., Gibco BRL, and J ackson Irnmunor es ea r ch Lab , I nc. were th e
suppliers of PCNA monoclonal mouse antibody jPCIO) , anti - human
fibronecti n , mAb (Clone I ), and goat a nt i -mouse IgG,
fluorescein isothiocynate (FI TC) - conj uga t e, respectively . CSC
was a kind gift of Dr . M. H. Bill i moria of I mpe r i a l Tobacco
Limi ted, Cana da.
BioTrace HP membra ne for Northern and Sou thern blots and
NA45 DEAE membran es were obtained f ro m Gelman Scienc es and
Schleicher & Schue ll, r e sp ec tive l y. Koda k wa s the supplier of
X- ray fi lm . Eight - well tissue c ulture c hambe r s lides , 35 nun ,
60 rnm a nd 100 nun tissue culture pl ates and 0. 5 ml eppencor r
micro test tube for peR were ob tained froll'. NUNC and Fi s he r,
respective l y .
The I s ot emp Vacuum OVen Model 28 1 and I n cubato r Mod e l 60
wer e pu r ch ased from Fishe r and Pre cis i on scientific,
r e spec t ively . Ph.armaci a LKB Biotechnolo gy wa s t he s upplie r of
Ultraspectrophotometer II and Ultros can XL Laser De nsitomete r .
The Labo rl ux fluorescenc e microscope wa s pu rchased from Lei tz
I n c, Germany . Bio/CAN scientific was the s upp lier of t he
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Hybraid Thermal Reactor for peR.
2 .2 CQl l,::ul t ure
Primary and HPV16 -immortalized endocervical cells we r e
maintained in serum-free KGM medium containing 1%
penicil lin/streptomycin. However, csc-t xeatec tumor cells an d
es tablished cervical carcinoma cell l i nes (CaSki a nd SiHa l
were rou tinely cultured in DME medium cont aining 10% FCS, 1%
penicillin/streptomycin , and 0.4 J,.lg / ml hydrocortisone.
Fibroblast cells used for raft fo rmation were mainta ined in E
med ium co ntaining 10 % FCS and U penicillin/streptomycin .
2 .2 . 1 Monolayer cuI ture
Al l the cells were maintai ned at 37 -c in an incubator
containing 5% COp For DNA and RNA extraction pu rposes, the
cells we r e us ually cultured in 100 nun tissue culture plates .
For th e purpose of growth measurement, the cells were cultured
i n 60 mrn plates. Whe n the cells reached confluency , the medium
was as p i r a t e d f rom the pIa tes a nd the cells were washed with
PBS. Then 2 ml of t r yps i n - EDTA was added i nto each plate,
which was le f t in the 37 °c incubator for 15 mi nut e s . For the
c e lls cultu r e d i n KGM, 8 ml, o f PBS co nta ining 10% rcs was
a dded t o t h e trypsinized cells to quench t he activity of
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trypsin. The cells were then suspended and centrifuged at
1,000 rpm for 10 minutes . The pe llet of cells was then
re suspended with KGM, dispensed into new plates at the ratios
of 1: :.0, 1:4 and 1:2. For the cells cultured in DMEM
containing 10% Fes, 8 ro1 of DMEM was added directly into the
trypsinized cells, which was further suspended in medium and
dispensed into new plates . The cells were usually maintained
at 37 DC by passage every three days or when the plates were
confluent .
For in situ hybridization and indirect immunofluorescence
experiments , the cells wer e usually cultured in 8 well tissue
culture chancer slides . When they reached 7 0~ con fluency, the
chamber frame was release from the slides, the c e l l s were
briefly washed with PBS and the slides were processed
differently depending on the purpose of expe riments.
2. 2.20rga notyp ic ( ra ft) cu lture
The procedure of organotypic raft culture was basically
accord ing to Meyers et a1. 11992} and 15 clearly illustrated
in Figure 5 .
The cervical cells and 3T3 J2 fibroblast cells were
cultured before starting the raft culture . Usually, for each
raft , 3 X 10~ fibroblast cells and 3 X 10 <' cervical cells were
required. When the fibroblas t cells were ready, the raft gel
50
Figure S. o rg&D.otypic (raf t ) c ulture sys tea. See description





wa s made by mixi n g the f ibroblast cells wi th collagen lIix
contai n i ng type I colla g en, reconstruct i on buffer (2 68 mM
Na HCO]. 200 mM HEPE S and 5 0 IItf Na OH!. and l OX E med i um ( 8 : 1 :1;
votcae sv ct ume rvct ume t , di s p ensin g 3 ml of collagen /fib robl ast
mix in t o ea c h 35 mrn pl at e . and leaving t he p l ates a t 37 °c to
s o lidfy for 30 -6 0 min utes . Subs equ en t ly , 2 rnl of E media was
added i nto each pla tes . The plates wer e kept i n 3 1 OC
incuba tor ro r ove r 2 days to r egai n th e morpho logy o f the
fib rob last cells. When the cervical cells we re r e a dy, 3 X l OS
t r yps i nized coIls wer e seeded i nt o eac h p la t e conta ining
collagen /fibroblas t gel raft. After t he cel ls attached to th e
gel in 4 hrs t o cv emtcnc , the media was replaced with fresh
E medi a . The r afts were raised o nto stai nl e ss s t e e l grids and
a llowed to g r ow at th e air- liqui d interface fo r 1 2- 14 da ys ,
d u ring whi ch th e medi um was changed every t wo days . The
c ulture was t hen fixed i n 4 \ pa r a form a ldehyde and e mbedd ed i n
paraffin for fu r t h er ana l ys is.
2. 3 Tumorigene8is ot HPV16· immo rtalized celb by esc
2 .3 .1 T r eatme nt of HPV16 - i rnmor t al1 ze d cells with e sc
HEN- 16 and HEN-16-2 mainta ined i n KG!'! medi um were first
adapt e d to grow i n DMEM. Then , at each passage, th ey
cultu r ed either in normal mE medium or DME medium containin g
75 , 100 or 1 25 J.1g / ml esc, respectively. One day l at e r . th e
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csc-ccntetn r ne medium was rep l a ced by fresh normal I»lE medi um. .
The cells were not t reated with esc again un t il t h e next
passage. The tumorigen icity was checked in nude mice every two
months.
2 .3 .2 In vivo t umorige ni city ass ay
Afte r ever y two months of esc t reatment , the cells were
trypsinized and resuspended in IX PBS. Fo r each cell lines , I
X 10 7 csc -euntrea ted, cac-tree ted, and SiHa cells in 0.1 ml
in j ected into each of 2 2-J-month-old female
immunocomp rimised nude mice , and the tumor incidence was
monitored weekl y for 4-8 weeks. Upon tumor formation, the size
of t he tumors was measured, t he mice were sacrificed, and the
tumo rs wer e excised. The tumors were placed in KBM containing
25 mg/ml fungizone and 50 IoU. penicillin and streptomycin for
20 minutes with one change in 10 mnu'tes . The tumors were
subsequently cut into two half : one h a lf wa s fi xed in 4 ~
para f ormald ehyd e and used for pathologic:al analysis ; another
half was dissected into pieces , t rypslnized at J7 °c for 20
min, centrifuged, and then cultured in [;'MEM medium a t 37°C .
2 . 3 .3 Pa t hol ogica l a nalysis
The fixed t umors were embedded in paraffin , sectioned in
a microtome, a nd stained wi t h hematoxylin an d eosin (Sun et
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al., 1992 ) . Th e stained sect ions wer e examined by ligbt
mic r oscopy unde r l OOX and 400X magnificat ion fo r tumor
morphology and invasion . The selected sections showing tumor
morpho l ogy
documentation.
photographed wit h Kodak 'rmax 400 fi lm fo r
2.4 MS8surBJflent of g r owth rate and satura t ion densi t y of
cervi c al c alh
The exponentially growing pr ima ry , i mmor t al ized a nd CSC-
transformed cells we r e tryps inized, centrifuged, and
resus pende d i n 2 ml of medium . The cell n umber s were c ounted
with a hemo cytometer , and about 2 X 104 cells Were dispensed
i nt o ea ch of three 60 nun plates fo r each cell l i ne . The cel l
numbers we re counted every two day s for 8 days .
The saturation density of each cell l i nes wa s measur ed by
count ing the cell numbe r 5 days afte r th e cells reached
confluence .
2.5 Sof t a goar or anc hor agQ ind4pon dQnt growth a ssa ys
The O.7'/. agarose underlying g e l wa s pre pared b y addi ng
an e qual volume of 2X DMEM containing t wi c e the amount of OEM
components and 20% FCS i nto low melting point ag ar ose
dissolved 1n s terilized distilled wate r , disp ensing 2.5 rol
i nt o 60 nun plates , and leaving the p l at e s at room temperature
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un t il the gel solidified . subsequently, the i mmo r ta li z e d
(HEN- 16 and HEN - 16-2 ) , csc-rtre ns r o m ed (HEN- 1 6T and HEN- l6-
2T) , and pos itive contr o l Si Ha cells were t r-yp aI nLz e d ,
resuspended i n 2X DMEM, and count e d . Th e n, t h e O . 3 5~, aga ro se
ov erlaying ge l was prepared by mixi ng about 1 X 1 0 ~ ' cerv ica l
c e l ls in 1.2 5 ml of zx DMEM with 1.25 ml, o f aq ar ose in
s t e rilize d dis tille d water , pouring t h e ntxuur e into 60
p l ates c o ntai ning t h e O.7 ¥. ge l, t empering t h e pl ates at 4 vc
f o r 5 mi n utes , and incubat ing at 3 7 'c . One week later, DMEM
wa s carefully added onto the s u rface of the so f t aga r t o
p rovide n u trients . The co lony forma t ion was moni t o red e ve r y
t wo days for 2 -4 weeks. Ge neral ly, tr i plicate as says we r e
c a rried out fo r each ce l l line . Representative pho t ograph s
were t a k e n fo r docume nt at ion.
2.6 Labelling of probes
2 .6.1 Radi oacti ve " probes f or Northern and Southern blot
hybridi zation assays
Ra d loac t i ve eDNA probes were generally p repared us ing t he
Random Primer DNA Labelling System (GIBCO-BRL). Briefly, about
50 ng o f cDNA were i ncubated i n random pr ime r buffer 10 . 67 M
HEPES, 0 . 17 M Tris-HCI, 17 l'flM MgC1 2, 33 l'flM 2- me rc ap t oetha nol ,
1 .33 mg/ro l BBA, 18 OD2bO units/ml o l igodeox yribo n Ucl eo t ide
primers (hexa me rs) , pH6.8 J with 0 . 5 rnM eac h of dATP, dGTP,
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dTTP, 50 I..lCl of a[ llP JdCTP, and 3 uni ts of Kl enow fragment at
25 OC for 2 hrs . Th e mixtur e was pas s e d t hrough a NICK c o l umn
IPh armacia Biotechnology ) t o re move t h e unincor po rated
a ( l1 PJdCTP. The labelled probe wa s denatured at 100 °C fo r 5
minu t e s and i mmed iate ly used fo r hyb r i diza tion.
The ol iqonucleotides were usual l y l abel l ed by t he 5 ' - end
labelling method as des cribed by Sa rnbroo k et al. (198 9 ) . I n
brief , abou t 10 pmol of oligonucleotide probe was incubated in
kinase bu ffe r (0 . 1 M Tris-HCl , pH9 . 5 , 5 roM MgCl z ) with 10 rnM
OTT, 50 I..lCi of y[ ' lPIATP, and 1 unit of T4 po l ynucleotide
ki nase a t 37 OC. Th irt y minutes lat er , 4 vol umes of 0. 1 M EDTA
added to s to p the r e a ction. The unincorporated y[UPJATP
removed by et hanol p reei pi t aUon . Th e l a belled
oligonucleo t ide probes were used di r e ctly to r hyb ridi z a tion.
Gen e r a l ly, t he spe cific ac tiv ity fo r bot h eDNA and
01 igonucleotide p rcbee was usu all y mor e than 8 X 10' cpm/ l..lg
DNA. The probe ac tivity us ed f or hyb r idiza tion was usuall y 1- 4
X 10· cpm/ml hybrid ization buf f er .
2. 6 .2 Non-radioacti ve probes for in s i tu hybridizati on asuys
Th e Bi oNi e k Labell i ng Sys tem (GIBCQ-BRL) was us ed for
labell i ng non-rad ioact i ve probes f o r i n s i t u hyb r idization .
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Generally, 1 ","g of e DNAwa s incubated i n IX d NTP mix (Biotin-
7-dATP, dCTP, d GTP, dTTP) and I X e nzyme mi x. at 16°C for 1 he.
One tenth volume of stop solution was then added to stop the
react ion. Unincorporated nucleo tides were r emoved by ethanol
p recipitation twice . The biotinylated probes were usually Leas
than 500 bp in size and could be stored a t - 2 0 QC i n Tris -EDTA
(TE l buffer for at least one year. Gene r a ll y, 2.5 ng of
l abelled probe was u s ed f o r in situ hybridization .
2 .7 Protocol f or mRNA expression ass a ys
2. 7 .1 Preparation o f t otal RNA and mRNA
All the ma t eri a l s and reagents used in RNA work were
first treated with 1% diethyl p yrocarbona te (DEPC) . Total RNA
was prepared basically according to t he CsC I gradient
c entrifugation method described by Samb rook et al. (1989) with
minor modifica t ions . Brief ly, the cel ls cultu red in monolayer
were firs t was hed o nce wi th ice-cold I X PBS, lysed wit h lysis
solution , scra ped from the plates wit h rub ber po licemen, and
then removed from the plates wi t h a syringe . The DNA i n the
l ysed cells was subsequentl y sheared by pass ing qti Lckl y
t hrough a 18 G needle 10 times. The t ot al RNA wa s pu rified
from the lysed cel ls by centr ifugin g with a SW41 ro tor at
3 0 , 000 rpm, 20 OC f or 20 h rs. Th e supe r n atan t was decanted and
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the RNA pellet was d isso lved in DEPC- t r ea t e d wat e r, ethanol
p reci pitated, centrifuged, and then dissolved i n DEPC- t reated
wa t er . The concentration and qua lity o f RNA was ch ecke d by
measuring the absor bance o f the s ampl e s at 2 6 0 mn and 280
The con c entration o f the RNA was calculated a ccordi ng t o t he
f ollowi ng fo r mula : I1g/ lll - dilut i o n fa c t or X A1GO X 40/ 1000 .
Gen er a l l y, t he ~ti<"A~60 rat io should be between 1. 4 to 2.0 . The
integri ty of the RNA was check e d by e l ectro p hor e s i s in a 1%
neut ral aga ro se gel. RNA can be s tored a t -10 OC fo r less t han
1 year .
Pu r ifica t ion o f mRNA was p erformed usin g the QuickPrep
mRNA Purifica t i on Ki t {Ph armac i a Biotechnology} accor ding to
t h e manufacturer's i ns tructions with mi nor modific at i on . In
b rief, about 5 0 0 Jlg of t o ta l RNA were f i r st d is so l ved i n 1.0
ml of ext raction buf fe r (a buf f e red aqueou s solu tion
cont ain ing guanidinium t hiocyan ate and n- Leu r oyt s arco s i ne),
mixed with 3 ml of dilution buf fer (10 roM Tr i s - HC I , pt{ 1 . 4 , 1
rnM EDTA l, and th en centrifuged a t l 2 ,000g and 4 °c for 5 - 10
mi nutes . The s uperna t ant was t hen lo a d ed on to the sur fa c e of
the r e s in of a n o ligo (dTI ce l l u lose spun c ol umn and mixed
gently wit h a rocki ng device for 30 minut es at
temperatur e . Subsequently, t h e column was c entrifuged in a
t a ble t op cen trifug e at 35 0g for 2 min . Th e supe rnatant was
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dis c a r ded, an d the col umn was wash e d t hree times with high
s al t buffer (10 rnM Tris-HCI, pH 7. 4 .. 1 roM EDTA, 0.5 M NaCI)
and t hree t imes with low salt buffer (10 roM Tri s-Hel, pH1.4,
1 roM EDTA, 0. 1 M NaCl). The mRNA was e l uted with 0 .75 ml
elution buf fer at 6 5 ct. Aft er ethano l precipitatio n, t h e rnRN/\
was d is solved i n 20 u l o f DEpe - t r eated wat er , and th e
concentrat i on was deter mi ned a s descr i bed above. Usually, tnRNA
was 1 - 8%o f th e t o t al RNA.
2.1 . 2 North e rn blot assays
The me thod used fo r Northern blotting was similar to that
described by Samh rook et a1. (1 989J wi t h s o me c hanges .
Briefly, 20 J.lg of total RNA o r 3 IJ.g o f mRNA t oge ther wi th 4.5
I1g of 0. 2- 9 . 5 kb RNA l adder were fi rs t mix ed with sample
buffer (20 mM MOPS, 0 .5 roM EDTA, 1.5 mM for maldeh yd n , 50'1,
for rnamide) and then sepa rated on a l'/. fo rmal d e hyde g e l 11 'I.
ecar-cse in 20 !I'M 3- I N-morpholino l propane~sul fonic acid (MOPS),
8 roM so d ium acetate , an d 0. 66 roM f orma l dehyd e I by
electropho r e sis at 40 volts o vernig ht or whe n t he bro mopheno l
blue migrat ed approximately 8 - 10 em . The RN A l a d der l an e was
then cut from th e gel , s t ai ne d wit h ethidium bro mide f o r 30- 45
minutes, des t ai ned fo r 30 minutes , a nd ph o tog r a phed u n der UV
light t ogether with a fluo r escent r ul er. The gel wa s t he n
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washed twice in DEPC-treated water to remove the forma ldehyde .
The RNA then transferred by capillary blotting onto
BioT race HP membrane (Gelman Sciences) following the
manufacturer's instruction . The membrane with transferred RNA
was subsequently baked at 80°C in vacuum. oven for 1.5-2 hrs
to immobil ize the RNA on the membrane . The membrane-RNA was
prehyridized in hybridization buffer (1% non-fat dry milk , 0 .5
M NaHzPO.. 7¥, SDs, pH 7.2) for 2-3 hrs , and then hybridized
with a " s - Laoef ed probe in hybridization buffer overnight at
65 -c . The hybridized membrane was washed twice with 2X sse,
0 . 1Y. 8DS solution at room temperature for 15 minutes, twice
with O.IX sse , 0.1% 50S at 42-65 °c for 10 minutes , depending
on the probe used . After washing , the membrane was exposed to
film for 5 hrs tc 10 days . The probe was removed by boiling i n
O.IX ssc, O.I ~ SDS solution, and the membrane was reused for
t he next probe. y-actin was usually used as an Ln t e rniL
control .
2 .7 .3 RT-PCR
The method used for RT-PCR was basically similar to that
described by Innis et a !. (1990), with modifications .
The total RNA used for RT-PCR was first treated with
RNase free DNase I . Then , I J.ig of DNA-free RNA was reverse
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transcribed to cDNA i n IX RT buffer , 0.5 mM d NTP, 10 mM OTT,
40 units of rRNase ribonucl ease i nhibitor (Promega), an d 1
unit of Superscript reverse t ranscr i ptase at 37°C for 1 h r .
One t enth of the RT product was f u rther us ed for the PCR
amplification using Hyraid t hermal reactor IBio/CAN
Scientific). The conditions fo r PCR we r e as follow: IX eca
buffer {10 ruM Tris-HCI, pH 8 .3 , 50 mM xc t , 3 roM MgCl ~, 0.011.
(w/ v ) ge latin] , 0.5 rnM dNTP, 0.2 roM of sense and antisense
primers , and 2 unit of Ta q po l yme r a s e (Promegal in 50 Ill . The
PCR program for the DCC gene was: 9 4 °C for 3 min for the
first cycle , then 94 °c for I min , 56 IIC fo r 2 min and 72 IIC
for 2 min for a tota l of 35 cycles, t hen 72 lie fo r 7 min for
the l a s t cycle and, finally , 25 IIC on hold.
2 .7 .4 In situ hybridization assays
The In situ Hybridization and Detection System (GIBCQ-
BRL) was used for in situ hybridization .
The slides, coverslips , staining jars , and forceps were
baked in 180 °C for 4 hr before use . All t he so l utions used
befor e h ybridization were treated with DEPC.
Cervica l cells grow n on slides were first fixed i n fresh
4% pa raformaldehy de a t 22 °C for 30 min , and then t ransferred
to 70% ethanol at 4 °e until use . Whe n usin g, the slides were
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immersed in 50% ethanol f or 2 minutes, rinsed with IX PBS, and
then incuba t ed in prewarmed 40 ~g/l'nl proteinase K in IX PBS at
37 DC fo r deproteinization. Five to 2 0 min later , the slides
were rinsed with PBS, dehydrated through a graded ethanol
series 13 min ea ch in 5 0%, 70%, 90 % a nd 100 % ethanol ). Af ter
being air d ri e d at ro om t empe r a t ur e f or 5- 10 min, the slides
were hybridized with de natu red biotin-labelled probe i n IX
hybr i d ization buffer (2X SSC, 0.1 M sodium phosphate, pH 6.5 ,
I X Denhart' s so lu tion ) , 10% dextran SUl pha t e at 42 DC
ove r night .
After hybridization , t he slides were washed twice wi th
0 .2X s se, O. H SDS s olution for 15 min, once with buffer 1
(0 . 1 M rere -acr, pH7 .5, 0 .1 M »act , 2 roM MgC12 , and 0 .05%
Tri ton X 100) , and blocked in blocking buf fer [3% (w/ v) bov ine
serum albumin in buff er 1J for 1 hr . The signals were de tected
by i nc ubating the slides sequentially with streptav idin,
biotin (AP), nitroblue t e traz ol1um (NBT) and e-bromo- s-cmcrc-
3-indolylphospha te (Be l P) . A purple color should be vis uali zed
under t h e micros cope f or positive samples . The results shown
a re t yp i cal f o r ce lls observed in at least three independent
exper iments .
2 . e Pr otoc ols f or DNA de t e c tion
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2. a .l Pre p a r a tion of h igh mol ecula r weigh t DNA
Protocols used for DNA extraction were as de s c ribed by
Sambrook et e i . ( 989) . Briefly, cells grown in 100 nun plates
were scraped from the plates in cold IX PBS, centri fuged, and
then incubated in extraction buffer (10 mM r ers-acr. pH B. O,
0.1 M EDTA, 20 ~g/ml pa ncreat ic RNase, 0 .5% SOS) a t 37 -c for
1 hr . Proteinase K at 20 mg/ml was then added i nto ea ch sampl e
to a final concentration o f 100 J.lg / ml . Afte r 3 hrs incuba t ion
a t 50 eC, t he DNA was pur i fied by three phenol extrac tions,
ethanol precipitated, and di sso l ved i n TE. The co ncentration
and qu ali ty of DNA we r e determined as described for RNA . DNA
concentration was calcu l ated a cc ording to the following
fo rmu la : J.lg /J.ll =dilut i on fa ctor X Al • e X 50/ 100 0 . The A~""/A/ ,,,,
ratio should be between 1. 7 and 2 . 0 . The in tegr i ty o f DNA was
checked on a 1% aga r ose gel .
2 . 8 . 2 Sou ther n blot assays
Southern blot assays we r e performed acco rding to the
protoco l provided by Gelman Sciences . Equa l amounts of DNA,
usually 10 119 ' were digested wi th specific res tr i c t i on
en zymes, run by electrophoresis in 1% ag aros e gels ,
transferred to Bi otrace HP membranes , and baked at 80 -c fo r
1.5-2 . 0 hrs . The c onditions for p r eh yb rid izat i oo ,
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hybridizat ion, and washing were the same as des c r ibed for t he
Nor the rn blot assays .
2 .9 Indirect inmunofluorescence assays
Indirect immunofluorescence assays were perf ormed
a c co rd i ng t o Bartek e t a1. {199 0 j , with modifi cations.
The ep i thelia grown i n r a f t c ultu re were fixed in 4%
paraforma ldehyde , pa r a f fi n - embedd ed , sectioned , and kept at
room temperature until us e . However, t he cel l s gr own on s lides
in monolayer culture wer e f ixed i n i c e -col d 50% methano l : 50 %
ac e tone f or 30 min , air dri ed , and left at room temperature
until use.
The fixe d epithe l ia grown on r aft s were fi r s t i n cu bate d
in xy lene t o r emove t he pa r affin . The n, the monolayer an d ra f t
cu ltu r e were i mmersed 3 t i me s in 100% e thanol , 3 t i mes i n 70 %
ethano , o nc e in dH:O, and 3 t i me s i n I X PBS. The raft
ep i thelia were sub s e quentl y t ryps i nized i n d iges tion s olution
(O. 2% trypsin, IS mM Ca Cl z, 50 mM Tri s -HCl, pH7 . 5 ) . Then, all
t h e cells grown i n monolayer a nd raf t c u l t u r e were i n c uba t ed
i n 2 0% goat se rum fo r 1 h r , wi th the respective antibody i n
PBS at 1:20-1:100 dilution for 1 hr, and with FITC diluted i n
2 0lJ, goat serum a t 1 : 40 f or 1 hr . The staining was visualized
by mounting in 3 '1. glycerol, c ov er i ng wi th coverslips , and
exam ining on a Leitz Laborlux S Fluorescence Microscope
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(Germany) in t h e dark . A green corer sho uld be v isualized for
pos itive samples . aepresentetnve photographs were taken with
Kodak Tmax films for documentat ion . The results shown were
typical for cells observed in at least three independent
e xperiments .
2 .10 Treatment of cervical cells with 'I'NF- a , TGF-p I , and RA
The concentrations of TNF-a, TGF-pl and RA for the
treatment of cervical cells were 250 U/ml , 5 ng/mI, and 3 j.tM,
respectively . For mRNA expression experiments, the cells were
untreated or treated 1 day for TNF-a, 2 days for TGF- p I , and
3 days for AA. The medium without or with TGF-pI or RA was
cha nged daily . After t r ea t men t , RNA was extracted for Northern
blot analysis. For growth inhibition experiments , 1 X 10~
cells were seeded in 60 mm plates and were untreated or
treated for 5 days with a daily change of medium . Five days
later, the cells in each p late were counted with a
haemocytometer. The percentage of growth inhibi tion by TNF-a,
TGF- pi and RA was then calculated as follow: 'J, growth
inhibition=100-[ (cell nUmbers in treated dishes/cell numbers
in untreated dishes) X 100) ) . The results presented the mean
of three experiments.
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2 .11 Differential displa y a eeays
Oi ffe r entia l display a s s ays wer e performed a c co rding to
Liang et a 1. (1992 a , bl , Figure 6 shows schema tically t he
t ec hn i que s f or ide n t i f ying and c loning differentially
expressed genes by t h e mRNA dif f e r e ntial disp lay method .
2 . 11. 1 RT- PCR
The RT- PCR method us ed in d if f erentia l d isplay was
basically simi lar t o that de s cribed 1n Sec tion 2 .7 .3 . , wi t h
severa l d ifferences . First , a[ HSJdATP was used i n t he PCR
reaction t o labe l t he PCR products. Second, the dNTP
concent rat i on was reduced from 500 j.!M t o 25 flM. Third, two
specific gr oups of primers were used . One group of primers ,
de signated TI2MN, were 3'-end primers co mposed of an oligo-dT
l2-mer and 2 additiona l nucleotides . In my study, T12CA, T12AC,
T,2CG, and TllAT were used . The second group of primers , the
a rbitrary primer s (AP) , was 5 ' - end p r i mers comp os ed of n i ne or
ten oliqonucle o tid es (9-mer or 10 -mer) . In my s tudy , 14
primers de s igna ted API t o AP14 were used . The sequence for
each arbitrary primer i s l i s t e d in Tab l e 5 . Four t h , a low
annealing t empera ture (40 0C ) and s hort extension time (30 se c )
were used i n PCR. The PCR program wa s as fo llow: fi r s t , 94 °c
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J'igure 6 . Sc:hema.tic: representation of maNA diUerential
display method . Dashed lines rep resent RNA, solid lines
r ep r e s e n t DNA an d arrows r ep r e s e nt the d i r e c t i on of RT and
PCR. Boxed sequences are t he primers. API repr esents a r bitrary
primer s containing 9 or 10 nuelec -.:. i des. onl y on e se t o f
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for 30 sec , <1 0 °c for 2 mi n and 72 °c for 30 sec f or a t otal
of 40 cy c l e s ; then, 72 °c fo r 5 min for 1 cycle; and , finally,
25 OC on hold. Fif t h, the PCR products were sepa rated on 6 %
sequencing ge l s at 100 watts for <1 hr , dr ied withou t f ixat i on
t o allow recovery of PCR products , and exposed t o X- r ay film
0 . 5 to 7 days .
2 . 11 .2 Recovery , reamplification and con f i rma t i on of
difforentially expressed eDNA
The autoradiogram was oriented wi t h t h e gel a f t e r
deve loping the film. The d ifferentially e xp ressed cDNAs were
identif ied by comparing duplicate of HEN, HEN-16, HEN-16T eDNA
bands on the film (Fi gur e 6) . The bands were l o c a t ed an d cu t
from t he 3MM paper . The gel slice along with the 3 M paper was
soake d in 100 u l H20 for 10 min , boiled for 15 min , and
centrifuged in the eppendorf tube to pellet the gel and paper
deb ris. The supernatant was transferred to another t ube,
prec ipitated with sodium acetate , glycogen (10 mg/ m1) , v.nd
ethanol. The pe llet was dissolved i n 10 1-11 H20 a nd <1 1-11 wa s
used for reamplification . The re amplification wa s done us ing
the same pr ime r set and PCR conditions e xcep t the dNTP
c once n t r a t i on was 25 jJM.
To dete r mine if the size of reamplified PCR products were
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c onsistent with their size on t h e DNA sequenc ing gel , the
c DNAs were subsequently ext racted from the L 5% eqaroee gel
using Schle i che r & Schuell NA4S OEAE membranes and protocols .
The isolated cDNA was used as probe t o ve rify the differenti a l
e xp r e ssion o f mRNA on Nor t h e r n b l ot assays as described in
Section 2 .7 . 2 .
2 . 11 • 3 Cloning
The cONAs t hat were diffe r en tia llY exp re s sed on Northern
b l o t assays were cloned into t he PCR II vect or using the TTl
Cl on i ng Sys t e m (I nvi t ro gen) followi ng the manufacturer 's
ins t ru ctions . In brief, a s ingle deoxyade no s i ne was added t o
t h e 3' -end of PCR cDNA molecules be ca use of t he non -template -
dependent acivity o f t h er mostab l e Taq po l ymer ase duri ng PCR.
The s e cONAs with 3 ' A-ove rhangs were then ligated into peR II
vector s which c onta i n ed single 3 ' T- overhangs. The li ga t ed
plasmids wi th cDNA i ns er t s were then transformed i n t o TA
Cl oning ones not competent ce lls a nd spread on LB pla tes
cont ain ing 50 Ilg / ml ampi cill in and covered by 40 mg/ml x-ca i
f or blue /white c olony s e l ection. The whi te co l on i es were
subsequently s e l ec t ed and grown i n 2 ml LB medium at 37 IJC
ove r ni gh t. The p l as mi ds were purified by the small -scale
plasmid purification method described by s embro c k et a L ,
(1999). The plasmids were digested with Ec oRI t o check the
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size of c DNA i ns e r ts .
2 .1 1 . 4 Seque n c i ng and Genbank data bank sea r ch fo r homology
The positive clone s that had i ns e r t s wi t h the same size
.a s t h e original e DNA were sequenced us ing the Sequenase
Version 2. 0 DNA Se quencing System (Uni t ed States Bi oc h emi c a l
Co.) o r t he f-mo l DNA Sequencing Sys tem (Promega), fo llowing
the ma nu fa cture r s ' i nst ructions .
The s e que nces of the repro duci b ly differen t ially
expre sse d eDNAs we r e compared wi th those i n the DNA sequence
databa s es, i n c l ud i n g: GenBan k Rel ea s e 8 6. 0 : GenBank cumul ative
da ily upd ates t o the major r e l ea s e (February I , 1995 ) : EHBL
DATA Li brary, Release 41 .0 : and EMBL Data Li b r a r y cumula ti ve
da ily updates to the maj or release (Feb ruary I , 1995 ) , through




3. 1 Tumorigenicity of CSC- tre a ted cell lines
Two HPV16-inunortalized endocervical cell line s , HEN-16
and HEN-16-2 , were either untreated or treated with 75, 100
and 125 J.lg/ml of esc and then i nj e c t e d into nude mice . SiHa
cervical carcinoma cells served as a positive control. Table
6 summarizes the results for each cell line.
All the treatments except treat....ene of i:EN-16 by 100
~g/ml of esc led to the formation of tumara in nude mice. The
tumors were generally apparent after 3 weeks and continued to
grow until 2-3 months . Seven of the 10 nude mice injected wi th
csc-eeeacee HEN-16 and 4 of the 6 nude mice injected with CSC-
treated HEN-16-2 cells produced tumors . SiHa cells gave rise
to tumors for all inj ected nude mice. None of the untreated
inmortalized ce lls induced tumors in nude mice after 2 months,
indicating that t he induction of tumors in nude mice by CSC-
treated immortalized cells was due to esc treatment. In
addition, the occurrence and s ize of the tumo rs were not
correlated with the concentration of esc , suggesting that
imnortalized cells would have been transformed at lower levels
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TIle tumors formed in nude mi ce were e xcised. Half of
t he se we r e used to establish csc-c r enerormec cell lilies,
designated HEN-16T a nd HEN-l6-2T, respectively , and used for
othe r a nalyses . The other ha lf of the tumors wa s used for
patholog i cal ana lys is . Figure 7 i s an examp le of histology of
tumors t r a ns fo nn ed after csc-u reetment of inunortali zed cel ls.
All the tumors displayed t he squamous cell carcinoma (SeC )
phenotype, whi ch was chara c t e ri zed by a local increase i n ce ll
number , l o s s o f normal arrangement o f cel l s , i ncrease i n
nu cl eus/cytoplasm ratio and density of staining, a nd
i nfi l tration o f tumor cells into or around t he normal mouse
t i ssues (Figure 7 ) .
3 . 2 Morphology of primary cells and HPV16 - immortalized and
esc-transfo rmed cel l l ines
Compared with normal ce l l s , tumor cells ha ve obvious
mor pho l o j Lca I abnormali t ies i n vitro . Therefore. the
morphology of primary, HPV16-immortalized untransformed , a nd
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Fig ure 7 . Hi stology o f tumors fonne d b y eS C- t r e a t e d
immorta lized cell linp.s . Panels A and B, a nd C and n rcpresoru
tumors u s ed to prod uce HEN-16T and HEN- 1 6 - 2T , reapect t ve ry .
The tumors formed i n nu de mice we r e ex c i.uo d , fixed i ll
paraiorma ldehyde , para f f in - e mbe dded , eect ioneo wi til
mi cro t ome , sta i ned with hamat oxy Lrn and e o e in , a ud o bae rved




CSC-transformed c ells was comp a r ed.
3 . 2 . 1 Monolayer c u l tur e
I n mono l ayer cul t ures, cells we r e grown i n e Lt ner KGM Ill"
OHEM . I n teGM, a serum-free medium t ha t con t a Lns O . I~ nlM
calcium (see Appendix II , all the c ells grew acti vel y rl1ll1
formed monolayers o f keratinocyte - l ik e cells ( Fi gu r e 81.
Howe ve r , whe n the cells were cul t ured i n DMEM, a mediurn
containing 10 \ FCS and a physiological level of c a lci um (' . ',
mMI with redu ced amount of growth fact ors (sec Appe nd i x I J ,
HEN s topped growing and died after 10 da y s . The l.wn
immortalized untransf ormed. cell lines, HEN- 16 and IIRN- J6 -2 ,
grew slowly and formed fl attened , d e ndritic (ha v ing bra nch ed
cy t op l a s m) , and un even s ized c el l s , whic h we r e d is t ri but ed
heterogeneously in the t issue cu l tu r e p l a t es. On t he other
hand , t he two csc- e r e n e t creea i lllllOrtalized c ells , HEN- 161' and
HEN-16~2T, grew well , h a d increased nuc leus /cyuplasm r-a t l o
an d di sp l a y ed a morpholog y comparable to t ha t i n KGM (FiglJ nJ
aj .
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Figur e r. Morphology o f c e r v i c a l c e lls grown in monolayers
with KGM a n d DMEM . Each cell line is i ndicated to the lef t of
t he figure. Left panel represents cervical ce r i s grown i n KGM.
Ri g h t p a ne l r e p r e s e n t s cervica l cells grown in DMEM. HEN could
n o t grow in DMEM. HEN was u s e d at passage 2. HEN-l6, HEN- 16- 2 ,
nrm - 16T a nd HEN-16 -2T were used at p assage 7 5 , 8 6, 80 an d 91 ,









3 .2 .2 Raft culture
In the raft cut t.ure sys tem, HEN cells formed thin well-
differentiated s tratif ied squamous epithelia that resembled
normal e ndocer vical e pi t heli a in vivo wi th well -defined basal ,
suprabasal, and superficial l a y e rs (Figure 9). I n contrast ,
b o th HEN- 16 and HEN- 16- 2 proliferated extensively a nd formed
t hi ck e r , aberran t , d i sorganized epi thelia (F i gu r e g)
resembling modera te t o severe cervical intraepithelial
neopl asia (CI N II - II I ) in vivo . HEN- 16T and HEN"-16· 2T
proliferated even faster t han their r e s pe c t ive immortal ized
cells and produced t h icke r, more undifferentiated layers of
cells (Fi gu r e 9) similar t o e I N III or carcinoma i n situ .
3 .3 Growth characteristics of p r i mary ce l ls and HPV16·
immortalhed and e SC -transformed ce ll l i n e s
To ch aracterize the growth potential of normal,
Lrnmo r t a Li zed and eSC -trans formed cells , I examined t he i r
proliferat ion in two types of med ia , KGM a nd DMEM, and t he i r
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Figure 9 . Morphology of endocer vica l ce l ls grown in raft
culture . Ea ch ce ll l ine is i ndicated to t he l ef t o f t he
f igures . Le ft pa ne ls show XI OO or- Lq in a I maq ni Li.cat.f on , Ri g h I
pa ne l s show X400 o r i g i n a l mag nif i ca tion . The ce t t u
di fferent iate away from the mouse f i b r ob l a s ts, shown be l ow .





100 X 400 X
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an cho rage- ind e pende n t gro wt h i n soft a ga r .
I n KGM, HEN- 16T a nd. HEN- 16 -2T cells prolifera ted sligI1tl)-·
h i g he r t ha n t ne i r unt rans fo rmed immortali:;:,ed c ounr e rpart a ,
HEN- 16 a nd HEN-16 -2 , r e spect i vely , but. <\11 f ou r t tuee
pr o life r a t ed fa s t er t ha n HEN c ells (Figure 10 AI. The dcub l I nq
t imes of HEll , HEN- 16 , HEN- 16 -2 , HEN- 16T , an d HEN- 16 - 2T we rc
43 , 4 0 , 36 , 36 , a nd 32 h r, respect ive l y . Howe ve r , i n DMEM, film
d id not pr o l i fe ra t e , an d HEN- 16 and HEN-1 6 - 2 pro l iferated more
slowly than in KGM, whereas HEN- 16T a nd HEN-1 6 - 2T prot i rer.u.cn
mu c h f a s t e r tha n HEN- 1 6 a nd HEN-1 6 · 2 (Fi g u r e l OB) . The
dOUbling t imes o f HEN- 16, HEN-1 6 - 2 , HEN-16T, a nd HEN-H. · ? ,.
were 109 , 4 3 , 35 , a nd 28 h r , res pe c t i ve ly . I n a ddi t i o n , e sc -
t rans formed c e lls ob t ained h ighe r satu r ation dens i ty tha n
t he i r itllllOrt a li zed co un t e rpar t s. The s a turation dens ity o f
HEN, HEN- 16 , HEN- 16- 2 , HEN-1 6T , a nd HEN- 16 -2T wa s 8 . 1 X 10~ ,
1. 1 X 10' , 1.5 X 10', 1. 6 X r c- . a nd 2 . 1 X 10' cells / 6 0 tml
d ish , r e s pe c t i ve l y .
Oncogen i c ity is corr e l a t.e d wit.h e uc ncreqe-fneepe ndent
g rowt.h o f t.urnor cel l s . To cha r a c t e r i z e t h i s on c og eni c
phe n o t yp e , sof t aga r a ssays were perf o rmed, in whi ch al l t he
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Figure 10 . Pr olife ration o f e ndo c e rvi c al c ell s i n KGM {A} and
DMEM (B) . Each value c ep r e a e nt.s the mean and s tandard
(S . B) calculated from three independent ex per iments. Bars
















. . . . -0 . ..~ 100 ....•.. .
c,






















i mmorta l i zed and csc-u r e ns eo rmec tumor ce lls and SiHa were
a llowed t o g row i n soft agar f or 2- 4 weeks. Genera l ly , t he
f or. matio n o f co l on i es was observable a f t e r one wee k of
incuba t ion, and t he colonies were unequivocal ly idcmtified
a r t er 2 weeks. HEN-16 (Fi gu r e llA ) and HEN-16~2 (Fi gur e lIB )
r e ma in ed a s sing le ce ll s a nd d i d not roim colonies i n soft
agar, whereas HEN-16 T (Fi gur e llC) and HEN-16- 2T ( Fi gu r e 1 10 )
fo rmed colon i e s tha t we r e s mal l e r than t ho s e formed by SiHa
(F igure llE ) .
3,4 Presence and express ion of HPV16 DNA i n i mmo r tal i ze d and
eSC- transformed cel l s
I nc r ea s ed v ira l expression alterat ion of vi ral
sequence s was r ega r d ed a s one of the mechanisms for
tumorige n i c ity o f HPV- i mmo r t a l ize d cell s (Cull e n et a l. ,
1991). To s tudy t he r ole of HPV i n on cogenesis from primary
c e rvical cel ls , t he p r es e nc e an d expression of HPV16 were
ana lyzed by Southern and Northern b lot hybridization assays
u s Lnq who l e l e ng t h HPV16 DNA as p robe .
BB
Figu r e 1 1 . Anc hora ge -in de pe nd e n t growt h o f e S C- t r a n s f o rme d
c e lls . A , HEN-16 ; B , HEN - 16 - 2; C, HEN-16T; 0, II BN- 16 - 2T ; e.
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HEN- 16T and HEN-16- 2T high molecular weight DNA sh owed
the same pattern of hy bridization wi th the HPVl 6 probe a s
their immortalized c o unte r pa rts, HEN-16 and HEN- l6 - 2 . Af t.e r
digestion with BamHI , which cleaves at a sing l e site i n t ile
HPVl6 ge nome , a single band about 20 . 0 kb , but not t he 7 . 9 kh
who l e l e ng t h HPV16 DNA, was det.ec t.e d (Figure 128, lanes 1, 3 -
6) . Af t e r diges tion with BamHI/Ps t I , f ive bands of 32 00 bp,
2817 bp , 1063 bp, 908 bp and 483 bp hybridized with t he HPV1(,
probe, whereas two bands of 17 76 bp and 641 bp t a il e d to
hybridize wi t h the HPV16 p robe, c ompared wi t h t he IlPV16 DNA
co ntrol (F i g u r e 12C, l a ne 1 , 3 -6 ) . The s e fragments con ta i n
s equences for the Ll ORF. I n all cases , no HPV16 DNA wa n
detected from HEN high molecu lar weight DNA ( Figu !" ~~ 12 B, c,
lanes 2) .
Northern analysis u s i ng HPV16 DNA as probe a lso show ed
that both immortali zed and csc-nrans rcrmec cella express ed
s imilar levels of the 2.3 kb and 4 . 5 kb mRN/l.s, which were
different from those of the cervica l carc inoma cell li ne ,
CaS ki , i n both pattern and level o f mRNA expression {Figu ra
12M .
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Figure 1 2 . Expre s s i o n and detec t ion of HPV16 DNA i n cerv ical
cells . A ) Northern b l o t t ing . Total RNA ( 20 j.tg ) f ro m HEN (lane
1 ) , HEN- 16 (l a n e 2), HEN-1 6 - 2 (lan e 3) , HEN-16 T (l a n e 4) , HEN-
1 6- 2T (lane 5), and CaSh HPV posit ive c e ll line (lane 6 ) was
hyb rid ized with the ' ~P-labeled f ull- length HPV16 DNA. After
the blo t wa s exposed to X - ray f i l m, t h e probe was stripped
from t he blot , and t he blot was then hybr i d ized for the
i n t e r na l ge l l o ad i ng a nd hybr i d i za t i on control, j -e c r In (lower
panel) . B) , C ) Southe rn b l ot hybrid iza t ion o f 10 ~19 high-
mo l ecu l a r we i g h t , Ba mHI -d i g e s ted (8) or BamHI !Pst I-digested
(e ) , cel l ula r DNA wi th f ull-lengt h "p-Lab e j ed HPV16 DNA. Lanes
1 , HEN + IlPV16 (100 pg ) ; l a n es 2, dEN: lanes 3 , HEN-16: l a n e s
4 , IlEN-16- 2 : l a n es 5 , HEN- 1 6T: l a n e s 6. HEN-16 - 2T , DNA or RNA
mol e cular weigh t ma r ke r s we r e us e d i n separat e l a n es and are
shown in kb o n the lef t o f e a ch f igure.
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3.5 Expression of cancer · related cellular genes
3. 5 • 1 Onc ogenes
Several stu dies have d e monstra t ed t ha t the activation of
oncoqen e a has an important role in t h e pathway s for t h e
transformation o f primary c e rv i ca l cells (Durst:. ee a l . , 1987;
Cr o o k et. al ., .1990) . Therefo re, t he expression of t wo
oncogenes , c·myc an d u-re s. which ha d been shown t o be
amplified i n cervical c arcinomas, a nd B- myb, a ne wly
id '2ln l;.if i ed oncogene t hat wa s t.rans activated by HPV E7
oncoprotein in cycling NIH 3 1'3 cells in vitro (Lam et a l.,
1994 ) , were examined i n p r i mar y , inunortal ized, and CSC-
tra n s fo r me d cells .
The levels of 2 .4 kb c-myc and 1. 3 k b H- ras mRNA
t r a nscripts were s imila r in a ll f ive cell types (Fi gu r e 13 and
Table 7) . While t he express ion of B- myb in was 1 7 .8- 2 7 . 0 time s
highe r i n immort a l iz e d cel ls th a n t ha t in HEN cells, i t was
1.9 t i me s higher in HEN- 16T csc - c rens eo rmed t um or c e lls t han
i n HEN- 1 6 immort.alized cel l s (Figure 13 a nd Ta b l e 7 ).
3.5 . 2 Tumor suppressor genes
To stud, wh ether the i n a c tiva t i on o f t u mo r s u ppressor
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Table 7. Transcriptionof cellulargenesinprimary and immol1alized.
and esc- trans formed cells
Relative expression level*
cenes HEN HEN- 16 HEN-1 6- 2 HEN· ' 6T HEN- 16-2 T
c-myc 1 1.1 1.' 1.2 1.3
,,",as 1 1.1 1.3 1.1 0.8
B-myb 1 18.8 28.0 36 .6 3 1.4
p53 8.7 ' .3
wat t 1 0 .' 0.- 0 .8 0 .2
PCNA 1 2.1 3.2 7.1 5.0
GAOO4S 1 0 .' 0 .8 1.1 1.0
GADO l S3 1 0.' 2.8 1.9 1.0
Fibronectin 1 0.3 0.03 0,01 0.01
"'The leve ls of t ranscription of each ce llular ge ne mRNAs in HEN-' 6 . HEN- ' 6 -2 .
HEN-16T. and HEN-16-2TwerequantifIed relative tothose of HEN after their
normalizat ,on to the Ieve!'Sof act in mRNAs RNAs were quantified by measur -
IflQ the optiCal denSIty o t each message at medium ellposure on X-ray him uSIng
densitometer.
Figur e 1 3 . Exp r es s i o n of mRNA f o r c -my c, B-myb , a n d H·r."'s i n
cer vica l ce lls . Lane l,HEN; lane 2, HEN-16; lane 3 , HEN- 16-2 ;
l ane 4 , HEN - 16T ; lane 5, HEN-16 -2T . Nort h ern bl ot
hybridi z a t i o n of 2 0 119 t o ta l cellul ar RNA f ro m the five
i n dica t ed ce l l t ypes wi t h c -my-c was carried out rtrs c , as
des cribed i n Section 2 .7 .2. Aft e r the blot was exposed t o x-
r a y fi lm, the p robe wa s stripped fr om the b l ot f or s equent ia l
h y brid i :za tions for B- myb, H- r as . and v- a c t i n . The s ize oE each
me ssage is s h o wn i n kb o n t he r i ght o f ea ch panel an d










genes was i n vol ve d in the in vitro oncogenesis of primary
cervical cells, the expression of th ree tumor suppressor
genes, p53 . WAFI/Cipl /Sid l , and DCC, was examined in my un ique
i n v i cr o model system using Northern blot and RT-PCR methods .
While the expression of p53 was 5 to 9 t i me s enhanced in
i mmor t ali z e d and CSC-transformed cells compared to primary
endocervi ca l cells, th ere was no cons istent difference between
immortalized ce l ls and esc-transformed cells (Figure 1 4 and
Tabl e 7) . The lev el of the 2. 1 kb Wafl mRNA transcript was
s imilar in i mmor t alized and esc· transformed cells, but all
four were 20-80\ l ower than that in HEN cells (Figure 14A and
Tabl e 7).
S ince the e xpression of DCC wa s very low, the RT·PCR
method was emp.Lcyed to check if Dee was deleted in
rnmor-t ai i aeo and CSC-t ransformed cells. T he expected 400 bp
f ragment, which was frequently deleted in some carcinoma cells
(Gao et al., 1993; Klingelhuz e t al .• 1993 , Thomp son et al.,
1993 ) , was detected in all the cell l i nes used a nd was
negative i n the no RNA. water con trol (Fi g ure J.4B ).
3 . 5 .3 DNA replication and r e p air genes
9.
Figure 14 . Ex p r e s s i on o f mRNA fo r p 53 , wa n and Dec i n
c e r vic a l ce lls . A) No r t.ne i-n bl ot hy brid i zat i on of 3 mg mRNA t o
p 5 3 , Hafl , and acti n probes was carried out as d e scribed i n
Section 2 .7.2 . Con d itions a nd labe l s a re describ e d in Figur e
13 . B) RT · PCR of DeC . Lan e s a r e: I , 1 0 0 bp ladder; 2, No RNA
control ; 3, HEN; 4 , HEN-16 ; 5, H~N · 1 6 · 2 ; 6 , HEN-1 6 T; 1 . HEN-
16 -2T. The 400 bp ampli fied OCC eDNA is i ndicated on t he right

















To decerei.ne if d e r egul a t i on of mRNA express i on of genes
for DNA r eplication and repair was involved i n t h e
immor taliz a tion and t u morigenesis , the expression of t hree
genes impl i ca ted in DNA rep lication a nd r e pair, pe N,.., GlIDO<\S,
and GADDl S 3 , was examined in primary, i mmortalized , and esc -
tran sforme d ce l ls .
The expression of PCNAwa s 1. 1 - 2 . 2 times h i ghe r i n HEN-IG
and HEN- l 6 - 2 ce lls than in HEN cel l s. On the other ha nd , PCNA
mRNA expr ession is 2 . 4 tim es higher in HEN-16 T cells than i n
HEN-16 ce l ls , a n d 56\- higher in HEN -16 -2T cel ls than in IIRN-
16-2 cell s (Fi g u r e 15 and Ta b le 7) .
To examine t he PCNA p rotein l e v e l , ind i rec t
inmu nofl uo rescence as s a ys we r e employed i n mon o l aye r and ra r t:
cultur e . In mon o layers , th e l evel of PCNA protein in H8N ce i t s
was very l ow a nd necercqenecuety expressed, where a s t h e
expression of PCNA protein was more apparent a nd more
homo geneously e x p res s e d in HEN-l6 and HBN-16 -2 cells. Re la tive
enh a ncement of PCNA prote i n was observ ed in s ome HEN- l6 -2T
cel los, but the hig hest ex p ress ion of PCNA p r ot ein i n t he
nucl e us wa s de t e c t ed i n HEN-16T cells (Figu r e 16, monol aye r
l a n e ) . These r e sul ts was c ompara bl e t o t h ose of mRNA
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Figure 15 . Expr e ssion of mRNA f or PCNA, GADD4S a n d GADDIS3 in
cer vical cel ls . A, PCNA; B, GA004 5 ; C, GADDIS3 . lanes 1 , HEN;
lanes 2 , HEN-16 ; l anes ~ , HEN- 16 - 2 ; lanes 4 , HEN-16T; l anes S,
HEN- 16 -2T . Conditions .urd lahels were as i n Figure 13.
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Figure 16. Indire ct immunofluorescence analysis of PCNA
protein in cer vical cells cu I tur ed in mo no l a y e r and raft
system . The na me of ea ch cell t ype i s i ndica ted on the lef t .
Le f t pane l s show t he results £0 :- ce l l s grown i n mono layer .
Ri ght pane l s repre s e n t t he r e sults f o r cells g r own i n t he ra f t
system . Exposure time an d print ing cond itions were i den t i ca l















expression studies (Figure I5C) . In ra f t cu lture, the sam e
trend of PCNA ex pression observed as i n monolaye r
culture: PCNA signal increa sed s eq uentially f r om prima ry
en docervica l ce l l s to un trans f o rme d an d to CSC-transformed
cells (Figure 16 , raft panels) . Proliferation a nd PCNA
co nfined to the ba sal layer of e p ithe l i a (Mer r i ck e t al .,
1992) . However, PCNA protein was present throughout the en tire
t hickness of the epithelia f o r HEN- 1 6 , HEN-16- 2 , HEN- 1 6T a nd
HEN-IG -2T cells. Th e signal wa s more pronounce d in t he t umor
cell lines . The presence of PCNA in the basal l ay e r i n the
raft was also observed by microscopy in HEN cells. but is not
ap pa r en t in t his pictu re .
No d if f ere nce in GADD45 mRNA expr ess ion wa s observed in
a ll cell lines (Figure 158 , Table 7). Rel a tiv e t o HEN, t he
ex pression o f GADDIS3 was l owe r in HEN-1 6 and h i ghe r i n HEN-
IG·2 c ells. The expr -es s Lon of GADD1S3 mRNA i ncreased 4 . 8 - fo ld
i n HEN- 1 6T a nd 2 .S -fold in HEN- 16 -2T , co mpa r e d with t he i r
immorta lized co unterparts (F igure ISC , Ta b le 7) .
3. S . 4 Se nescen c e - r e lat ed fibronectin ge ne
1 06
Since primary e nd ocervical ce lls usua lly d ie a r t er -lo - S
passages in t i s sue cul ture as a consequence o f sene s cen ce .
i mnorta lizat ion of thes e pri mary cells should b ypa s s the
senescence pathway . Thu s , e xpression of the senesce nce-xe ra ced
gene. FN. was e xami n ed . As sh own in Figure 1 7A and Table 7 ,
the expres sion ot FN was grea t l y d i mi n ishe d i ll bo t h
i nunor t a l i zed and e SC-t r a n s f o rmed ce ll s . Tumor i ge ne sis l ed to
a 30 -fol d decrease for HEN- 16T a nd a 3 - f o l d decrease for IIBN-
1 6 - 2T . In si tu hybridizat ion of mono l a ye r ti s s u e cultu r e
further conf irmed t ha t FN was expre s s ed sig n ifica nt ly .
although he t erogen e ously. only i n HEN cell s but n o t in mm·
16, HEN-1 6-2 . HEN- 1 6T , and HEN-16- 2T cells ( Figu r e 17B). -rue
FN signals ....ere u s ually detec t ed in the c yt o p lasm . In
addit ion . indi rect immunofluo r e s ce nce of FN p rote i n a loo
showed that FN p r otein was abun dant a nd heterogeneou s l y
expres s e d on l y 1n HEN cel l s bu t no t in immor tali ze d an d esc .
transformed cells ( Fi gu r e ia t • which was co nsisten t with the
1 0 times reduct i on of FN in HEN-' .6 after t umorigenesis (F igure
1 7 ) .
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Figure 17 . Exp re s sion o f FN mRNA in cervical cells .
AI Northern blot a ssays . Lane 1 , HEN; l a ne 2, HEN-l6; lane 3 ,
IIEN- 1 6 - 2 ; lane 4 , HEN- 16T; lane 5 , HEN-16- 2T . Cond ition s a nd
labe ls we re as described i n Figure 1 3. 81 Detectio n of FN
mRNA by in s i t u hy bridization. HEN (a l , HEN-16 (b) , HBN-16-2
Ie) I HBN- 16T (d), an d HEN- 16 - 2T (e) cells we re g r own i n
mono layer a nd then hybri d i ze d to biot in-la be led FN p r obe as
de s cribed i n Se c t i o n 2 .7 . 4. Exposu r e t i me a nd print ing
conditions were i de n tica l for a ll photographs. (Origi netl
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Figure 1 8 . I n d ire c t i JllIl\unofluore s c e n c e ana l ysis o f PN of
cervical cel ls . Pa ne l s are: A, HEN; B, HEN-16 ; C, HEN- 16 ; D,
HEN- 1 6T ; and E, HEN-16 - 2T. Conditions we r e a s described i n








3 .6 Response of p r imary , immortal ized a n d tumor ce l l s to TNP-
ree-m • and RA
As discussed in the I n t r oduct i on , loss of respons e to
cy tokines is regarded as a characteristic of some t umor ce ll
lines . To unde r s t an d the relationship between this p r oce s s ,
irrrnortalization a nd tumorigenicity, the effects of TNF-a., TGF-
Ill, a nd RA on cell proliferation, an d the express ion of HPV
and cellular genes were examined in p r i mary ,
i mmo r t a l i ze d , csc-r.renerormec an d CaSk i ce lls.
3 . 6.1 niP- a
Treatment of cervical cells wi t h 250 U/ml of TNF-a
inhibited, to a similar extent, proliferation of a ll cell
lines i ncl uding HEN, HEN-16 , HEN-16-2, HEN- 16T, HEN- 1 6 - 2T , an d
CaSki (Figure 19) cells.
Treatment with TNF-a. almost co mpletely abolished t he
ex pression of HPV16 , and g reatly r educed t hat of c -myc i n 3 of
5 cell t ypes (Figure 20) . In add ition , no s i gnif icant
diffe rence in the response o f HPV a nd c - my c expression to TNF-
n was found between inunortalized cells an d tumor ce l ls (Figure
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Figure 19 . Effec t o f TNF- a on prolifer at i on o f c e rvical
cells . The results represe n t the mea n and S .E . o f t h r e e
e xp e rime nts. Bars s how S .E. See also t he text for de t a i.Ln .
11]

F igure 2 0 . Ef fect o f TNF-u on mRNA expr ess ion of HPV1 6 and c-
my c . Northe r n blo t hybrid izat ion of 20 ~g RNA from TNF-ot -
untreated ( -I and · t r e a t e d ( +) cells with HP - 1dbe l e d HPV16,
Section 2 7 .2. Conditions a nd labels we r e
c-myc, and v-ecc in probes carried out descri. bed i n





N ~~ ~ ~ ~ ~
..... W W w «
_ I I__I I _ _ U__






Since it was suggested that the loss of JE: or MCPl gene
expression and the induction of this e xpression by TNF-a. is
one of the important characteristics of tumor cells and that
the JE/MCP l gene played a pivotal role in intrace l lular
communication by t.riggering an intracellular pathway which
Lnte r f e res with viral transcription in HPV-pos i t i ve
nontumorigenic cel ls (Ro sl et a l. , 1994; zur Hausen and de
Vi ll iers, 1994b) , the induction of JE/J~CP1 mRNA after TNF-a
t reatment was examined . No i n d uc t i o n of JE!MCPl mRNA was
observed after treatment. of al l inunortalized and t umor cells
with TNF-ll (data not shown) . In addition, Southern blot assays
showe d t ha t JE gene genomic DNA could be d etec t e d easily in
these cells (Figure 21). However, after digestion of high
molecular we i ght DNA with BamHI, an extra ba n d about 6.5 kb in
size was detected only i n imncr-t.al i aed and tumor cells (Figure
21 ) .
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Figure 21 . Dete ction of JE gene in ce r vica l cells . Sout h ern
blot hybridiza tion of BamHI - d i ge sted h igh mc j e cula r- wei gh t DNII
110 ~Ig l wi th l a belled J E eDNA f o r the i ndicated ce l l lines wan
ca r r i ed out as descri bed in Section 2. 8.2 . Size ma r ke rs
i nd i c a t ed on t h e l ef t . See the text t or details .
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3 .6 .2 TGF-Pl
Treatme nt o f ce rv ical c e ll s wi t h 5 ng / ml TGF-r\1 for 5
days i nhibi ted pr ol ife r a t i on b y 78\ , 79\ , and en in HEN. nes -
16, a nd HEN - 16- 2 ce lls , re s pect ive l y (Fi g u re 22 ) . The CSC-
t ransformed ce ll s we re significant l y less sens i t ive to TGF- I\I
t ha n primary and irrrror t a li ze d ce l ls IP < 0. 05 ) . TIle g rowt ll
in hi bition of HEN- 16T and HEN-16 - 2T wa s 58 'l and 56\,
respectively (Fi g ure 22) . CaSki ce l l a were resi stan t t o t h e
gr owth i nh ibi t ory e ff e cts of rce-na (Fi gu r e 22 J • Theref or e.
t he relative r es i s t ance to TGF - rll growt h i n h i bi t i on wa s
cor r e l ated with t he t umo rige n ici ty. bu t n o t i mmo r ta l i aecton ,
of the cel ls .
TGF-p l trea tment s u bstantially i nhi b i ted t he ex press i o n
of HP V in a ll fi v e HPV-cont a i n i ng c ell lin es: HEN- 16 , HEN- 1 6 -
2 , HEN-1 6T , HEN- 1 6 - 2T, a nd CaSH ( Figu re 231 . De ns i t omet r i c
ana l y s i s c nfl rme d t ha t th e le ve l of s upp ress io n of H P V
exp r e s sion was no t re lated t o th e s t atus of ce l l s (da ta not
shown) . Howe ver , s uppres s io n o f c -my c was mos t s e ve re i n IIEN -
16 a n d IlEN- 16-2 , l e s s s evere i n HEN- 1 6T and HEN- 1 6- 2T, and no t,
found i n CaS ki cel l s (Figure 23) .
1 20
Figure 22 . Effe ct of TGF-fl~ on proli f era t i on of cervi ca1
ce ll s . The resul t e represent the mean and S. E . o f thre e
expe riments . "P e r cen tage of growth inhibition
significant. l y lo wer (pe o . 05) , comparing HEN - 16T a nd HEN - 16-2T
wi th HENand with H EN- 16 and HEN- 16 - 2 , respe ctively . Bars sho w









Figure 2 3 . Effect of TGF- fll on mRNA expression of HPV16 , c-myc
and pIS . Nor th e rn blot hybrid i zat i on of 20 j.lg RNA from 1GF- PI-
unt r eat ed (- ) or -treated (+) cells ....ith "p- Labe Ie d HPV16, c-
mye, pIS a nd y-actin wa s c a rried out as des cribed i n Section








Recently, a cyclin kinase i nh i b i t or , pIS wa s cloned and
identified as a po tential effector of TGF-pl -induced growth
arrest. (Hannon and Beach, 199 4 ). To s tudy its possible r o l e in
dHferential inhibition of immortal i zed and tumor c e lls b y
TGF- tJl, its i n duction examined after t reatment o f
immorta l ized and tumor ce lls with TGF-pl . Before treatment,
pIS wa s not. expressed in any of t. he cell lines examined .
'rreac reent o f the cel ls with TGF- pJ. for :2 days caused the
i ndu c t i on of pIS mRNA in bot h inmortalized cells (HEN-16 and
tlEN-16 -2 l and cs c -t.rans tornect cells (HEN -16T and HEN-16 -2T) .
whereas no induction of p1S was detected i n CaSk i cells
(Fi g u r e 23) .
3 .6 .3 RA
T rea t me nt of cervical cells with 3 p.M RA for S days
resu l ted in growth inhibition of HEN, HEN-16 , a nd HEN-16 - 2
67\, GO\- and 63\, reepecctve t y (Fi g ure 24 1 . However, grow th
inhibition was very lo w (27 \ ) in HEN-161 and unde tectable (0 \ )
in HE N-16-2T, a nd CaSki ce lls (Figure 24 ) .
Interestingl y, RA treatment d i d not have a ny sign ificant
>25
F i gur e 24 . Effec t of RA o n proliferation of ce r v i ca l c ells.
Con d i t i o ns a nd l abels we x e as descri bed i n FhJure 7.7..
1 2 6

Figure 25 . Effect of RA on mRNA expre s s ion of H.l?V16 And c-eyc .
Nort.h ern blot hybridi za t i on o f 20 jJ.g RNA f r om II: A -untrea t e d ( - )
and -t r ea ted (..-) cell s wit h J ~ P - l abe l /:!d H PVHi, C' lIIyC, and v-:
actin prob e s was carr i ed out as described ill Sec tion 2 : / .2 .
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effect on t he ex pression of HPV16 and c-m y c in all of t he
irrmor t a lized and tumor cell lines (Fi.g u r e 20;)
3 . 7 Identification , isolation and characterizatio n o f novel
genes differentia l l y expressed in endocervical cells
3 .7 .1 Identif ication of d ifferentially expressed g enes using
differential d i s p lay assays
Th ree ce ll type s , HEN, HE~- 1 6 , and HEN-16T, represe nt i ng
d i f f e r ent sta ge of o nc og e nesi s, were u s ed i n an at t emp t to
isol a t e pu t a t i ve oncogene s or t umor suppre s sor g elleD
r e s ponsible for mul tistage carcinogenesi s o f cervical ce nce r.
For e a ch c e l l line , 64 different combinations of primer eee e
were used f or RT -PCR . Approximately 12 0 eDNA ban ds per lane
were d i spl ay ed on 6\ sequencing gel a f t e r RT-PCR f o r ea ch
combinat i on o f p r i me r s . Of t he 35 ca nd i date cDNAs t ha t were
shown t o be d if f e r e n t i a l l y d i spl a yed on s equencing gel, two
cDNAs, de s i gnate d PA4 an d PA9 , were confirmed to be
d iffe r en t i a lly e xp ressed by Northern b lot a s sa ys . PM was
s pe c if i ca l l y ex p r e s s ed i n HEN- 16 and HEN- 16T ce ll s bu t no t I n
HEN cell s (Figure 26M, whe r eas PA9 was un ique ly e xp re s s ed i n
HEN cells (Figu re 26 B) . Af t er r eampli fi c a tion , the e DNA
13 0
Figur e 26 . Ide n ti f i c a tion of PA4 a nd PA9 b y mRNA d i fferen tia l
dis pla y . AI, B) Aut o rad iogram of differential display of PA4
(A) and PA9 (B) (arrows ) mRNA RT-PCR products from HEN (l a ne
1, 4 ), HEN~16 (l a ne 2 , 5) , and HEN~l6T (lane 3, 6 ). In RT~PCR.
T"CA was used as the 3 ' primer for both PA4 and PA9: AP4 and
AP9 were used as the 5' pr imer fo r PA4 and PA9 , respectIvej.y .
The differentially d isplayed PM and PA9 cDNAs are indicated
with an arrow . Size markers are shown on the r ight of e ach
figure . C) Ethidium bromt de -ecatned gel for reampli fication
and c loning of PA4 (l a ne 3 , 4 , 5 ) and PA9 (l a ne 6, 7, 9)
cDNAs . Afte r the first reamplification of PA4 (l a ne 31 a nd PA9
( l a ne 6 ), the cDNAs were amplified a second time ( l a ne 4 for
Pl\.4 and lane 7 for PA9) to get enough eDNA for Northern blot
(See section 2 11 .1 for details ) . The PA4 and PA9 cDNAs were
cloned into the PCRIl vector (4 kbl , and the plasmids we r e
d i ge s t e d with BcoRI to check the size of the PA4 (lane 5) or
PA9 (lane 8) inserts . Lane 1 and lane 2 are 1 kb and 100 bp
size markers, respectively .
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products for bo th PA4 and flA9 were consistent in size wi t h the
bands in the original display gel : about 310 bp for PA4 an d
290 bp fo r PA9 ( Fi gu r e 26A , 8 and C) .
3 . 7 . 2 Isola t ion a nd Northern hy bridi za t i on a ssays of
dif fe r e n tia l ly expressed mRNAs
Due to the he te rogene ity of PCR fragmen t s . s omet ime s
nond ifferent i a lly expr essed mRNA sp ec i e s ca n be det ec t ed
togethe r with d if f e r e nti a lly expre s s ed can d i da t e s . Therefor e ,
PM a nd PA9 were individu ally subcloned i nto the TA c loning
vec tor . Severa l clones from e ac h s ubc lon i ng reac t i on were
exami ne d for t he s i ze o f the insert and hy b r idization t o RNA
by Northern b l o t analysis . Of t.he 5 c l one s f rom t.h e subcloning
of PA4. a ll had an insert size slightly l arger than the
o riginal cDNA because it a lso con t a i ned a 35 bp polyl inker
region of the vector . One c lone hyb r i di zed i n Northern bl ot
assays wi th a single 4 .5 k.b mRNA transcript that w
13 3
Figure 27. Expre s sion o f PA4 (A) and PA9 (B) mRNA in cervical
cells . Nor t h e rn blot hybrid i zatio n o f 3 Ilg IIlRNA from HEN
t i enes 1) , HEN ~ 1 6 (lanes 2 1, HEN-16-2 (l a nes 3), HBN- 16T
(lanes 4 ) , and HEN- 16 - 2T (lan e s 5 ) with v p - LabeLed PA4 , PA9,
and v-ec t. tn c DNAs was carried out as d e s c ri b ed in Se c t ion
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tran script that wa s specifically expressed onl y i n HEN ce ll s.
Other clones detected e ither no sign al o r nondifferen t iolly
expressed tra n s c ript s . Figure 26C and Figu r e 27 show an
example o f t hese re s ul ts of the d i f f e r e n t i a l l y e xpressed
mRNAs .
3 . 7 . 3 DNA sequence analysis of two isolated clones
The PM a nd PA9 cDNA clones we re a na l y zed by DNA
sequencing, and the sequence da ta are shown i n Fi g ure 20 . The
size of PA4 and PA9 are 315 bp and 292 bp, respe ctive l y . Both
PA4 a nd PA9 have flanking pr imer sequen c es id en ti ca l t o cnouc
use d in d ifferential display : AP4 and AP9 a r bi t r ary pr i meru
sequence were ident i ca l to t he 5 ' end of PA4 and PA9
(und e r l i ne d) , respec t ively, and the T"C A pr ime r
complementary t o the 3 ' e nd of both PA4 and PA9 cDNAs (Tab l e
5 and Figure 28 ) . No ORFs or polyadenylation signal s we r e
f oun d in PA4 and PA9 cDNAs. A compu t e r search i n the
GenBank .EMBL Genbank DNA sequence da t a ba s e s i ndicated t ha t
both PA4 and PA9 had n o sign ificant ho mol ogy t o a ny de pc n i t.od
DNA sequence.
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Figure 28 . Nucleotide sequ enc e o f PA4 a nd PA9 eDNA. A. PA4;
B. PA9 . Sequences of each p r imer sets orig ina l ly u sed f or
di fferent ial d i s pla y an d po l yad enyla t e t ail s a re unde r lined .
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Al
10 20 30 4 0 5 0
GGTACI.C.CAC GAATATGA GGAAGT ATG AGT AGAGGGGAACTGGTACAGAA
60 70 80 90 100
CAGAAGTTA TIT'I'GGGTAAGATCMGGGCAGGATGTAAGM M CTAGT'I'T
110 1 20 13 0 14 0 150
T CAGTIACAAGGGAATAACCATrGGG AATAGAGCTTGGCTTCAGTGMGT
160 170 18 0 190 200
ACTCAA'I'GGTTIAATCCAGGGCfAAACCTCATGTTCTGGGCAGTCG'I'GCC
21 0 2 20 2 30 2 40 2 5 0
CCCTGTAGTGCTTTA.ATTCACTATG GGAAAAGCATCCAA TCTGTG'!TTTA
260 27 ,j 280 290 30 0
CAA AAAA GTACT'ITTTGGAACCCAGT ACCTACTAGCAGAGAGGACCT CCT
300 3 1 5
01lllAMllAlIAAA
Bl
10 2 0 30 4 0 50
OOGTAAC.G~TGGTATATCACTG1,TTTTGTAGAGCTGCGGGAGMCC
60 70 eo 90 10 0
GGAAGAATAACATCCA'ITGTCAATACAGCl'CCAAACMC'ITCAGATGAAT
11 0 1 2 0 13 0 14 0 15 0
TTTACAAGTTACACAGATTG ATACTGTTTAGCTTACAAT'mCCTATT ACA
16 0 1 70 1 80 190 200
ACTTG CTATAGJ\AAGTrGGTACMGTGATCTG CA(' TGT CAAGTAAACTAC
210 2 20 2 3 0 240 2 '50
AGTTAGGAATCCTCAAAGATTGGTTTGT ITGATI"lTTAACTGTAG1"r CCA




DISCUSSION AND FUTURE DIRECTIONS
4 .1 In vitro evidence of cigarette smoke a s a ce-eeeece in
cervical cancer
It has been well recognized that cervica l carcinogenesis
is a multistage process in which HPV and other co-factors are
necessary for the full malignant transformation of primary
cervical cells [ zur- Hausen, 1990 , 1994) . As mentioned i n the
Introduction, smoking has long been regarded as a r isk factor
for cervical cancer (Winkelstein. 1986. 1990). Despite the
extensive epidemiologic and other evidence in support of the
hypothes is of an association between smoking and cervical
cancer (Phill i ps and Smith, 1994), the interpre t ation o f the
association remains equ ivocal, and convincing, more direct,
evidence i s lacking. Therefore , neither t he International
Agency for Research on Cancer nor t he US PUblic Health Service
l i s t cervical cancer as smoking related (Winkels tein, 1990 ) .
I n vi ere system has be e n used widely i n t h e studies on
the role of HPV in oncogenesis of cervical cancer, an d has
provided most of the direct evidence t ha t l i nked HPV to
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immortalization and transformation of cervical cells (zur
Hausen 1990, 1994). In addition, in vi tro system has also
been successfully used to study the roles of some chemical
carcinogens such as NMU, benzo[a)pyrene, and MSEE, oncogenes
such as v -eos , and herpes simplex virus in the maligna nt
transformation of HPv-containing keratinocyte cells (Di Pa ol o
et al., 1990; Li CI:; al ., 1992; Garret et al ., 1993;
KlingeIhutz et al ., 1993 ; Xu et al., 1993 ; Shin at al., 1994) .
However, few in vitro systems have been set up to mimic the
multistep carcinogenesis of cervical cancer. Even though HPV-
1 6 and HPV-18 immortalized foreskin and cervical cell lines
have been widely established, tumor cell lines derived from
HPV-immortalized cervical cells are rare. Most of tumor cel l
lines used for tumorigenicity studies, such as aeie , SiHa , and
CaSki, are derived from cervical carcinomas, have been kept i n
culture for decades and do not have isogenetic nontumorigenic
counterparts. In addition , while the endocervix is the origin
of over 95\ of cervical tumors, HPV-immortalized cell lines
and tumor cell lines that are der!vee from endocervical cells
are lacking . An in vitro system mimicking the multistep
carcinogenesis of cervical cells from the same original
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primary e nd oce rvi ca l ce l ls will be ve ry useful to study t he
molecular mechanism unde r l y ing th i s onco g e nesis process.
In t h i s study, it was found that endocerv i cal cells
Lnmor t a Ldaed by HPV16 were not t umor i gen i c and cou ld not form
t umor s i n nude mice (Table 6 ). However, when the immorta lized
cel ls were t r ea t ed during cul ture with cigarette smoke
condensate , the t rea t ed i mmor t a li ze d ce ll s were malignantly
t r a nsf ormed and formed squamous cell carcinomas in nude mice
as conf irmed by pathologica l ana lysis (Fi g ur e 7 ) . The
t r a nsformed t umo r ce l l lines obtained the general growth
Cha r a c t e r i stic of t umors : faster growth in serum-containing
medium , an ch orage-independent growth, and reconstruction o f
more undifferentiated epi thelia in i n vi tro organotypic
c ul t u r e. These results provided the first in v i tro evidence
t hat cigarette smoke can i nduc e cervical c a r c i noma . In
addition , they supported the epidemiologic suggestion that
c i garette smoking has a late stage or promotional effect in
the on cogenesis of cervical cells (Da l i ng et al., 19 92) .
Neoplast ic transformation o f other cells , such as bronchial
epi thelia l cells immorta lized by adenovirus l2 -SV40 hybrid
virus , by esc was also observed in vitro i n other studies
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(DeMari ni , 1983 ; Klein·Szant o et a 1., 19921. Howeve r , be cau s e
o f the co mpl ex i t y o f e s e compone nts and t he trans formation
process , the mechanism by whi ch ese ca use s t he neoplastic
transformation o f human cells is not yet fully und erstood . esc
has been demonst r ated to produce many g enet ic and ep igenetic
effects usually associat ed wi th carc inogens a nd promoters ,
s uch as alterations i n cell growt h and EGF binding , tcrmet t ou
of single strand DNA brea ks, inh i bi tion of DNA repai r, a nd
induction of t e rmi na l s quamous differen t iation (DeMar i ni ,
199 3 ; Will ey et al., 19 B7 ; Klein-Szan t o et a l ., 1 992 ; Si mons
et a l . , 1 995) .
Despite t he s i gnifican ce of t he present s t udy. several
points have to be cons idered caref u l ly when di scus s i ng the
above results . First, the esc used in thi s s tudy is composed
o f over 3 , 000 component s . The r efore , i t i s dif f icu l t to
determine which component i n CSC i s re s ponsible for t.h i s
tumorigenic t r a ns f orma t ion. Se con d, the l owe s t co nc ent rat ion
o f esc that was used for the trans f orma t i on of HPV16 -
immor talized endocervical cells was 7 5 ~tg/ml . Athaug h t umors
could not be f orme d af ter treatment o f HPV16 -immortali zed
ce lls with low concen t r at i on of e s c , such as 25 and 50 ~tg /ml ,
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ov er 1 ye a r {unpu blis he d da tal. lower co ncentra t ions ma y a l s o
be effective. Since the esc co ncen t ration used in the present
in vitro study may be h igher than tha t in cervical basal cells
whi c h mos t receive carcinogens via the epithelial Laye re from
t he mucus i n vivo, it took only 6 - 12 mon t hs for t he
i mmortali ze d cells to be transformed into tumo rs by esc in
vi tro. On t he other hand , it usually takes decades for HPV h
infected pa tients to de ve l op cervica l cancer (aur Hausen,
1994). In fact, it has been demonstrated that the r isk for
developing ce r v i c a l cancer is enhanced with increased number
of c igarettes smoked (Wi nke l s tein, 19 90), indicating that esc
concentra tion in ce rvix fluid may be critical i n determin i ng
t he interval be tween HPV i nf e c t i on and cervical c ancer . Third,
t he i n vi tro monolayer cells and in v i vo epithelia
markedly d ifferent . The status and ex p ression of HP V , t he
ce l l-cell i nteractions, t h e concentrations of add i t i ona l
cofactors , such as hormones , and g rowth factors an d the host
i mmune response are some t ypical d ifferences. Thus, how HPV
and esc interac t to t ransform cer--Lc et cells i n vi t ro and in
vivo i s still unclear.
Des p i te the above uncertainties , the in vi tro s ystem set
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up in thi s s t ud y r emains use f'u I for u s t o understand the
molecular mechani sm o f multistep carcinogenesis of cervica l
4 .2 Role o f HPV and cellular g enes in i mmort.. : ~7.at ion o f
primary c e rvica l ce l ls
Although i rmta r t al i za t i on of human cells in vitro i s a key
step in oncogenic progression, the molecular mechencsma
underlying this event are still poorl y unde rstood (Shay ct.
a l . , 19 91) .
4 . 2 .1 . HPV
Pr e v i ou s s tudies have demonstrated that HPV 86 and 87
products a re the main proteins responsible for i mmortalization
of human cervical c e lls (Munger et aI. , 1989a, 1992). Our t wo
immor t alized cell l i ne s were establ ished by transfection of
HPV16 DNA i nto the human endocervical cells, an d E6 - ln
transcripts are the ma in transcripts in the HPV16-immortalized
cells (Tsutsumi et aI , 1 9 92; Figure 12). I n addi t i on , HPVlI>
DNA was not episoma l in inunortalized c ellS, and at least 2 .6
kb DNA coding fo r p a r t of the L1 ORF have been deleted in
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immortalized cells (Figure 12B, ct . Therefore , expression of
E6 and E7 proteins, integration of viral DNA into h o s t genome
and deletion of part of its DNA may be nec e s s ar y for
immorta lization. This conclusion was a lso supported by
observat ion that HPV DNA wa s episomal in cervical cells before
crisis a nd became integrated after crisis or immortalization
by HPV18 (Yokoyama et al ., 1995).
Even though continuous expression of HPV has been
regarded as necessary for the establishment of immor t a l i zed
c ells, expression of HPV per se can n o t account for
i mmortali zation , For example, when t wo HPV1S-immortalized
cervical cells wer e fused , the hybrid cells b e came senescent
b ut still expressed HPV, indicating that s enescence o f t he
hybr i d cells wa s not due to loss of HPV18 rnRNA e xpr e s s i on
(Chen et; a1., 1993) . Therefore , alteration of cel lular genes
t hat ei ther are regu lated by HPV or function i n di vidually must
contribute to or be directly responsible for irrmortalization.
4 .2. 2 Onc ogenes
It ha s be e n shown tha t early passage ro dent cells can be
immortal ized b y oncogenes such a s H-ras, c -myc, c -jun and v-
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s rc (Cole a nd Kelekar. 1987 ; Linde r and Marshall . 1990 1 .
Furthermore , amplification and ec t Ivaercn of some oncogenes .
most freque n t l y c-myc and u -ras, has been ob se rved in cervical
carcinomas (Dur s t ee al. . 1987; OCadiz e t al . . 1987 ; s eqae at
;01.., 1990; Riou e t a l . • 199 0 ; Crook et al . , 1990) . Therefore.
oncogenes ha ve been pos tulated t o be corec t oce for
i nmortalizat i on . However, s i nce co nflicting r e su lts have
been obtained by othe rs (lkeberg et a l., 1987 ; s aga e e c al . ,
1 990; Pel i s s on ec a l. , 1992 ) , t he ro le o f oncogenos i n
t r ansformation of cervical ce lls is sti ll d i s p u t a b l e .
Res ul ts in this study clearly sh owe d that amplification
o f c -my c o r x -ras was not found in HEN- 16 a nd HEN- 1 6 - 2 ce lls
(Figu r e 131 , indicat ing t hat ne ither oncogene is involved i n
t he ilmlOr talization o f primary endocervical ce ll 5 by HPVI6 . On
t he other hand , B-myb expression was enhanc ed 19 - t.o 37 · f o l d
in immortali zed cells ( Fi gu r e 13 and Tab le 7) . B- myb ha s bee n
recognized as an oncogene t ha t regulates the p r o li f era t i on or
cells by inter acting wi t h cell - cycle regu lat i ng genes (Nomura
et a l . , 1988 ; sara an d Cala br e tta, 1992; Lam and Wa t s o n , 1992,
1993). Rec ently , i t ha s been demon s t r a t ed t hat B-myb ca n be
t ransact i vated by the HPV16 E7 oncoprotei.n (Lam et 011 ., 199 1) .
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Therefore , the act iv at ion of e·myb i n i mmortali zed ce l l s may
be caused by t he transactivating ef fect of HPV16 E:7.
Furthermore, it rec e ntly found t hat cons t i tutive
express io n of B-myb c ou ld bypass p53- induced Wafl ! Cip l -
medi ated Gl ar re st (Lin e t al . , 19941 . Thus, act ivation of B-
myb in HPV- posi t i ve ce lls co uld allow t hes e ce l. ls t o bypas s
the n ormal cell cycle ar r es t me di ated by some t umo r suppr esso r
gene s, such as p53 and Rh , and lead to immor t al. i za t i o n . This
can also be compl icated by the act i on of E6 an d E7 o n t hese
tumo r sup p ressor genes (Lin et a L. , 1 994 ) . This stud y
provided the fi rst evi dence that deregulat.ion of B·myb by HPV
may be invol ved in o ne o f the p at hway s l eadi ng to t he
immor t ali zat i on of pr im ary cervica l cells.
4 . 2 . 3 Tumor s up p ressor gen es
Inact.ivation of tumor s u ppressor ge nes , especi al l y p53
and Rb, has been r eg arded as on e of the mo st impor t ant.
pat hways leadi ng to Lmmor t-e Lfaat.Lon of cell s (Li nder and
Mars hall , 1 990 ; Shay et. a1.. 19911. However, t h e path ways b y
which t he s e tu mor suppresso r gene s fun ct i on are unc lear. I n
add ition, whether t he inactivation of a s pecif i c tumor
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su ppr es s or gene i s a n e arly or late even t in cervi cal c ance r
is al so u nce r t a i n .
The p5 3 tumor-sup p r essor gene has been ide ntified as a
pa rticipant in cell cycle con trol. DNA synthesis and repair ,
maint enance of genom ic stab il ity, cellular diffe rent i a t i on ,
an d programme d ce ll death (fo r review , se e n oneb owe r a nd
Br a d l ey, 1993) . I t wa s a lso recogn ized as one o f the
i mp o r t an t ce l lula r g ene s known to be i nacti v a t ed by HPV
(We r nes s et al . , 1989 ) . Deg rada t ion o f p 53 by the HPV16 or
HPVl a E6 pro tein ha s been s hown to b e ne ce ssary b u t 1I0t
s u ffici e n t f or the Lmnort.aj.Laa t Ion of p rimary cervica l ce ll a
(Pe cor a r o e t al ., 1989 : ae ee r a e t al . , 19921 . Interest ingly ,
i n t his s t udy , the ex pression of p 53 was g re atly en hanced in
all i mmort alized cells (Figu r e 14) . Similar r e sults were al s o
found i n HPV18 - irrmor talized ke rat i nocy t e s by others (Li et
a l ., 1992 : Sh i n et al . , 1994 ) . Although p 53 p r ote in leve l s
were no t. chec ked in primary cervi ca l cells an d i mmorta li zed
cel ls in t hi s s t udy, a lmos t a ll the p r e viou s stud ies ha ve
demonat r-e t.cd t ha t the p53 prot e in l evel s are much l owe r i n
i mmor t a l i zed c e lls t h a n i n p rimary ce lls a s a r e s ul t o f t heir
degradation by the E6 protein (f o r reviews see Munger e t e L,.;
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1992 and Scheffner et a1., 1994). The i ncre a se of p53
expression in inmortalized ce l ls may be a s trategy of cells t o
compensate for the degradation of p53 proteins under t hi s
"stress" condition . This result provided additional
i n f onna tion for t he action of tumor su ppressor genes i n
immorta lization of cervical cells .
Wafl/C ip l /Sid l is a recently identified uni v e r sa l
c ycli n - ki na s e l nh i b itor up-regulated by p53 (Xi o ng ec a1.,
1993; Harpe r et al., 1993 ; EI -De i ry et al . , 1993; Noda e c al.,
199 4). I t participates in ce ll cy cle regulation , DNA
replication , DNA damage -induced Gl a rrest, apopcoe ts ,
s e nescence and differentiat ion by a pS3-dependent an d p53-
i ndep e n dent pa thway (Noda et a l . , 199 4 ; EI -Deiry et a1., 1994 ;
Waga e t al . , 1994; Jiang et aI. , 199 4 ; St einman e t al ., 1994;
Ha l evy ec a l . , 1995 ; Parker e t al., 19 95). In this study , it
wa s found that Waf l was suppressed in all immortalized cells
{Figure 14M . Since p53 p r oteins are usually deg raded in HPV-
i nunor t a li ze d cells, it is re asonable t o conjecture that the
t ransactivation o f Wafl b y p53 was decreased as a res u lt of
d e cre ased pS3 prot eins. This result indicated that
d e reg u lat ion of Waf1 may be involved in one of the pathways by
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whi ch p53 func t ions i n t he i mnortal i : atio n of c e rvica l cells .
4 .2 . 4 DN A replicat i on- an d r epair- re late eS gen e s
Human ce l ls are u s ual ly cont inuously exposed t o various
ag e n ts, s u ch as chemical carcinogens, irradiat ion or D NA tumor
vi ruses, that c a n damage ce l l ul ar DNA, RNA, and pr oteins . T il l!
damage can have two consequence s : cel l death or neop last i c
co n v ers i o n of t he c ells . Therefore, maintenance of t.h e
integrity of DNA. in somat i c cel l s ove r ext en d e d t i me is or
imp o r t an c e in k eepi ng t he n ormal function o f t he cells . To
the genotoxicity o f DNA- dalllag i ng ag e nts, cells a r e
equ i pped with several molecular d efens e mecha nisms wh i ch
ei t her p r even t the i nduct ion o f DNA d amage or r e pair the
da ma ge ( Kaufman and Kaufman, 19 9 31. In the c ase o f norma l
ce l ls, cells u s ually stop d i visio n by transie n tly arres t i ng
cel l cyc le pr o gression , ca lled GI erree r or G2 arre s t , and
permit ting the repai r of damaged DNA. {znen et al . , 1993 ) .
Failure of DNA repa i r allo w for t he inherita nce of damaged
genes and may r esul t in t h e emergence o f neoplast i c ce l ls.
Recent s t udy indicates t hat ce rvi ca l a nd or a l ce l lu
i mmor t al ized by ' high rislt ' HPV DNA fa i l to arrest cell cycle
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progression when ex posed t o DNA da ma gi ng agents , such as UV-
radi at ion or act.inomycin D ( Kuerbi tz e t al . , 1992; Ke ssis a t
al. , 1993; Gujuluva e t; a1 . • 199 4 ; Slebos et; a1., 1994 ) .
Therefore, deregu l at i o n of DNA re p H eat a e n and repa i r genes
may b e one of t.he pa thways lea ding to immortali za tion of
cervical cells.
peNA , a lso called "cyc Ld.n s , i s an auxiliary pr o t ein o f
DNA p o l yme r a se p , whi c h is as s o ci ated wit h DNA r e p licat ion and
repa ir (Al me ndra l et a l., 19B7; Zeng et a I , 19941 . Re c ent l y ,
t he amplification of PCNA express ion was fou nd in cervical
intra ep ithelial lesions in vivo (Deme t.er ec al., 199 4 ;
Karakitsos et a 1., 1994). Using No r t hern hyb r idi zat ion and
indirect immunofluorescence as says, it c lear l y
demonstrated in this study t ha t P CNA wa s al s o a ctivat ed in
immortalized ce lls in vitro {Figure 15 AI. Althou g h the
mec tr e ntam b y which PCNA is involved in t he immo rtali zatio n
process i s sti l l unclear, recent studies demonstrate d that
Waf1 may b J ock DNA repl ication by interacting wi t h PCNA (Wa g a
et a l . , 1994J. ThUS, depression of Waf 1, inde pendent or
depe ndent on pS3, i n immo rta l i zed cells may be par t o f one of
the me cha n i s ms for th e relat i ve increase ::.' ; PCNA proteins i n
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immortalized cells .
GADD4S is an ubiquitously expressed mammali an gene t hat
is i nduc e d by DNA damage {pa pa t h ana aLou et al ., 1991; xa et.an
et al . , 1 992 ; Hollander et al . , 1 993; Ca rrie r et al . , 19941 .
I t is associated with DNA damage-induced growth arrest t zn au
et al . , 1994). Recentl y, it was found t h at GJ\DD45 c o ul d
interact wi th PCNA t o repair damaged DNA (Smi t h e c al . , 1994) .
In this study, no signif icance d ifferenc e i n GADD45 exp re a e ton
was observed be t.ween HEN and HPV~b-lmmortal.i.zed c .e I l s ,
indicating that GADD45 is no t involved i n immor talizat ion . No
Change in GADD4 5 expression was found in HPV-ifTlllo r ta lized o wl
kerat inocytes (Gujuluva et aI., 1994 ) . Since GADD45 i s a l s o
transactivated by p 53, this result i nd ica t e d t ha t modulat i on
of immor t.ali zation by pS3 is not performed throug h the GADD4S
p a t.hwa y and t.he degradat i on of p53 by HPV16 E6 has no
significant e ffect 1n this in vitro sys tem .
GADDI S3 is another me mbe r of t he 0,\.')0 gene family , wh i ch
i s associated wi t h growth arrest af t e r DNA damage or at r-eas ,
and differentiation. but is not regulated by p53 (Carlso n ec
al. , 1993 ; Barone et a1., 1994 ; Luethy a nd Ho lbro ok. 1994 ) . I n
this study , although the exp eriments were r epe a t e d s e ve ral
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e i eee , a dec r ease of GADDiS) mRNA was obs erved in HEN-16 cells
(Tabl e 7 and Figu re l SC) , and a 1. 9- f old i n c r ea s e of GADD1S3
mRNA wa s found in HEN- 16-2 . An opposite effect occurred
during t.umorigenesis. A d e cr ea s e of GADD1S3 was found in HPV-
i rrmor t ali zed ora l ke ratLnocyt.e cells lGujul uva et a l . , 1 9 94) .
Thus, t he r o l e of GADD1S3 in the i mmor t a l i zat i on of norma l
end ocervi cal cells is st ill elusive.
4.2. 5 Senescence- related gen e s
At t he cellular l eve l , three gen eral me c hani s ms fo r
suppression have been d ocumented : stabilizing the human
genome , controll ing proliferation. and terminally
differentiating, which involves t he irreversible loss of
prolifera tive capacity. Senescence is a p henomenon in whic h
cells can no l ong e r respond to a ny p r o li fe r a tive st imul us . I t
has bee n regarded a s the r eversa l of immor t a lizat ion . Previ ous
evidence has suggested t hat there are four dominant genes or
complementa tion groups that are i mp lica t e d in senescence ,
i mpl y i n g t h a t the l os s of t he s e genes or their functions is
e s sentia l for tsmor ce tf aa t i cn (Pereira - Smith and Smith , 19BB ).
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FN is a we ll establ i shed marker of ce l l ul ar senescence
(Ku rnazak i et a r. ; 1991; Khandjian et; a l. , 19921 . Previou s
s t u di es indica ted that FN mRNA and protein i ncrea sed
significantly d uring t he process of ce l l ula r aging in t t c c uc
cu lture (Kumazaki e t a l .• 1991 ) . Howe ver . PH mRNA l e ve ls
became l o w in $V 40 tra nsformed cells I Khandj ian ec at , ; 1 9 9 2 ;
Noda et a1. .• 19 9 4) . In my study, FN mR~A was almo st complete l y
abolished in a ll th e itm'lOrtalized and t u mor c e lls (Table 7 and
Figure 17M. In situ hybridiza t ion and indirect
i mmunof l u o r es c e nce sh owed t hat FN mRNA and protein
e x p r ess e d onl y in HEN cells ( F igur e 178 an d Figure 19) .
Furthermore, expres s i on o f a recent l y i dent i fied senes cence
cel l ·deriv ed inhi bi t o r ge n e, Sidl , whi ch l a ter wa s proven to
be Wa f l. (Har pe r e t al ., 1 993 j N od a e t al . . 199 4) . was a t sc
e n h anced i n s enes cent c ells (NOOa et e t , ; 19 941 and
s u p pres s e d in i lllllOrtalized cells (Fig ure 14) . The s e rea u n, s
confirmed tha t loss of eeneecence - rela t ed gen e s may be
i nvolved in o n e of the mechan i s ms fo r i mmor ta l izat ion of
pr imary cervical cell s by HPV16 .
4 .3 Rol e of HPV and cellular genes invol ved i n !Mligna nt
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p r ogression o f i mmo r ta li z e d cells
I t ha s been generally accep ted t hat i mmor t a l i zed human
c e ll lin es are not tumorigenic wh e n i noculate d i nto nude mice
(zur Ha usen, 1..994 a nd Tabl e 6), indi cat i ng t hat oth e r cha n g es
are re q uired fo r the fu ll malignant t rans f ormation of the
c ells . Ho weve r , our knowledge of the molecular me ch anism of
t his malignan t progression proc ess is still f ragmenta ry .
Previous studies have demonstra t. ed t h at some chemical
carcinogens, UV and low-dose X - r ay irradiation , and s ome
viruses, such as HSV and probably HIV, may cause the mali gnant
convers ion of irrrnortalized cells <DiPa olo et aI. , 1990; Li et
a l., 1992 ; Garrett e t al ., 1993 ; zur Ha usen a nd de Villiers,
1 9 94) . In addition , hormo nes ha ve been shown t o enhance t he
transformatio n of HPV-immo r t al i z e d ce l l by a n activated
oncogene (Pat e r e t al ., 1 9 88 , 1990 ,1 994; Durst et a l. , 19 89 ).
I n my s tudy , cigarette s moke c o ndensate wa s also shown i n
v i ere t o be a cofacto r fo r t h is ma lign a nt progr ess ion .
Howeve r, how t his fact or contribu tes to th e maligna nt
convers ion, o r whi ch ge nes a re affected t o me diat e t h i s
conver s ion, i s stil l unc lear .
So me stUd ies s uggested that fu r ther increases of HPV
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expr e s s ion o r mod i fica t ion o f HPV i n t egra t ion may be
respo n sibl e f or t h i s rnal.ignan t progress io n (Li e t a1. . 1990 ;
eur Hausen . 1991) . Howe v er, my resul. t s and th o se of others
(McDo u gall, 19 9·4) clear ly demo nstra t e d t h a t no c ha nge in the
le vel of HPV express ion was de nect ed be twe e n HPV - illlllOrt ali::cd
cell s and t.u morige ni c cells , i ndica t i ng that HP V may b e not
i nvol v ed i n t he mal ignant p rogress ion o f HPV-inrnor t alized
cell s .
Oncog e n es h a ve been suggellt ed t o b e inv olved ill t he
malig n ant trans fo rmat i on of HP V-immo r tal i zed cells f or the
followi ng r e a sons . Fir s t, cren s rectf.cn of x - ras o r v-fos into
HPV i mnorta1 iz ed cell s can induce tumor i genic ity o f t hes e
cell s (DiPa o lo e t at. ; 1989 ; Durst e t d . , 198 9; xu e t; a1. .
1993 ) . Secon d , amplific a tion o f. '}neog enes s uch a s e-eyc- a nd II·
r as, e rb B2 has been det e c t ed i n cerv ical c a rcinomas toc e cns ee
al . , 19 87 , Riou e c al . • 1990 ; Saga e et a l . , 1 9 89; Mi t r il ec
al . , 1 9941 . Thi r d , enha n ced expr essi on of H-ras a nd c- my c has
been f ound in tra nsforme d cell lines (Li et at. , 1992 ; Shin nt;
al . , 1 9 94 ; I wasak a et a 1 . , 1993) . However , uncha nged oncogene s
also were found fr equently in transf ormed ce ll lin es and
cer v i c al ca rcinomas (I k e nber g et al . , 19 8 7 ; lwasaka e t aI. ,
1 5 6
199]) . In this study, no obvious amplification of c-myc and B-
ras was observed, further suggesting that these oncogenes were
not i nvo l ved in the malignan t transformation of HPV-
immorta lized ce lls by CSC. Therefore , the r ole of oncogenes in
t.he maligna nt progression of immortalized cells needs further
study.
Although tumor suppressor genes playa central ro l e i n
t he devel opment of t umor s and they can usually suppress the
g rowt h of t umor c e l l s , t he exact f unct ions of t he s e genes in
inhibit ing the mult i step carcinogenesis of ca n ce r remain not
fu lly understood . In my s tudy, the t h r e e tumor suppressor
genes, p5 3. wae i • and DCC did not show any changes of
expression in e SC- trans f ormed ce lls compared with immortalized
cells (Figure 14A,B) . However, the expression of pS] and Wafl
was subs tantially changed after immortaLzation, indicating
the t. they may playa ro le in the early stage of endocervical
cell oncogenesis- immor ta li za t i on. This result clarifies t.he
confounding role of pS3 in immorta lization and tumorigenicity
o f cervical In addit ion, as discussed in t.he
Introduction, p5] was shown t o be involved in the late stages
of co lon cancer , sugges ting that the same tumor suppressor
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gene may function at different stages of multistep
carcinogenesis of different human cancers.
Several studies have shown that Dee was deleted in some
chemical carcinogen-transformed HPV-immortalized kerat inocytes
(Klingelhntz et; al., 1993 and Shin et al ., 1994 ) Recently,
wild-type full - length Dee but not the t runcat.ed form was shown
to suppress the malignant phenotype of NMU -trans formed HPV-
Lnmort.af f aed epithelial cells {Klingelhutz et al ., 19951. Th i n
indicated that DCC is a tumor supnreaeor' gene, the loss of:
wh i c h may be involved in tumorigenesis of HPV-immortalized
cells. However, no deletion of Dee was detected in CSC-
transformed cells i n this study (FigUl'e 148), suggesting t hat
Dee deletions are not a common phenomenon in the cnemtcat
carcinogen-induced malignant progression. Alteration of DCC
expression may also occur by point muta tion and loss of
heterozygosity, which needs to be further studied .
Overexpression of PCNA is observed in many types of
malignancies inclUding lymphomas, breast, and pancrea t i c
tumors (Hall et al ., 1990). In addition, PCNA amplification
was ooaer-ved more frequently in biopsies from patients with
high grade lesions , eIN III and koilocytosis, than those with
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low grade l esions, CIN I and CIN I I (Kar akitsos e t a1 ., 1994) .
The increase of PCNA mRNA in CSC-transformed cells compared
with HPV-immortalized cells was consis ten t with the above
clin ica l observations . Both resul ts suggested t hat PCNA can be
used as a molecula r marker fo r t he mul tistep carcinogenesis of
ce rvi ca l cancer .
Although the GADD g ene family was originally kn own to
r ep resent DNA damag c - i nduced genes, recant studies
demonst rated that t hey can s uppr e s s the g rowth of tumor cells
{Zha o ec al . , 19 94 ) . GADD4S and GADDIS3 were shown to suppress
s pec i fica lly t he growth of an establ ished cervical cell line,
HeLa (Zhan et a l. , 1994 ), suggesting that the l os s of their
f unct i on may be associated wi th malignant conversion of
cervical ce lls. Howeve r , in this study, no significant
al tera t i ons were observed in t he leve l of GADD45 and GADDIS3
exp ress i on in csc -t reneeormee cells compared with >'1i r
un t ransformed c ount e rpa r t s. Recent studies suggested that the
l oss of the response of p53, Wafl, GADD45 , and GADDIS3 to DNA
da mag ing age nts , such as tlV l i gh t a nd ecctnomycm D, in HPV-
i mmort a l i zed cell s may be one o f t he imp ortant pathways
lead ing t o t umorige nesis of HPV~immortalized cells (Bae k et
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al ., 1994 ) . Thus , the func t ion of ce llu l a r ge nes i nvolved i n
DNA repa i r may be impaired by inactivating their response to
DNA da mag i ng agents but not their basal transcript ion . Th i s
needs t o be furthe r s tudied.
4 .4 Response of c e rvica l cel ls a t di ffe r ent sta g e s o f
oncogenesis t o cytoki nes and RA
4.4 .1 Cytokine s
Recently , i ncrea s ing ev i dence suggests t hat the e xistence
o f an int ra cel l ul a r surve i l l ance system i s very i mpor tant t o
protec t host c e lls from the potent i all y de l eterious er re cc
caused by vi ra l t r a nsformi ng genes and other factors . Loss ot
this a utoc r i ne self ·regulating syst em is one of t he moot
important pa thways leading to t he malignant trans f orma t i on of
cells (zur Hausen , 1994 ) .
Cytokines suc h as TNF-l>, TGF. f\I , and i nt e r f e r on -yar e one
group of molecules released by immune ef f ec tor cells an d a re
::.h ough t to be i nvolved i n the int racellular surve i lla nce
system. Recent s tudies have shown that some cvcos inee . suc h as
TNF-p, TGF·l>I, INF- y, a nd I L-6 , can su ppress proliferat i on and
e xp r e s s i on of HPV i n HPV·positive cells , and the loss o(
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response to these cytokines is very common in established
c e r vi ca l carc i noma ce l l lines, such as CaSki and HeLa (Brau e t
a l . , 1990 , 1 9 9 2 ; Woodwor th et; a l . , 1 9 9 2; Vil la e t a1 . , 1 9 9 2 ,
Kyo et a L. , 1994, Ro s l et; a l . , 1994, Agarwal e t al. , 1994).
Thus, i t was s ug gested t hat t he loss of sensi tivity to
i nhibition by c ytoki nes may be an important step in the
deve l opment of cervical carcinomas . However, f rom the a bov e
s tudies , several qu estions co uld be asked. First, did the
t umor cell lines lose sensitivity to all cytokines or did
t he y lose sensitivi ty t o onl y a specif ic type of cytokine?
Second, i n most of t h e above stud ies , only established
cervical carcinoma c e ll lines or hybrid cell l i nes were used
(Brau e e al ., 1990, 1992 ,' nest et a l . , 1994 ) . These
es tablished cell lines have undergone marry genetic ch anges
whi le being mai ntained in cul ture for several d ec ad es . So, are
these c e ll lines rel iable representatives of t umor cells?
Regard ing hyb r i d cells, the ge netic complexity of t hes e cells
make the results diff icul t to i nterpret . Th ird, since c ervica l
c arcinoma cell lines were used i n mos t of the s tudies , i t
r emai ns unclear whe the r l o s s of sensi tivi ty to cytokines i s an
e a r Ly or late event . Fourth, the loss of sens itivity to
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c:ytok ines may mean t he loss o f sup p r e ss i on of p r ol i fe ra tion or
l oss of suppre e e t en o f HPV expres s i on by c:y t oki ne s . Were t hese
two effects the same? Fi f th, by wha t pa thway s d id t he
cytokines su pp res s the p roli fera tion and HPV ex press ion? To
address t h e se issues , I perfo rmed several exper ime nts us i nq
primary , HPV16-irrrnortali zed , CSC- trans fonned a nd CaSk i cet r e .
Fi r s t , i t was f oun d t ha t t umo r ce lls may obta i n m se ns i ctv tuv
t o certa i n ki nds of cytok i n e s but not to all c ytok i nes . For
exa mp l e , CaSk i i nsen s itive t o TGF-111 but no t 1'N[1·11
(Fi g u r e 19 an d Fi gure 22). Second , i t wa s s ho wn t hat t he
resul t s obt a i ned wi th e s tab l i sh ed cerv ical carc i no ma ce l l
l ine s were some times not repres e nta t i ve results f o r ot he r
t umor cell s . Fo r ex amp l e , t h e l o s s of g rowth inhibition by
TGF- JlI in t umor c e lls ha s been regarded as a coeenon phe nomenon
for t umor cells (Brau et; a l ., 1990 , 1992) . Howev er , Figure 22
sho wed t hat , even t hou gh no su ppre s s ion of proliferat i on by 5
ng /ml of TGF- Jh wa s f ou nd in CaSk i cells, the proli f e ra t i o n
of t wo CSC- t r a n s f ormed t umor cell lines , f18N- 16T an d HI::N -1 6 -
21', was suppressed fo r TGF-p1 by over 50\. Thu s , t he 101m 0 1
res ponse t o cytok i ne s may be no t ge ne ra l fo r t umor ce t i u .
Third , s i n ce t he loss o f se n s it ivity to TNF-fL and rcr -m wa s
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no t o bserved i n HPVl6-immortal ized cells an d CSC-transformed
cell s , i t is difficult to say i f it is an early or l a t e event
in this system . However, complete loss of response to TGF-Pl
was found only i n ca rc inoma cells that have und e r gone
e xtensive c ha nge s i n women a nd i n cu lture (Ge e s t e t a1.,
1994 ). Thus , i t was s ugges ted that l o s s of sensit ivity t o
cytoki ne s might be a l ate event . Fou r th , i t was demonstra ted
from my experiments t ha t t h e inhibition of proliferat ion by
cy tokine s may be different from the suppression of HPV
e xp r e s s ion by cytokines . As sh own i n Figure s 2 2 and 23 ,
although no suppression o f proliferation by TGF-pl
obs e r ved for CaSki cells , t he i r HPV expression
s ignif i cantly suppressed after treatment with TGF'-Pl (F igure
22 and 23). This conclusion was consisten t with that drawn by
Agarwal et al . (1 99 4) , who studied the effect of IFN -yon the
proliferat i on and HPV expression of HPV16 - immortal ized
cervical ec tocervical c ells.
Suppress i on o f prolifera t ion and /or HPV expression of
c e r v ica l c e l l s by cy tokines has been observed by many
r es e a rchers over many years (Br a u et a l . , 1990, 1 992 ; Vil la e t
a l., 1992; Woodwon . h et al., 1992; Male jczyk et a l., 199 4 ;
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Geest e t al. , 1994 1. However, t he e xac t eecuen t sm u nder l y i ng
this suppres s i on is Rtill poor ly unders tood . Unt il now, only
o ne cellular gene , name ly NF-IL6 , ha s been s hown unequ i v oc a lly
t o mediate suppress i on o f HPV exp ression by I L~6 th r ough
binding t o the noncoding region (Kyo et al ., 1993) . I t has
be en suggested that t he suppres sion of HPV expression by
cy tok i ne s is med i ated by t r ans cript ion f a ctors binding to t he
LCR of HPV (Kyo et al ., 1994 ) . It has been pr op o s ed by others
t hat c-myc is one of t h e ce l lular genas related to growt.h
suppression by TGF·pl , since c- my c expression was usually
suppressed after TGF- p l e reew-ent (P i etenp ol et a l ., 19 901 .
Ba s ed up on the a bove informat i on , I c heeked the c-m y c
express i on after nlF- p and TGF-pl t reatment . I t wa s found that
c - myc expre s s i on i n a l l cell l ine s wa f! su pp r e s sed after
t reatment b y e i t he r (Fi gu r e 20 and 23 1 . Since c -my c i s a well -
kn own oncogene t ha t r egulates ce ll proliferation , the
suppression of thi s gelll? j mplies that i t may mediate t.he
supp r ession of proliferation by TNF-p a nd TGF-pl treatment .
The J E gene, a lso cal led MCP· l , MCAF , and SMC-CF, en cod es
a secr eted g l y cop r o t ein with c ytokine- like properties , whi c h
s timul ates human monocytes and i nduc e s monocyte -media t ed
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i nh i b i t i on of t umor cell growth i n vivo and i n vitro (Rollins
et al. , 1989 ; Rolli ns and Sun day , 19 91 ) . Rece n tly , it was
s ho wn by Rosl e t a l. (199 4) that the JE gene was only
e xp ressed an d i nduce d by TNF-a i n non tumorigen i c xer.a -
fib r obla st hybrids but not i n t umo r i ge ni c hybrids, an d t ha t a
c ha nge of JE: ex press i on i s accompanied by a simila r change i n
HPV tra nscr i p tion. Thus , it was sugges ted that the los s of JE
g e ne express ion and the i nduct i on of this express ion by TNF-a.
is one of t he importan t char acteris t ics of tumor cells and
t hat t he JE ge ne p layed a p ivotal r o le i n intracellular
co mmunic at ion by t r i ggering a n intracellular pa t hway wh i ch
inte rferes wi th viral t r a nscription in HPV-positive
nontumorigenic c e ll s (Ros l e t al ., 1994 ; zur Hausen and de
v t r i r e re , 1994b). From a bo ve results , three ques t i ons we re
asked 111it L L'ty , 1l Is loss of J E express ion or induct ion by
TNF-a an ea r l y or l a t e event? 2) Are either loss or i nduc t i on
specif ic f o r tumo r ce ll s or only for t umorige n ic HeLa-
f i brobl ast hybrids ? 3 ) Is t he c orrel a tion be tween suppress i on
of HPV by TNF-n and t hat of JE by TNF-a a c oi n c i d e nce or a
common phenomenon f or noncumorigen i c cells? In this study, it
was f ou nd that 1 ) while JE: ge ne DNA was de tected in a ll the
165
cel l line s e xamined, no JE rnRNA wa s detected or i nduced by
nlF-a in i mmor t a l ized cells an d t umor cells (data not shown),
suggesting that loss of JE gene expression or i nduction by
'nlF-a was an ea r ly event but not specif ic for cursor cells . The
l os s of J E expression or induction by 'rs e- « may be related
t o t he rearrang ement of t his g ene (Figure 211. I n addition, 21
s i nc e HPV16 was ex pressed but J E was not e xp res se d in bo t h
i mmo r t a l i z ed cells , supp r e s s i on of HPV by TNF-a may be
unrelated t o t ha t of J E. These results cha llenge the role or
JE in the supp r e s s i on o f HPV by TNF- n a nd provide ne w
informat ion on t he r ol e of J E in t he mult istage tumo rigenesin
o f c e rvi cal ca n ce r .
Some studies suggest that p53 and the Rb tumor su ppressor
genes products may interact with but not directly mediate the
gro wth inhibi t i on by TGF-~l. and this interaction was p r opos ed
t o be ass ocia t e d wi t h t he r egu l a t i on of c yc lin- d e pendent
kinase activity (Mass ague e t al . , 1992 ; Bl aydes e t al .• 1995) .
To understand t h i s p r o cess , I ex ami ned the i nd uction of p I S ,
a newl y c loned cyc lin-dependent k inase Lntd.t .i t.or induce d by
TGF- P1 in human ke rat inocy tes (Hanno n a nd Bea ch, 19 94 ), in
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immorta lized and t umor cells after treatment with TGF- Ill.
Interest ingly, p lS was induced in a ll immortalized an d CSC-
transformed cells after TGF~ Pl treatment but not in CaSki
cells (Figure 23 ) . This result suggests that loss of
inhibit ion of proliferation in CaS k i cells by TGF- !ll may be
caused by t he l oss of i nduction o f pIS by TGF- Ol, and that
i ns e nsi t i v i t y to TGF-P l only occurs in sor-e t umor cell lines.
I n addi tion, since pIS and Wafl are cyclin de pend ent kinase
(c dk l i nh i b i t o r s upregulated by p S3 , this r e sul t provides
evidence for a new pathway l e ad i ng to the inhibition of cell
proliferat ion by TGF-pl treatment .
Taken together, the resul ts i n t h i s study add important
new information on the response o f ce lls to cytokines i n t he
multistep carcinogenes is of cancer . The ir exact roles in
oncogenic progression i s an important area for future study.
4 . 4 . 2 RA
RA is a vitamin A metabolite which i s known t o b e an
i mpo r t an t regulator of epithelial cell growth a nd
differen t iation i n vivo a nd in vrc.ro (for review see Robe r t s
and Sporn, 1.9841 . Mor e importantly , RA has b e e n shown to ha ve
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an a nt ineoplastic effect on many vi rally and chem ically
i nduced neoplas ias , i nc l ud i ng cervi ca l lesions and dysp1as ias
(Cr ee k et a1. , 1994) . Recently, i t has be en found that RA ca n
inhibit pro lifera tion and HPV expression in HPV-immo rta lized
cells and non- t umo rige nic HeLa - fibrob1as t hybrids, but no
suppress ion o f HPV express ion was ob s e r ved i n HeLa cells or
tumorigen i c He La - f i b r ob1a s t hybr i d s ( pi ri s i e t a l., 1992;
Ba rtsch et; a 1 . , 1992 ; Creek et a1 ., 1994 ) . Thus, i t has been
sugges ted that loss of sensi t ivi ty t o RA may be relat ed t o
the tumor igenic ity o f cells (z ur Hausen and de v i Ll i e r s ,
1994b) . In my study , loss o f suppressi on of proli r e r e t I ou
induc ed by RA was detec ted , wher-eas no suppress ion of HPV
expression wa s observed in both i mmo r t a li zed and both t umor
cell lines (Figu re 25) . No significant s uppres sion of HPV
expression by RA wa s found by others in HPV16· immorta lizcd
cervical ce lls (Agarwa l et a L. , 1994 ) or HPV18-irnmo r tal ized
cervica l cells (Nakao , unpublishe d dat a ) .
Taken t og e t he r , two conclus ions c an be d r awn from the
pr e s ent experiments: 1 ) The loss of sensitivi t y t o RA
suppression of HPV expression is not specif ic for t umor ce l ls .
2) Sup pression of p roliferation by RA might be diffe rent from
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that of HPV express i on by RA.
4.5 Si gn if i c a nc e o f using mRNA differential display method to
i dent i f y the genes involved in oncogenesis
As d iscussed above , mult istep ca rcinogenesis of cancer is
dri ve n by a se ries of changes in gene exp r ess i on. Thus,
i d e nt ifyi ng t he genes tha t a r e differentially expressed .
e i ther onc oge nes or tumor s uppressor ge nes, in the on cogenesis
process is crit ica l t o understand the molecular mec hanism o f
A number of strategies ha ve been devised to identify
differen tia lly expressed g enes . The f irs t approach is ca l l ed
differential hybridizat ion , i n which radioactive eDNA probes
from two different sources (us ua l l y designated + and - ) are
separate ly hybridized wi th e ither + or - genomic DNA or a eDNA
library and differentially hybrid ized + versus - radioactive
genom ic cDNA plaques or colonies a re identif ied . Th i s method
has been used to i dentify genes induced by specific factors ,
such a s growth factors (e . g . PDNF) , onc ogenes (e. g . ras) , and
serum (Or en and Lev ine , 1983, and references therein) .
However , only mRNA o f above 0.1% abundance can be identified
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with this method . Thus , a s econd met hod ca lled suot r ect t ve
hyb r i d i za t i on , whi ch c an i dent ify d if f e r e n t i a lly expr e s s ed
genes t ha t are pre s ent i n O.DOl\: to 0 . 1\ abundance , wan
de ve loped . In thi s method , mos t of t he cceeon sequences ImRN/\
o r cDNA) in • an d > sources are fi r s t r emoved by hybr i di z<tt i o l;
of comp l eme nta ry s eq u e nc e s o f + a nd -. Th e r e sul ti ng
' s ub t r a c t ed ' mixt ure c a n e i ther be u s ed a s a p robe to s cre en
the + or - l i b r a r y or mak e a 'subt r a c t i on library ' whi c h C il l l
be fu r t he r screened by probes from eit her + c.':" - a ource . T he
subtra ct i on s t ep usually e nriches t he diffe r entially expres sed
genes by 10 - f old or great e r (Sc hwe i n fes t a nd Pa p as , 19 9 :::1 .
Sub t r a c t i ve hybridizat ion has been u s ed to isol ate s eve re f
genes involved i n t he c a r c i nogenes i s o f cancer, i nc l udi ng Wa f !
(Le e e t al . , 199 1 ; Sc hwein fe s t an d P<:.pas, 1992 ; Rl- Deiry e l
a i . ; 1 993 J .
Recently , a method ca l l ed mRNA. d iff E" r en t ial d i s pl a y ha t;
be en deve l op ed a nd r e fined l Li a ng a nd Pa rdee , 199 2 ; Li an g e t;
al . , 19 93; Bauer et al ., 1993; Mou e t a l . • 1!l94 ; Li e c a I . •
1994 ) . Th is met hod ha s seve r a l techn ica l advant age s over t he
exist ing method s mentioned ab ov e . The f i rst ad va ntage of mP.NA
differential d i s play is its simplicity and s peed . Tec hnically ,
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on ly peR a nd m;A sequencing gel erecrrcpuores t s are used in
the experiment, and cand idates can be identified, Lsojat ect and
confirmed within 1-2 weeks. The other rnet.ho d s wil l take <It
least 3 -6 months to identify differentially expressed qencu .
Another adva ntage of the mRNA different .ia I d.i ap l ay is itt;
s e nsitivity . Onl y 2-20 Jl9 of tota l RNA i s enouqh to ac r een a l I
the mRNA once. By contrast, more than 5-50 p.g of mRNA Lrom
500 -5000 /1g of total RNA are need; d for t l.'l"l ro.mdc of
subtraction in the subtractive hybridi za t;ion mot.nee
(scnseanrest; and Papas, 1992). Most importantly, oecauso of
its h Lqh sensitivity, t he differentia l display method can he
used directly t o i d e n ti f y the mRNAs or sequence t.aqc , which
d i f fe r e n t i a lly expressed in cancer biopsies (Watson and
Fleming, 199 4). The last important advantage o f t.he mRNl\
d i f f e r e n t i al display method is that multiple cell i tne e can he
compared i n t he s ame gel, and that over-expressed ge nes such
a s oncogene s and suppressed genes such as tumor suppressor
genes can be i d e nt i f i ed simultaneously.
UsinS t.he d if f e r e n t i a l display method , at least 15 ge nes
h ave been identified so f a r to he specifically expressed in
tumor cells , developing cells , glucose-treated cells, and rea -
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transfected cells (Li a ng et al., 1992; sager et al., 1993;
Zhang a nd Medina, 19 93 ; Ni shio et al , 1994 ; Mou et; al ., 1994;
Sun et al ., 1994; Kumar and Haugen , 1994; Pau l et al 1994;
Zimmermann and Schultz, 19 94 ; Liang et a l. , 1994).
Using this mRNA differential display method in my
experiments, mRNA from three ce ll types, HEN, HEN-16, and HEN-
16T, representing normal cells and two stages of oncogenesis,
was simultaneously reversely transcribed , PCR ampl ified , and
displayed on the same sequencing gel . Since about 120 bands
can be d isplayed in each lane, and since 64 co mbi nations of
peR primer pairs were used , we screened a bou t B,OOO mRNA
s pecies in total . Generally, there are about 15,000 ge nes
expreased i n any single type of mammal ian cell. Therefore,
about 53\ of all expressed genes have been screened, of wh i ch
2 genes designated PA4 a nd PA9 we r e identif ied to be
d i ff e r en tial l y expressed i n t hese cell l ine . PA4 wa s a c t ivated
in Lmmoz-ta Ld-ied cel ls and CSC-transformed tu mor cells
compared wi t h HEN cel ls . There wa s no d i f f e r en c e i n PM
exp r es s i on between i mmorta lized a nd tumor cells, ind i c a ting
that i t may be an oncogene i nvolved i n the i mmort a liza tion of
p rima ry c ervical cells. PA9 was i na c tiva t e d in i mmortalized
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cells and tumor cel ls, i ndi ca ti ng that i t may be a tumor
s up p res s or gene. Both PA4 and PA9 are novel genes because no
ho mology wi t h any other genes wa s found in the NIH c enbenx
da t aba s e . Further ch aracterizat ion o f t hese t wo genes ",'ill be
very helpful for us to und e r s t a nd t he molecular mechanism o r
i mmortaliza tion of normal cervical ce l ls .
Although the advantages of d i I fe rent Laj d i s pla y a rc
s i g ni f i ca nt , a f ew problems were experienced u s ing t h i n
method. One of these was the high i.nc idence o f f a l se
positives . Of the 35 posit ive cDNAs i s o l a t ed from t he display
gel , on ly t wo of them we r e con f i r med by No rther n blot assay s
to be differentially exp ressed. The second problem e n cou nt ered
wa s that the cDNA cut r rom the sequencing gel contains several
s pe c ies . The eDNA o f int erest may be lost after cloning .
Furthermore, since the di fferentia l d i sp l ay method provide s
c lones of only 150 -500 bp s in l ength from the 3' - j-eqr on o f
mRNA, it i s frequently difficult to identify the coding r eg i o n
if the eDNA h as a long 3 ' -unt ranslated region . Al thoug h PM
an d PA9 contained polylA) sequences, t he y do not contain
coding r egions . Thus, S ' -end rapid ampli fica tion of cDNA e nds
(RACE) or libr ary screening will be r equired t o find t he full
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lengt. h t r a nscript. Rec ently, a revised meth od us ing two
a rbit. rary p r i me r s as pr ime r pa i rs i n t he di ff erent i a l d i sp l ay
has been d eve l oped to identify d if f ere ntially ex p r e s s ed cDNAs
rtf coding r eg i on s lSkolov an d prockop , 1994 } .
Since t he ce llu l a r genes d ire ct ly i nvolve d i n the
:.lul t i s t ep carcinogenesis of cervical cancer a re still un known,
differential display remains one o f t he most useful method s
av a ilable to identify the no vel g e nes invo lved i n
oncogenes i s.
4 . 6 Fu tur e direc t i ons
Th is thesis ha s described i n detail a n in vitro study of
the oncogen esis of pr imary cervical cells by HPV and ciga r e tte
smoke . This study provided a lot of useful i nfo rmation f or us
to further u nderstand t he molecular mec hanism o f cervical
cancer. However , to fullY under stand t he oncogenesis process
i n my in vitro system, several ex pe rimen t s co uld be d one ;
1 ) To f u r the r undez-atand t he mech an i sm o f e Se - induced
tran sformation o f HPV- i mmo r t a lized cell , the e ff ect o f
d if f e re nt concentrations of esc on growth , DNA damage , etc .
ca n be mea su red . Fur the rmor e, t reat ment of other i mmor t a l ized
cet r c with esc should be ca rri ed out.
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2 ) Since a-as point mutat i ons are very common i ll chemica l
carcinogen· induced tum ors, .ras po i nt mutations should b e
checked in CSC-t r a ns fo rmed c e lls.
3 ) Since overexpress ion of B-myb i n i mmo r t ali ze d and esc-
transformed cell was f ound , c r e n s tecc i on of anti -se ns e B-myb
p lasmids i n t o immortalized ce l ls o r csc- t .ceu s r ormec ce l l s c a n
be carried out to c heck i f i t playS a d irec t role in t he
process of oncogenesis i n vi t ro.
4 ) To obtain a more co mpl ete p i cture, the ef f ec t o f o t.her
cy tokines, such as IFN-y and I L-6 , on p r oli f e r a t ion , IIPV
e xp reas i on and some ce llular genes should be fu r t her
characterized.
5) The da acover-Les of the rol e of the J E gene an d p iS j n
t he path way of TNF-ct - and TGF-p -mediated cell de r en ce arc
i n t e r e s t i ng and they sh ould be further studied .
6 1 5 '- RACE or eDNA l i b r a r y screens shou ld be u ned to
isolate the who l e - l e ng t h cDNAs f rr PA4 and PA9. The c omplete
characterization of these cDNAs could then be ca r ri ed ou t. The
mRNA ex pression of PA4 and PA9 i n diffe rent tissues and in
biopsies of normal ecto- and endocervix, Cl N I -II I a nd
cervical ca ncer could be compared.
175
IlEFElmNCES
Ada ms, G. E. a nd Co x, R . (1991) Ra dia tion carcinog e nesis. I n
Introducti.on to the Cellul ar and Molec ular Biology of Cancer ,
secon d ed i tion , pp2 0 2 - 2 26 . Fra nks, L . M. a n d Teich , N . M. (e d a ) .
Oxford Med i ca l Pub li cat i o ns, Oxford.
Agarwal , C., Hembree , J .R ., Pa r ke, B. A. a n d Eck er t , R.L.
(199 4) In t e r fe r on a nd r e tinoic a c id supp r ess t he g rowth of
human papillomavirus t yp e 16 immo rt a lized c ervical e p i the l i a l
ce I I s , but only interferon su p pres s e s the l evel of t he human
papillomav irus t ransforming oncogene s . Cancer Res . 54: 2108-
2 112.
Ai e llo . L .P ., Robinson , G.S. , Li n , Y-W. , Nish io , Y. a n d Ki ng,
G. L. (1994) I den t if i c at i on o f muLt.Lp.l e genes i n b ov i n e r e t inal
pe r icytes al te r ed by e xposure to e l ev a ted l e vels of g l ucose by
using mRNA differentia l display . zece . Nacl . Acad . Sci . USA
91 : 6231 - 62 35 .
Alme ndral , J .M. • Huebsch, D., Blund ell , P .A ., Macdona ld-Bravo ,
H. a nd Bravo, R. (1987) Cloning and sequence o f t h e huma n
nu c lea r p r o te in cyc Lt n , homology wi th DNA- b i nd i ng prote ins .
Proc . Natl . Acad . sec. USA 8 4: 1575-1579 .
Armitage, P. an d Doll , R. A. (1954) The a ge distribution of
ca nc e r and a mul t i s t a ge t h eo r y o f carcinog e nesis . Br . J .
Can cer 8 : 1 - 12.
IIr r oyo , M., Bagc hi , S. a nd Raychaudhuri, P . (1993) As s o ciat i on
o f the hu ma n pa pi1lomav irus t ype 1 6 87 p r ote i n wi th S-pha se-
specific E2F - cyc lin A complex . Mol . Cell . arez . 13 : 65 37-6 546.
Ba l mai n, A. an d Br own , K. (1988) Oncogene a ctivation in
ch emi ca l carc i nogen e s i s . Adv . Cancer Res . 51: 147-1 8 2.
Ban d , V. , Zajcho ws ki, D., Ku l e sa , V. and Sa ge r, R . (1 990)
Human pa pilloma virus DNAs immortali ze norma l huma n mammary
ep i t he l i a l cells a nd r ed uc e their growt h f a ctor requirements.
176
Proc . Natl. Ac ad . Sc i . USA . 37 :4 63 - 467 .
Barker , J .N . , Sarma , V. , Mi t ra , R.S .. Di x it . V. M. a nd
Ni ckoloff , B.J . 119891 Marked syne r g i s m be t wee n tumor ue c roe t s
recece - p and rn cereeron -r i n regula t i on of keril t i noc yt c
derived adhes i on molecules a nd cne ecee cc i c factors . J . Clin .
In ves t . 85: 605 -6 08 .
Barone , M.\ . , crceec , A ., Ta ba ee , A . Ph il i pson, L . a nd ROil. D .
11994 1 CHOP (GADD1S 31 a nd its oncogenic va ri a nl , TLS · CIIOP,
ha ve opposing e f f ec t s on t he induct i on of G I IS ar r e a t . Gene s
nev . 8: 453 -464 .
aarueck, J . , Ba rtkova, J " Lal ani, E-N " Br-ez i na , V. and
Pap ad i mi t r i ou, J . (1990) Selective immortaliza tion or
phenotypically distinct e pithelial cell t ype by mt c r o tn j oct . i ou
of SV40 DNA i n to cultured huma n milk cell s . In t:. J. Cancer
45 : 11 05-1 11 2 .
Bartsch , D ., acy e. B., Baust , C., au r Haus e n, H. a nd scnvera
E . (1 992 ) Re tinoic acid - mediated rep r e ssion of hu ma n
papillomavirus 18 transcription and d if f ere nt l i gand
regulation of the r etinoi c acid r e ce ptor p ge ne i n non -
tum o r i g e n i c an d t umor i g en i c He l a hybri d ce l l s . EMBO J .
11 :2283 -2291 .
Baur , D., Mul er , H. , Re ich , J . • Ri ede l , n ., Ahre nk icl , v .,
Warthoe, P . and St raus s , M. 119931 Ide n t if i ca t i o n or
differentiall y expressed mRNA species by a n Impr -oved d La play
technique W DRT-PCRI . Nuc lei c . Ac ids Res . 21 : 4272 - 4280 .
Beasley, R.P . , Lin , C.C . , Hwang. L .T . an d Che Ln, C. S . 11~8 1l
Hepatocellular ca rci noma and hepatiti s B vi rus. Lance t 2 : 1129 -
1133.
Beasley , R . P . and Hwang , L.Y . (19 9 1 ) Ove r v i e w on t.ne
e p i d e mi ology of hepatocellular carcinoma . I n Viral Hepatiti s
li nd Liver Di s ell se , pp . 532 - 535 . Grune, S. T . a nd Statton,
L. K. t ee s} , Raven Press, New York .
177
BEl k IV (Committee on the Biological Ef f ec t s o f I oni z i ng
Rad i a tion) (198 El) Health Risks o f Radon and Other Internally
Depos ited Alpha- F.'!<rit ters . was hington : Nationa l Academy of
Sc ience s .
Be r enblum , I . and Shu b i k, P . (1 949) An e xperimental study of
the i nitiating s t a ge o f ca r cinogenes i s, a nd a re-examination
o[ t he somatic cell t :utat i on t he ory o f cancer . Br . J . Cancer
] :109-11 8.
meydes , J . P. , Sch 1umbe rger, M., wyn f o r d - Thoma s. D. a nd
Wyll i e, F . S. (1 995) Inte ra ction be twee n p 53 and TGFp 1 i n
cont r o l o f epitheli a l ce l l prolifer at i on . Om:ogene 10 :3 07-3 1 7 .
a r au , L . , DUGt , M., Mi kumo , R. and Gru ppu s o, P. (199 0 )
Differentia l response of non tu mor igeni c and tumorigenic human
papil l omav i r u s t ype i a -posLt I v e ep i thelial cells t o
trans fo r mi ng g r owt h f a ctor p l . Cancer Res . 50:7 32 4 - 73 3 2.
Brau , L . , Dus t , M. , Mikurno , R. , c r owley , A. and Robins on , M.
( 19 92) Regu lation of growth and g e ne expression in human
pa p i llomav iru s- t ransf orm ed kera tinocytes by t r a nsformi ng
growt h f a c t.or-c p r i mplications fo r the cont r o l o f
pa pillomav irus i n f e ct i o n. Mol . Car cinog . 6 : 100 -111 .
Brinton , L .lI. . (1 990 ) Edi t oria l co mme nta r y : smok ing and
cervi ca l ca nc er'- cu r r en t status . Am. J . Epidemiol . 13 1: 958 · 96 0.
Butz , K.• Shahabedd in , L. , Gei s en , C . , Sp itko v s ky, D., Ulmann ,
A . an d Hoppe - Sey ler , F . (1995) Functional p 53 p rot e i n in human
papillomavirus ·posi tive cancer cells . Onc ogene 10: 927-9 36 .
Can n , A. J. and Che n, I. S. Y. (199 0 ) Human T- cel l l euk e mi a virus
type-I and II. In Virology , 2nd ed ition , pp.1501 -1527. Fi e l d s ,
B .N . and Knipe , n .M. {ed al . Rav en Pr e s s. New York.
ce r j son , S. G. , Fawcett . T. W. , Bartle t t , J.D . , Bernier , M. and
Holbrook, N. J . (199 3) Regulation of C/EBP-related gene gadd153
by g l uc o se d eprivation. Mol . Cell . BioI . 13: 47 36- 47 44 .
1 78
Ca r rier, F . , Smith . M.L . . s ee . 1. , Kilpa trick . K. R . • 1«1I1S i 119,
T . J . , Chen , C- Y., Engelstein, M.. Friend , S . H. , Henner , W.O . ,
Gilmer , T . M. , Kastan , M.B. and rcmece , A. J . t 1 9 ~ 41
Charact erization o f human cacc.rs, a p5 3- regtlla ted prot e in . J .
Bi o I. Cbem . 269 : 326 72- 326 7 7 .
Ca s t e llo , G. , Es po sito. G • • Stellato , G . , Mora , L. D. AlMtc , G.
an d Germano, A . (198 6 1 Immunologica l abnormalities i n pil t i enL N
with cervical c arci noma . Gynec ol. Oncol . 25: 6 1 - 64 .
Che n , T-M. , Pecora r o , G . a nd Defendi , V. {l 993al ueuet. t c
a n aly si s of in vitro p rogres sion o f huma n papi llomnvirus -
transfected hu man c ervical c e lls . Cance r Res . 53: 1167 -1 17 1 .
Chen , T- M., Chen, C- A. , Hsieh , CoY, Cha ng, D- Y. , Chen, Y- Il .
a nd Def e ndi, V. (1 99 3b ) The sta t e o f p 5 3 i n p r Lmarv hurn;lll
c e r v i c a l carcinomas a nd i ts effe ct s in h uman pap i Ll.oma v Lr-uu -
i mmor t a l i z e d human cer vrc a r c e ll s . Onco ge ne 8: 15 1 1- 1518.
Co l e , M. D. and xeaekar , A. ( 1987 ) Dosage-dependent.
i mmortalization and t r a ns fo rma tio n by t he H- r aG oncogene <lee
accompa n i ed by al tered c -my c regu latio n . I n Curren t
Communications i n Molec u l ar Bi o l ogy: Nuc l e a r Oncogenes ,
pp .1 92-198 . Alt, F .W. , Harlow , E. a nd z i ff , IL B. [e ds} . Co l d
Spring Ha r bor Laboratory Press , Cold Sp ring Harbor , NY.
Coleman , D . , Wickenden , C. a nd r<la l c o l m, A. D. B. C198fll
As s oc iat i o n o f human pa pillomav irus wi t h s qu a mous c arc inoma o f
t h e u t e r ine cervix . I n Pap!l l omav1ru s e s , p p . 186 -1 90 . C i b<1
Fo undat i o n Symposium . The Ba th Press , Ne w Yo rk .
Coo pe r , G.M . (1 990 1 oncogen e s . J ones an d Ba rt l e t t publ i a hn r n ,
I n c . , Oxf o rd .
Cree k, K.B ., Jenkins , G .R ., Kha n, M.A . , a atov e , A. , lIod a m,
J. R. , Tolleson, ii . H. and Pirisi , L . (199 4 ) Reti noic a cid
suppre sses huma n papillomavirus t y pe 16 (HPV16 ) - me d l a t.ed
trans f o rmation of human ke r a t inocy t e o a nd i n h i b i to t he
expression of the HPV16 oncogene s . I n Diet a nd Cancer:
Markers, Pre ven t ion, and Treatment, pp . 19 -3 5. J acobs , I"I.M.
led). Plenum Pre s s , New York .
179
crcener , F .V ., Snijders , P .J .F ., van de r Brule . A. J . C. ,
r.e nemans , P . , Meijer , C. J .L. M. and Walboomers, J . M. H. (~9931
MHC class I expression in HPV16 posit ive cervica l ca r cinomas
i s past-t ranscr iptionally controlled and i nd ependent f rom c -
myc overexpression . Oncoge n e 8 :2969- 2975 .
Cr oo k , T. , Almo nd, N. , Osborn, K. and Crawford , L. (1 98 8)
lIuman papillomavirus type 16 cooperates with a c t i vated r a s an d
t oe oncygenes in the hormone dependent t rans f o rma tion o f
primary mouse ce l ls . Peoc. Na t l . Acad . Sci. . USA. 85: 882 0-8 824 .
Crook, T . , Green f ield , I ., Howa r d , J . an d Stanley , M. (1990)
Al t e rat i on s in growth prope r t i e s of human pa p illoma vi ru s type
16 immortal i s ed human cervical ke r a t i noc yt-e cell l i ne
cor r e l a t e wi th ampl i fi cation and averexpression of C' '!lye
oncogen e. Oncogene 5: 619 - 622 .
Crook , T . and Vousden, K.H . (199 2 ) Propert i e s of p5 3 mutation s
det ected i n primar y a nd second a ry cervical cancers s uggest
mechanisms of me t a s t a sis a nd i nvolvement of env ironmental
carcinog enes is . EMSO J . 11 : 3935 -3940 .
Cullen , A.P . , Reid , R. • Ca mp i on , M. a nd Lorincz, A .T . (1991)
Analysis o f the physical state of d ifferent huma n
papillomavirus DNAs in intra~pithelial and inva s ive ce rvical
neoplasm. J . Vi ral . 65 :606 -612 .
Daling, J.R . , Sherman, K.J. . Hi s l op , T .G . , Made n , C.,
Mande lson , M. T . , Be ckma nn , A. M. and Weiss, N.S . (1992)
Cigare t te smoking and the r i s k o f anagenital ca n ce r . AlII . J .
Epi deJlliol . 1)5 , 181 - 18 9 .
Da v ies , R. C, Hicks , R. , Crook , T . , Morris, J . and Vousden , K.
(199 3) Huma n pa pi llomavi rus t ype 16 £7 a ssociated with a
h i s tone HI kinase a nd with pl07 throug h s equences necessa ry
f or t ransformation , J. Vi ral . 67 : 25 21 - 2528 .
Davies, R.C . and Vousden, K.H . (1 99 3) Human papillomav i r u s
(HPV) a nd cerv ica l cancer . I n Mol ecular Biol ogy tor
oncologists , pp .2 )1 - 239 . Ya rno l d , J . , Strat ton , M. and
McMillan , T . (eds) . Elsevi e r Science Pub lishe r s .
180
Demarini , D.M. (1983 ) Genotoxicity of tobacco s mok e an d
tobacco s moke condensate . MU~ . Res . 114:59 - 8 9.
Demers , G .w . , Halbert , C.L. a nd Galloway , D. A. (1994) Eleva ted
wild- t yp e p 53 pro t e i n levels in human epithelial cell Ji ne s
ill1\\o rta l i ze d b y the human pa p i ll omav i ru s type 16 £ 1 gene .
Vi rol ogy 19 8 :16 9 -174 .
de Vi ll i ers , E . -M . (1989 ) ne cercq ene c f e v of t he human
papi llomavirus g roup . J . Vi r al. 6 3 :4898 -490 3 .
de Vi lliers , E .-M . ( 1994 ) Human pa t hog e n i c pap i lloma v i r us
types : an upda te . CUrr o Top . Microbial . I llUlIun o l . 186 : 1 - 12 .
Di Pa o l o , J . A. , Woodwort.h, C.D., Pop es cu , N. C . , Nota r i o , V. an d
Don iger, J . (1 9 89 ) I nduct i on of human cervica l squamou s c el J
carcinoma by s e qu en t ia l t rens tect ron wi t h hu ma n pep LkIornav Lru s
16 DNA and v i ra l Ha rvey r-as . Oncogene 4: 39 5- 399 .
Di Paolo , J .A . , Wo od wor t h , C .D.. Popescu, N. C., Kova l , 0 . 1,. ,
Lop e z , J . V. , and borde c , J . (1990 ) HSV-2 - indu ced t umor i g enicity
i n HPV-1 6-ilTll'\Or t ali zed human genital ke r at inocy t e s . Virology
111: 117 - 1 79 .
Di Pa o l o, J.A . , Popesc u, N. C . , Ablashi , D.V .,
Zimo nj i c , D.B . and Woo dwort h, C .D . (199 4)
carcinog e ne s i s u til i zing hu man qe nita l cell s
pa pillomav i ruse s . ToxJ. c o l . Le t t . 72: 7 - 11.
Lus s o , P . ,
Mu l t i s t a ge
an d human
Durst , M. , Cr oce , C.M. , Gi ssmann , L . , Scharz , E. a nd Hue bne r ,
K. (198 7al s epa i roeevt ru e s equence s i n t e g r a t e ne a r cellu l a r
oncog e ne s i n some cervica l carc inomas . Pr o c . Nat:l . Aca d . S c I.
USA 84 : 10 1 0 -1 014 .
Dur s t, M. , Dza rlie va - Pe t rus e vs ka , R.T . , Bouka mp , ? , Fus en i g ,
N. E . a nd Gissmann , L. (1987bl Mo l e c ul a r and cytogen e t i c
a nalys is of immort alized human p rimary ke ::,atinoc yt e s obte i ned
after t r a ns fe e t ion wi th huma n p ap i llomavi ru s t y pe 16 DNA.
Oncog en e 1 : 2 5 1 - 2 5 6 .
18 1
Durst, M., Gallahan, D., Jay, G. and Rhim, J.S .(1990 )
Neop lastic t rans forma tion of huma n ke ratinocyt es by human
papillomavirus type 16 and ac tivated ras oncogene. I n
Papillomaviruses , pp.255 -263. wile y- Li s s , I nc. , New York .
Dyson, N. , Howl e y , P.M ., Munge, K. an d Harl ow , B. (198 9 ) The
human papi lloma v irus-16 E7 cnccpr-ot.e Ln is ab le to bind to t h e
ret inoblas toma gene p roduct . Sc ience 243 : 934-937 .
EI -Dei r y, W. S . , Tokino, T., Velculescu, V. E., Levy, o. B.,
Pa rsons, R., Trent, J.M ., Lin, D., Mercer , W. E. , Ki nzler, K. W.
and Vogelstein, B. (1 9 93) Wa f 1 , a po tential med i ato r o f p53
tumor suppression . Cel l 75: 817-825 .
EI -De iry , W., Har per, J . W., O'Conno r , P . M., Velculescu , V.E.,
ceec.ran, C.E., Jackman, J. Wi ma n, K.G. Kastan, M. B . , Ell ed ge,
S.J., Ki m: l e r , K. W. and voge ls t ein, B. (1994) WAF1 ! CI P1 i s
i nduced i n p53 -me diated G1 arrest and ap op t os i s . Cancer Res .
54: 1169- 1174.
Elu f -N~to, J . (1 9 94 ) Number of s e xu al pa rtners a nd s mok ing
be haviour as r isk factors f o r cervical dy spl a s i a ; coeme nt.e on
t he evalua tion of i n t e r a c t i o n . Int . J . Ep idermiol . 2 3 : 11 0 1 ~
11 03 .
Fearon, E, R , a nd votqet s eetn , B. (1990) A genet ic mode l f or
c o f o r octat t umo rigene s i s . Ce ll 61 : 759 - 767.
Feingold , A. R . , Vermun d , S .H ., Burk , R.D., Kel ley, K. F . ,
Schrage r , L. K., Schreiber , K., Munk , G. , Friedland, G. H. and
Kl e i n , R . S . (1990) Ce rvical cytologic a bnorma l ti e s a nd
pa p i l l oma vi r u s i n women infected wi t h h uman immu node fi c i e nc y
virus. J . AIDS 3:896- 903.
pe Lt e j s on , M.A., Zhu, M., Duan , L . X. a nd London, W.T. (1993)
He pa t i t i s x a ntigen and p53 are a s .soca e t e d in vi t r o a nd i n
live r tissues from pa t i ent s wi t h primary hepatoc e l lular
carcinoma. Oncogene 8: 1109-1117.
Fi erbe ck , G . , Schiebel, U. and Muller , C. (1989)
I mmu n oh i stology of gen i tal warts i n d if ferent s t a ges of
182
regre ssion af t er t he rapy with interferon garrrna . Dermato l og i ca
179 ;191- 195 .
Gallo, R .C. and Munt ag n i e r , L . (1 988) AID'; i n 19 88 . Sci. Am.
259 : 4 1 - 48 .
Gao , X • • Honn, K. V. • Grignon . D., scxr , w. a nd Che n Y.O .
(1 993 ) Frequ e n t l oss o f e xpre ssion and loss o f heterozygos i t.y
of the putati ve tumor s uppressor gene DeC in p ros ca e rc
carcinomas . Ca n c e r Re s . 53:272 3 ·2 727 .
Garland, S .M., Fa u lkne r - J one s. E ., Fo r tune . D. W. a nd Qui nll ,
M.A. (1 992 ) Cervi cal ca ncer- wha t r o l e [or truman
papil lomavirus? Med . J . A u s er. 156 : 204 -212 .
Garre t t, L .R . , Pe r ez-Reyes , Smit h, P ,P . and McDoug a ll,
J . K. (1993) I nteraction o f HPV- 1 8 a nd ni t r o s ome t hylurea i n t he
i nduct ion of squamous c e Ll, carcinoma . Carc i no ge n es i s 14: 32 9 -
332.
GeE"'St, K.D . , Bergman, M .E ., Turyk, M.E ., Fr a nk , B . S . and
Wilbanks, G .D . (19 94 ) D1.ff erent i a l response o f ce rvi ca l
i n t r a e p ithelia l an d cervical ca rcinoma cell lines t.o
trar.s forming growt h fac tor -p l . G,Y7l ec o l . One o l . 55 :376 · ]85 .
Gujuluva , C.N ., Baek , J -H .• Sh i n, K-H ., Che rr ick , H. M. and
Park , N-H . (1 994 ) Ef fect of UV-irradiation on ce ll cycle,
v i a b i li ty and the expres sion o f p53 , g ad d1 53 a nd g add4 5 qenen
in normal enc HPV-immortal ized huma n oral k e ea t m ocyt.cu .
oncog en e 9 :1819 - 18 27 .
Halbe r t , C. L., Demer s , G .W. a nd r.a lloway, D .A . 11991) Th e WI
gene of human papillomavirus t.yp e 1 6 i s sufficie nt for
immortalization of huma n epitheli dl c ell s . J . Vi r ol . 65 : 4 '1] -
478 .
Ha lbe1.-t, C. L., Demers, a .w . a n d Galloway, D . A . (1992) The Ell
a nd E7 genes of huma n papil lomavirus type 6 have wea k
i mmor t a lizing a c t i v i t y i n human ep ithelial cells. J . Viral .
66:21 25- 2134 .
1BJ
Hal ev-y , 0 ., Nov itch, B., Skapek, S.X ., Rhee , J ., Hannon, G.J .,
aoecn , D. an d Las s a r , A.B. (199S} Correlation of terminal cell
c yc l e arrest of skele ta l musc le with induction of p 21 by MyoO.
Science 267: 1018 -1021.
llall, P .ll., Levison, D .A., Woods , A .L . (1990) proliferating
ce ll nuclear antigen i mrnunol oc a 1 i za t i on in paraffin sections:
an index o f cell prol iferat ion with evidence of deregulated
expression in some neoplasms . J . Pathol . 162:2a5~294.
Hammerschmidt, W. and Sugden, B. (1989) Genetic analysis of
immo r t.a L'ia i nq functions of Epste in-Barr virus in huma n B
lymphocytes. Nature 340 :393-397 .
Hannon,G.J and Beach, D . (1994 ) P1 5 J ""'~ is a potential effector
of TGF -!'- induced cell cycle arrest. i'iature 371:257-:':60 .
Harper , .r,w.: Adami, G.R., wei , N., Ke yoma r s i , K., and
at Iedqs , S.J. (1993) The p21 cdk-interacting protein Cipl is a
potent inhibitor of G1 cyclin-dependent kfneaes . Cell 75:805-
B16.
Hashida, T . and Yasumoto , S. (199 1 ) Induction of chromosomal
abnormalities in mouse and human epidermal keratinocytes by
the human pap i1lomavirus type 16 E7 oncogene. J . Gen. Viral .
72:1569 ~157 7 .
Hawj e y- NeLaon , P ., vouscen, K.H ., Hubbert, N.L., Lowy, D.R.
and Schiller, J.T . (l989~ HPV16 E6 and E7 proteins cooperate to
immort.a1 ize human foreskin keratinocy t es. EMBO J . 8:3905 -3910 .
Herrington , C.S . (1995) Huma n papillomaviruses and ce rvical
neoplasia . II. Interaction of HPV with other factors. J . Clin .
Pathol . 48 :1 ·6 .
Hickman, E .S., pLck s Ley , S.M. a nd vousden . K.H .119941 Cells
express ing HPV16 E7 continue cell cycle progression following
DNA damage induced p53 activation . Oncogene 9: 2177 -2 181.
Hl1desheim, A., Reeves, W.C. , Br ington, L .A., La ve r y , C. ,
Brenes, M., Guardia, M.E. , Gody , J. a nd Rawls, W.E . (1990)
>8'
Association of oral concentraceptive use and huma n
papillomaviruses in invas ive cervical oancer-s . I n t . J . Can c er
4S: B60~B64 .
Hod i va l a, K.J., Pe i, X-F ., Liu, Q-Y. , Jones, P.H., Rytina,
E.R.C ., Gilbert, C., Singer, A. a nd Watt, F. M. (1994) .tntegrin
exp ression an d function in IIPV-16-immortalise d human
ke r at i noc y tes in the pr'e aence or absence of v-ue -z-ac
c omp a r i s o n with cervical intraepithelial neopl asia. Oncogene
9:943-948.
Ho f f mann , D. and Wynde r , E.L. /1986) Chemical constituents and
b i o a c t i v i t y of. tabacco smoke. I n Tobacco : A Major
Interna tional Harzard , pp.1 45-1G5 , rARe Sci flntific
Pub l i ca t i o ns , No. 74. Za ride, D. a nd Pe t o , R. t ects j . Lyall:
Inte rn ational Agency f o r Research on Cancer.
Hol l a nde r, M.e., Al amo , I ., Jackman, J ., Wan g , M.G., McBride,
C .W. a nd Fo rnace, A.J . (1993) Analys is of the ma mmal i a n ga dd45
gene and its response to J:lNA demaqe . J. Bi ol . Chem. 26 8:24385 -
24393.
Hol lsberg, P . and Hafler,D.A. (1993) Pa t hogenesis of d i s ea een
induced by human lymphot ropic virus type I infection. N. Eng!.
J . Med . 32B:1173~llB 2.
Hop pe-Seyler , F. and 8utz, K. (199 4) Cellular control of huma n
pa p i lloma v i ru s oncogene t ranscription. Mol . Carc inog . 10: 13 4-
141.
Howle y , P . M. (198B) The hu man papillomaviruses : a n ove rview.
Am. J, Med . 85:155 -158.
Howl ey , P. M. (199 1 ) pa p il l oma vi r i n ae a nd their repl ication. I n
Fundament::al Vi rol o gy, pp . 131-142, second edit ion. Fie l ds,
B . N., Kn ipe , D. M. et a l. (edar . Raven Press, Ltd, Ne w Yor k.
HuiBregtse, J .M. , Scheffner and Howley, P. M. (1991) A cellu lar
p r o te in me diates a s s o c i a t i on of p53 with t.he E6 onccprotem of
huma n pa pillomavirus type 16 or i a. EMBO J . 10: 4129- 4135.
185
TARC (1986 ) IARe Mon ographs on the Evaluation of Cacinogenic
Risk of Chemicals t o Humans , Tobacco Smoking , v olume 38 . Lyon:
In t e rnat i onal Agen cy fo r Re sea r ch on Canc er.
I ARC (1987) ZARC Mon ogr ap h s on the CB:cinagenic Risks t o
Humans , supplemen t 7. Lyon ; I nte r nat i onal Agency for Research
o n Ca nce r.
I kenberg , H., Sc hwor e r, D., Pfleiderer , A . a nd Pol yack ,
A . ( 19 87) La ck of c-m y c gene amplif i cat ion in genital tumors
with di ff erent HPV s tatus . Lan cet 7 : 57 7 - 578.
Iwasaka , T . , Yokoyama, M. , Haya s h i , Y. and sugimori, H. (1993 )
Huma n pa pillomavirus 16 and 18 DNA can solely i nduc e oncogenic
tra ns fo rma t i on of mammal ian cells in primary cu l ture . Acta
Obstet . Gynecol. Scan d. 72:81-86.
.jewe r s , R . J . , Hi ldebrand t, P. , Lud low, J.W . , Kelt , B. a nd
McCance, D.J . (1 992 ) Regions of huma n pa p i llomav i ru a type 1 6 E7
o nco p r otein required fo r immort a li zatio n of human
kerat inocy tes . J .Viral . 66 :1 329 -133 5.
Jiang, H., Li n , J., Su, Z-Z, c ot i art, F .R., Huberman, E. and
Fi sher , P .B . (1 994 ) I nd uc t i on of d i fferent ia tion i n human
promyelocytic HL-60 leu ke mi a c ells act ivates p2 1, WAFl/Cip1 ,
express i on in t he ab s e nce o f p 53 . Oncogene 9: 33 97-3406.
Kamb, A. , Gruis, N.A ., Weav er- Fe ldhau s, J. , Liu, Q ., Harshman ,
K., Tavtigian , S . V., sr.cck e rt., E. , Day I I, R.S . , Johnson, B .E .
and Sko lnick, M.H . (19 94) A cell cy c le regulator potentially
involved i n genesis of man y tumor t ype s . Science 264: 436 -440 .
Karak itsos , P. , Kyroude s, A., Apos t olaki , C. , Pa i z i , P.,
vo ulgar is , Z . , Alekou, G. and Kyrkou , K. (1 994) The evaluation
of PCNA/cyclin expression i n cerv i ca l int rae pithe lia l lesions .
GyneeoI. Oneal . 55 : 101 -107.
xas can, M.B . , Zhan , Q . , El-De iry , W.S., Carrier , F ., Jacks ,
T. , Walsh , W. V. , Plunke t t , B . S., Voge lstein, B. a nd For nace,
A.J . (1 992) A mammal ian ce ll c yc l e chec kpoint pa thway
ut ilizing p53 and GADD45 is de fective in Atax ia-
18 6
Te l an giectasia . Cell 71:587·597.
Kaufmann , W.K. and Kau fma n, D.G. (1993) Ce l l c yc le control ,
DNA r epair and i nit i at ion of carcinogenesis . FASF.B J . 7 , 11 88 ~
1190 .
Kaur , P . a nd McDougal l , J . K . (198 8) Cha racte rization of primary
human keratinocy tes t ransforme d by huma n papilloma v Lrus t y pe
18. J . Viral. 62 :19 17 -192 4 .
Kaur, P . , McDouga l l, J . and Cone , R. (19 8 :!) t nmo r r a Ld aat Lo n o f
primary huma n epi thelial cells by cloned c e r vi c a l carcinoma
DNA containing human papil l omavi ru l:l t ype 16 E6/ E7 open re a d i ng
frames. J . Gen . Viral . 7 0 : 1 2 6 1 - 1 2 6 6.
Ke e n , N . , Elston, R. a nd Crawford, L . (1994 ) I nt e raction o f t he
E6 protein of huma n papil lomav i r us wi t h cellular prot eins .
Oncogene 9 : 1493 -1499 .
Keiff , E. and Liebowi tz . D. (1990) Epste in-B a rr virus . In
Vi :olagy , pp.1l89· l 9 20 , 2n d edi tion. Fie lds , B . and Knipe, P.
{e de I , Raven Press, New Yo r k .
Kessis, T .D., Slebo s, R . J . , Ne l son, W.G . , Kas tan, M.B . ,
Plunkett , B.S ., Han , S,M. , Lorincz, A . T ., Hed rick , L. a nd Cho ,
K .R . (1 9 93) Human pap i lloma v i r us 1 6 E6 express ion di s rupts the
p 53 -media ted cel lular response t o DNA damage. Proc . NatI.
Acad . Sci . USA . 9 0: 39 88 - 3 992 .
Khandjian , E. W" Salomon, C. , Le onard , N.. Tremblay , S. and
Turler , H. (1992 ) Fibronectin gene expression i n prolifera t.ing ,
quiescent, and SV40- i nfected mouse k idney cells. Exp . Cell
Res, 20 2:464 -470.
xtetn-aaeneo, A.J. P. , Iiza sa, T ., Monik i , S . , Gar c i a- Pal a zz o ,
1., Caamano , J ., Met calf, R. , Welsh, J . and Ha rri s , C .C.
(1 992) A t o b acco - s pecif ic N-n i trosamine o r ciga r et te sm oke
condensate causes n e op las t i c tra n s fo r ma t i on o f
xenotransplanted human bronc hi al ep ithel ia l c ells, Proc. Na tl.
Acad . Sci. USA . 89 : 6693 -6697 .
187
Klingal hutz, A.J. , Smit h , P . P . , Garre tt. L.R . and McDouga l l ,
,J . K. (1993 ) Al te r a t ion o f the DCC tumor' - supp r e ssor gen e i n
tumorigenic HPV-l B immortalized hu man ke r at i nocy t es
transformed by nit rosomethy 1u rea s . Onco g en e 8: 95 · 99 .
Kl i nge l hu tz , A . J . , Hed r i ck . L. , Cho , K.R. a nd McDougal l , J.K.
e1 995) The DCC gene suppresses the malignant phen o t yp e o f
transfo r med human epithelial cells. Oncogene: 1 5 B1 · 1 5 96 .
Kn owles , D.M., Chamulak, G., Subar, M. , Pal icci, P.G., Duga n ,
M. , Burke, J .S., Ra pha e l, B. and Da l l a - Fave r a , R . B. (1 9BB)
Clini copatholo gic, immunophenotypic, an d mol ecula r genet ic
ana l ys i s of a rb s -a s s c c t e t e d lymphoid neoplasia. Pa tbol . Annu.
2 3 : 33 -67 .
Kumar, R. and Ha uge n , J.D . (1 994) Human and r at os t eo b last- like
ce l ls express stathmin, a growth -regulatory protein . B.iocbem .
Biopbys _ Res . COl7U7\ . 201: 861 - 865.
Kuma za k i , T., Robe t o r ye , R . S . , Robe t o r ye , S . C. and Smith
J .R. (199 1) Fibronectin expression increases during in vi t z o
cel lu la r aen e acence : correlat ion Idth increased cell a rea .
Ex p. Cell Res . 195:13 -19.
Ky o , S., Inoue, M. , Ni s h i o , Y., Nakanishi, K. , Ak ira , S .,
I noue , H . , Yu ti su do , M. , Tanizawa , O . an d Haku ra , A . (1993 ) NF -
IL6 represses early gene e xpression o f huma n papillomavirus
type 1 6 through binding to the noncoding r eq ron . J . Vi rol .
67: 1058- 1066.
Kyo , S., Inoue M., Hayasaka, N . , Inoue, T. , Yuts ud o, M.,
Ta niza wa, O. a,II. Ha ku r-a , A . (1994) Regulation of earl y ge n e
e xpression of human pa p d Ll omev i.r-u s type 16 by inflammatory
c ytokines. Virology 200 : 130 -1 39.
Lam , E . W. - F . a nd Watson, R .J. (1992) cnar at. er i.a a t i o n a nd ce l l
c yc Ie c r-e qukat e d express ion of mouse B·myb . Oncogen e 7 :1185-
1 8 9 0 .
La m, E. E . · F . an d Wats on , R.J. (1993) An E2F ·binding site
me d ia t e s cell -cycle r egul a ted repression of mouse B·myb
188
t r a n s c r i p t ion. £MBO J. 12:2705 -2713.
Lam , E. W.- F . , MQrr i s , D.H., Davies, R., Crook, T., Watsom,
R .J. and v cus d e n. K.H . (1994) HPV16 87 cuccoroc e t n de r e qulat. e s
B- myb express i on :c o r r e lat i o l1 wi th t argeti n g of p l 07 /E: 2 ?
complexes . EMBO J . 13 : 871 -878.
Layde , P.M . ( 19B9) Smoking and cervical ca n ce r.
i nc i d en c e? JAMA 261: 1631-1632.
Lechner, M.S., Mack , D , H., Finicle, A.B., Crook, i. , v oueden ,
K.H . and La i moni s A . Laimins. (1 992) Human p e p i t t omavt r ue E 6
p rotein s bind p53 i n vivo a nd ab roga te p 5 3 -med i a t e d repression
o f transcription . EMB O J . 1 1 : 304 5 - 3052 .
Lee, E. Y .-H. P( 1991) Tumor suppressor g en e s: a new e r a f o r
mo l e cu l a r gene t i c st.udies of cance r , Br e as t Can c e r Re s. and
Tre at . 1 9:3-1 3.
Lee , S.W . , 'r crnase c co . C . an d Sager , R. (1 991) pos I r.Lv e
selection of candida te tumor> suppressor genes by eu bt.ract Ive
h y b rid i z a t ion. Proc. Na t l . Acad. Sci . USA 88:282 5 -2829.
Levin, A . J. (1993) T h e tumor s u p p res sor g e nes . Ann u. Rev .
Bi ochem . 6 2: 62 3 ·651.
Li , F., Ba rnathan , E. S . a nd Ka ri k o, K. (1.99 1) Ra p id method fo r
sc r eening an d cloning c DNA generated in dif feren t. i al mRNA
display: ap plic a t i on o f Nor t.h e rn blot f o r aff i ni ty captur i n g
of cDNAs. Nucl. Ac ids Re s . 22 :1764 -1765.
Li , S-L. , Ki m, M-S . , Cherr i c k , H.M ., Don i ger, J. an d Pa rk , N-
H . (1992) Se quential combined t umo rigenic ef f ec t o f HPV- 16 a nd
chemical carcinoge ns . Ca r c inogen esis 1 3 : 1981-1987 .
Li , Y. , Jerkins , C., Ni ch o l s , t"l.A . a n d Xi ong, Y. (1.9 9 'l ) Cell
c y c l e expression a n d p53 r e g u lat.ion o f the c yc1in- depende n L
kinase inhibi t.or p 2 1 . Oncogene 9: 2261 - 2268.
Liang, P. and Pard e e, A. B . (1992a) Differe ntial d i spla'{ of
eukaryotic messenger RNA by means o f the polymer a s e c h ai n
lB9
re action . Science 257 : 9 67 -9 70.
Liang, P . , Ave r bo ukh , L ., Keyomars i, K. , Sager, R. a nd Pardee,
A.B . (1992b ) Differen t i a l di s p l ay and clo ning o f messenger
RNAs from h uma n breas t cance r vers us maimary epithelia l c e lls .
Cancer ReB . 52 :6966 - 696 8.
Liang , P. , nve rbou kn , L . an d Pardee, A.B . (1993 ) Distribution
and clonin g of e uka r-yo t.Lc mRNAs by mea n s of differential
d i splay : refinemen ts and opt i mi zation . Nuc lei c . Ac ids Re s .
21: 3269 w 327 5 .
Li a ng, P . , Averboukh , L . , gb u , W. and Pa r dee , A. (199 4 ) Ras
act i va tion o f genes : Mob- I a s a mode l. Pr oc . Nacl . Acad. Sci .
USA 9 1 :125 1 5 - 12 51 9 .
Lin , D. , Fiscella, M., O'Connor, P .M., J ac kma n, J. , Chen , M. ,
Luo L .r. ., Sa la , A . , TravaI i , 5 ., Appella , E . a nd Me r ce r , W. E .
(199 4 ) Constitu t ive exp r e ssion o f B- my b can bypass p 53 -induced
Wa El / Cip 1 - med i a t e d G1 arres t . Pr oc . Na cl . Acad. Sci. USA
91 : 10 079-10083 .
Linder, S. a nd Marshal l , H. (1990) I mmo r t a l i za t i on o f p r i ma ry
cel ls by DNA t umo r v iruses . Ex p. Cel l Res . 191 : 1 -7 .
t c wy . D.R. , Ki rnbauer, R. a ncl Sc h i l l e r . J .T . /199 4 ) Genital
human papil lomavi r us infec t i on . Proc . Natl . Acad . Sci . USA
9l :2 436 w2 440.
Luethy, J. D . and Holbrook, N, J . (1994 ) The pathway regulating
GADDl53 induction i n r-espons e to DNA damage is indepe nde nt of
protein k i nase C and t yros i ne ki na s e. Can cer Res . (Suppl )
54: 1 902 - 1906 .
Mai man , M. , Fruchter , R .G . , Se ru r, E ., Re my, J . C . , Fe u e r , G.
and Boyce, J. (1 990) Human i mmunod e f i c i e nc y v i r us i nfection
a nd cervical neoplasia . Gyn ec ol. Oneal . 38: 377-382 .
Mal e j cz yk , J. , r-taIe j cayk , M. , Majewski, S. , Br e i t burd, F . ,
Lug e r , T. A . , J ablonska , S. a nd Or-t.h , G . (l994 ) I ncrea s ed
tumorigenicity o f human ke r a t i n o c yt e s harbo ring huma n
1 9 0
papillomavirus t y pe 16 a ssociate d wit h resi s t a nc e to
endogenous tumor ne cros i s r e c cc v - p -mecte ce d g rowth Lfrm t a t Lo n.
In t . J . Cancer 56:593 -598.
Mandelblat t , J . (1993 ) squamous cell ca nc e l' o f the cerv i x ,
i mmune senescence an d HPV: is c ervic a l cancer <In age · r elated
neoplasm? I n Th e Under l y i ng Mol ecular, Cellular . and
Immunological Factors i n Canc er and Ag i ng , pp .13 - 26 . Yan g ,
S . S. and War ner , H. R. (e d sl . Pl e n um Pr e ss, New Yor k .
Mansur , e . and Andrnphy , E. J . (199 3l Ce llul a r transformation
by papillomavirus c ncopr-ot.e In s . Bioch . Bi ophys . Ac ta 1155:323 -
3 4 5 .
Massague, J . , Cheife t z, S ., Laiho , M. , Ralph , D . A. , we I s ,
F .M.B. a nd Zentel l a , A . ( 1992 ) Transfo rming growt h f act. or-c p .
Cancer Su rveys Vol . 1 2: Tumor Suppressor Genes , the Cel l Cycl e
and Cancer . Co l d Spri ng Harbor t.ab . Press .
Masui , T. , Yoakum, G. H., Lechner, J.F., Willeys J.e ., Amst a d,
P . , Trummp, B. F. a nd Harris, c . e. {l986 \ I n vi t r o
carcinogenesis stud ies of h uman b r on c h i al epi t helia l ce lls. III
Mechanisms in To ba cc o Car c i nogen e s i s . Ho f f ma n n , D. and Harr i s,
e. c . {e d a) . Cold spr i ng Har bor La b .
May, M. , Dong, X. , Beye r -Fi nk l e r , E" Stub e n rauch , F., Fuchs,
P. G. and Pfister , H. (1 994) The E6/E7 pr omoter o f
ex t rachromosom a l HPV16 DNA i ll cervical c a ncer escape ( rom
cellular repress i on by mutation o f ta rge t seq uence s fo r YYl .
EMBO J . 13 :14 60 -1466 .
McCann , M.F . and Irwin , D.E . (1 992 ) Ni cot ine and cot i ni ne i n
the cervical muc us of smo kers, pa s s ive smo kers , and
non smokers . Cancer Epi dem i ol. Biomar k . Previews 1: 125 -129.
McDona ld , F. a nd Ford , C.H . J. (199 1 ) Onco g en es and t umor
s uppressor geneB . p Los Scien t i fic Pu b l i s he r s , Oxford.
McDougall, J . K, (1 99 4) I mmortali zation and t r an s fo rma t ion of
human cells by human pap i Lj ornav i r-us . Cur r o Top . Mi crobiol .
Immunol . 186 :101 - 119 .
19 1
Melillom R.M . , Helin, Y.., Lo','Y , D. R. and Sc hille r, J.T . (1994)
positive a nd negat i ve r egula tion of cel l proliferation by E2F-
1 : i nf l ue nc e of protein l ev e l on coproteins . Mol . Cell. BioI .
14 , 824 1 - 824 9 .
Merrick , D.T ., ai encon, R .A .. Gown , A .M . and McDouga l l, J ,K.
(1 992 l Altered express i on o f prolifer a t i on and differenti ation
marke rs in human pap illoma v irus 16 and 18 i mmorta l i zed
ep ithel ial cells grown i n orqan o t ypi c c ul tur e . Am. J . Pathol .
140 ,1 67 - 177 .
Meyers, C . , Frattini, M.G. Hudson . J . B. and La imin,
L. A. {1992) Bi osynthesis of huma n papi llomavi rus f rom a
co ntinuous cell l i ne upon ep i thelial d ifferent iation. Sc1enc e
2 57 ;971 -973 .
Mey ers, C. and Laimins, L .A . (1 99 4) In vitro system fo r t he
s tudy and p ropagat ion of huma n pap i llomaviruses. Cur r o Top .
Mi crobi al . Immunol. 186 :1 99 -2 1 6 .
Mich i c li , P ., Chedid, rot., Lfn , D . , Pierce, J .H., Mercer, W.E:.
and Givol , D. (1 99 4) Indu c tion of Wafl !Cip1 by a p 53 -
independent pa thway. Ca n c e r Res. 54: 3 3 91-3 3 95 .
Mi.t r a, A.B., Murty, V. V. V.S . , Pr a tap , M.P ., Sodhani , P . an d
Chga nti, R .S .K . (1 994 ) ErrbB 2 (HER2/ne ul onc ogene is f r eque n tly
ampli fied in squamous c e ll ca r c i noma of the uterine cervix.
Cancer Res . 54:6 37 -63 9.
Mitta l, R., Tsutsumi, K.. Pa te r , A. a nd Pa t.er , M. (1993} Ruman
papillomavirus type 16 expre ssion i n c ervica l keratinocytes :
role of proge s t erone and gl u c o cor t. i co i d hormones . Obs t et .
Gynecol . 81 : 5 - 12 .
Mitran i -Rosenbaum, S . and Ts v i e li , R. (1992 ) Differe ntia l
cooperation ot a c a rci noge n wit h human papillomavirus type 6
and 16 DNAs in i n vi t r o onco geic transformation. In tervlrology
33 :76-85 .
Morga n, D. , We l t y , D., Gl ick, A., Greenhalgh , D. , Henni ngs, H.
and Yus pa , S.H . (199 2} Deve l opme nt of an i n vitro model t o
1 9 2
study carcinogen- i ndu c ed neopl as t i c proqres s i o n of i n it i ated
mouse epidermal c ell s . Cancer Res . 52:3145 -] 15 6 .
Mou, L., Miller , H. , Li , J . , Wv.ng , E. a n d Chalifour , L. (199 4)
Improvements to the different i al display me thod f or gen e
ana lysis . Biochem . Bi op hy . Res. Comm. 199:564 -569 .
Munger , K. , Phelps , W.C ., Bubb , V., Howl e y, P .M . a nd s c hl eg el,
R. (1989a) The 86 and 11:7 ge ne s of the human papi llomavi rus
type 16 together are ne cessary and suf fic ient f o r
transformation of pr imary huma n ke ratinocyte s . J . Vi r ol.
63: 441 7 -4421 .
Munger, K. , Wernes s , B .A., Dyso n, N. , Phelps, w.e. , Ha rlow E.
and Howley, P . (1989b) Comp l e x formati o n o f huma n
papillomavirus E7 p rotei ns with the r-et i nob l a s t oma t umor
supp ressor gene product . EMBO J . 8 :4 099 -4 105 .
Munger , K., Schef fner , M. , Huib regtse, ,T. M. an d Howley ,
P.M . (1992.) I n t e ract ions of HPV E6 an d E7 on c oprote t ns wi th
tumor suppressor ge ne product s . I n Can c er Su r v ey Volum e 12:
Tumor Suppressor Genes , t h e Cell Cycle and cancer , pp.197 · Z17 .
Imperial Cancer Research Fund, Londo n.
Nagaya , T ., Nakamura, T. , Toki no, T. and Tsurimot o, T.(1987 }
The mode o f hepatit is B vi rus es DNA i nt e g r a ti on i n chromosomes
of human hepatocellular ca r cinoma . Ge n es 1 : 773 -78 4.
Naguib, S.M., Lu ndin, F. E . and Dav is , If . J . ( ~ 9661 ae Lat i.on or
various epithemiol egic factors to cerv ica l c ancer a s
determined by a ecree ntnq p r ogram . Obstet. Gyn ecol . 2 8 : 45 1 ~
455 .
Nakayama, T. , xaneko. M. , Kodama , M. and Nag a ta, C . (1985)
Ciga re tte smoke i nduces DNA single - s trand b r eaks in human
cells. Nature 3~4 :4 6 2 - 4 6 7 .
Nishie , Y., Aiello , L . P. a nd King G .L . (1994) Glucose i nduce d
genes in bovine aortic s moot h mu s cle ce l l s ident ified by mRNA
dif ferent ial display. FASEB J . 8 : 103 -106 ,
193
Noda , A . , Ning , Y., Venable , S .F . , Pereira-SmiCh, a. M. and
Smi t h J . R. (199 4 ) Cl oni ng o f se ne scent c e ll-de r i ved inhibitors
of DNA synthes i s us i ng a n ex press io n s creen . Exp . Cell Res .
211:90 -98 .
Nomura, N. , Takahash i , M. , Ma t s ui , M. , Ishii , S . , Date ,
'r e k ay as u , Sasamot o, S . and Is hizaki, R . (1 9 B8) Iso lat ion of
h uman eDNA. clones o f my b - re l a t e d genes , A -myb and B -myb.
Nucleic . Acids Res . 16:11075 · 1108 9.
Ocadiz, R., Sau ceda, R. , Cru z, M. , Graef, A.M. and Garig lio,
P. (1987) Hi g h co r r ela t ion between mo l uc ul a r alternation of
t he c -mv c onc o g ene and carcinoma o f the u t er ine cervix . Cancer
Res. 47: 4 173~4177.
Oren , M. and Levine, A.. (1 98] ) Molecular cl oni ng of a eDNA.
specif i c for t he murine p 53 cel l ular t umor an t i ge n. Proe .
Natl. Acad. Sci. US A 80:56 -59.
papathanasdcu , M.A . , Kerr, N. C. K., Robbins , J .H ., McBride,
O.W., Alamo, I . , Barrett , S. F., Hickson I .D. and Fo r nace , A.J .
(1 991) I ndu c tio n by i oni Zi ng r a diatio n of the gadd45 qerre in
c u lture d human ce ll s: l ac k of mediat i o n nby p r ot e in kinase C.
Mol. CeU. BioI . 11: 1009- 1016 .
Park , N-IL, Mi n , a -ei.. Li, 5- L ., Huang, M.Z ., Cheri ck, H.M.
and Don iger ,J. (199 1) Immortali zation of no rmal human oral
kerat i nocytes with t.y pe 16 hum an papilloma v i ru s .
Cardnogeneais 12 : 1627 -16 3 .
Park , D.J . , Wi l czyns k i , S . P., saquet t.a , R. L. Miller , C.W. and
Koeffler , H. P. f199 4J P53 mutation i n IIPV-nega t ive cervical
c a r cinoma. Oncogene 9: 205-210.
Parke, S.B . , Eich e le , G., Zhang , P. , Rawls , A. , Sands , A.T.,
Bradley , A., Ol s on, E.N. , Harper, J . W. and Elledge, S .J.
(1995 ) P53-independent e xp re s sion of p21e ; p , in mus c l e and
other t.e rmi na j Ly differen t iating c ell s _ Sdence 267 , 1024- 10 27 .
Pater, M.M . , Hughes, G.A ., Hyslop , D.E . , Nakaha ti r-L, H. and
Pa t e r , A. f198 8l Glucocort icoid -dependent oncogenic
19 4
tra n sforma t i on b y t ype 16 but not. type 11 h uman p ep t n oree
vi rus DNA. Na t ure 33!:1:832 ·835 .
Pa t e r , A., aaya epeue , H. and Pater, M.M . 11 9 90) Oncog e nic
transformation by human p apj I Ioma vt t-n e type 1 6
deoxyribonucle i c acid i n the pr e s ence of p roges t e ro ne or
pro g estins f rom o r al c ontraceptives . Am. J. Obs t e t . Gyne co l .
16:': 1099- 1 103 .
Pat er, M.M . , Mitta l , R . and Pater, M. (l 9901l Role o f s teroid
hormones i n potent ia ting transformation o f ce rvi ca l cells b y
human papillomav i ru se s . Tre nds Mi c robi a l . 2 :229-23 5 .
Pec ora ro , G. , Mo r gan , D. and Defendi ,V . (1989) Dif f e rent ia l
effects o f human papilloma v i r us t y pe 6 , 16, a nd 18 DNAs on
i mmo r t a l i z at io n and tra n s f orma t ion o f hu man c e rvt c a t
epi thelia l cells . Proc . Nat-I . Acad . Sci . USA 8h:56 3 -567 .
Pei, X. , Meek, J.M., Greenh algh, D . an d Sch legel , R . 1199J )
Cot. r ans f e c tion o f HPV-18 an d v- fos DNA ind uces t umor i genici t y
of p rimary human kerat.inocy t es . Virol ogy 196 : 8 55- 86 0 .
sei a s scn , I . , Soler, C . and Pechoux, C. ( 1992) C · JIlYC' and e - Ra -
res ce llu l ar cn c oqenes and human pa pillomavi ruses i n benign
and malig nant cu t.aneous l e s i ons . J . Dennatol . Sc i . 3:56-6 7 .
sexetra-smrm. O .M. a nd Smit.h , J .R . 11988 1 Genet i c analysis o f
in definite division i n human cell s : Ident ifi c a t i on of f o u r
comp leme n tation group s . eeee , Nat .! . Acad . Sci. USA. 85 : 60 4 ::1·
604 6.
phe l ps, w. e. • vee, C.L . • Munger, K . and Howley , P. {l9861 Th e
human pa pillomavi ru s 1 6 E7 gen e encodes r .ran e acttva t i cn a nd
transformat i on f u nct i o ns similar to t ho s e of adenov i rus E 1A .
Ce l l 53 : 5 3 9 -5 47 .
tlhi 11 i ps , A .N. a nd Smith, G.D .1 19941 Ci garette Smo ki ng a s a
po t e ntia l caus e of ce rvi c a l ca n ce r: h a s confo und i ng b een
co n t ro lle d ? rae . J . Epidemiol . 23 : 42·4 9 .
195
Phi llip, w. (1994 ) c igaret te smok ing a nd cervica l cancer. In t: .
J, Ep i demi ol . 23: 1 099 - 1101 .
Pietenpol, J. l\.. , Holt, J . T . , Stein, R.W " and Moses ,
H. L . (1990 ) TGPpl suppress ion o f e-eo-c gene t r ans c r i pt i o n : role
i n i n hi bi t i o n of keratinocyte proli f e ra t i o n . eroa , Na l::~ . Acad .
Sci . USA , 87 :3758-3 762.
Pi r La i , L., rescrnoco. S . , Feller , M., Doni g e r , J. and DiPaolo ,
J .A. (1987 ) Transformation of human papil lomav irus t ype 1 6
DNA. a . V.! r ol. 61 : 106]. - 1066.
Pon ten , J ., Adami , H- D. , Bergstrom, R. Dillner , J.,
cos ceeseon , L . Miller, A,B., parkin , D. M " Sparen, P . a n d
Trichopoulos, D . (1994 ) Strategie for g lobal control of
cer v i ca l cance r . zne. J . Can c e r 60: 1-26.
Prime, 5. S . , Matthews, J. B. , Patel, V. , Game , S.M., Donnell y ,
M.. Stone, tv., P a terson , I. C . an d Sandy, J.R.(1994) TG~-p
recepto r regu la t ion mediates t he response to exogenous ligand
but is i nd e pende n t of the degree of cellular differentiation
i n h uman oral kerat in o cytes. I n t . J . Canc e r 56:406-4 12 ,
Riou, G., Bourhis , J . a nd t e , M.G . (1 990 ) The c-mj-c
pro tooncogene in invas ive carcinomas of t he uterine c ervix :
cl i n ical relevanc e of overexpres s i on i n ear1.y stages cue
cancer. An t:1 canc-e r Res . 10: 1 2 25- 12 3 2.
Roberts, A.B. a nd Sporn, M. B. (1984 ) Th e r e t inoi ds . sporn ,
M.B. , Roberts , A . B . and Goodman , D.S . (ed s ) . Academic Press ,
Or l a ndo, FL. Vol . 12 pp . 209-286 .
Rol lins, B .J . , St i e r, P . , Ernst , T. and Wong , G .G.(1989 ) The
huma n homolog of t he JE gene encodes a monocyte secretory
protein. Mol , Ce .ll. Biol . 9 :4687-4695 .
Rolli ns, B . J . and Su n d ay, M.E , (1 9 91 ) Suppress ion of t umo r
format i on in vivo by expression of the JE gene i n malignant
cel ls. Mo l. . Cell. Si o l . 11 :31 25 -31 31 .
i s
Romanczuk , H., Vil l a , L.L. , Schlegel, R. and Howler ,
P. M.1199J. ) The vi ra l t z-anacr Lp t Iona L requ Lator-y reg i on
upstream o f t h E" 86 and 87 g enes is a maj or dec a mnne nr of t he
different ia l i mmor talizat.ion activi t ie s of hum an
papillomavirus t ype 1 6 and lB . J. Viral . 65 :2739 -27 4 01 .
Rosl , ~. , Lengert, M. , Albrecht , J . , Kl e Ln e , K. Zawat ;;!o::y, R . ,
Schraven, B. and zur Hausen , H. ( 1 9 94 ) Di ff er ential regulat i on
of the JE gene encoding t h e mono c y te c h emca t.c r -a cren t; pro te in
(MCP- l) in ce r v ical carci n oma c e lls a nd der-Lv ed hybl'ids . J .
Vi rol. 68:2142-2 150.
RUbelj , I. and Pere ira-Smith, O . M.(1994 } s v-t n-t r-an sro rme d
hu man cells in c r isis c}:h ibit Changes tha t o c cur i n nor-ma t
c e l l ul a r senescence. Exp . Cell Res . 21 1 : 8 2-89 .
Sagae , S. , Kud o , R. , Kuzumaki , N. , Ilisada, T . , Mug i kuril, V. ,
Nihe i, T . , Ta k e da , T . and Has himot o, M. j 198 9) RdC onco 'qe ue
e xpression and progre s s ion in in trae pithel i al n e opl a s i a o f the
uterine ce r vix. Canc e r 66 : 2 95· 30 1 .
Sager , R., Anisowi cz , A . , Neveu , M. , L i 'l Ug, P. and
sot.Iropou iou . G. (19 9 3) Ident if i ca t ion b y diff e r entia l dl a p l ay
of alpha 6 i n t e gri n a s c1 candid at e t um or s uppres sor gene ,
FASEB J . 7 : 964 - 9 70.
Sa1a, A. and Calabr e tta , B. (l 9 9 2) Reg u l atl o n of SAI,o/c 31'3
fibroblast proliferat ion by B-myb i s ac c ompani e d by select ive
activation of cdc2 and cyc l i n 01 expression . Pro e. Nat!. Ac a d .
Sc i . USA 89:104 1 5- 10 4 1 9.
Sambrook, J ., Fritsch, ILF. and Mania tis , T. (1 9B9) Mol ecular
c.lonlng .. a lab o r ator y man u al. Co ld Sp r ing harbor La boratory
Pr e s s , Ne w York .
Sang, B -H, and Barbosa , M.S . {19 92) I n c reased EGl in
tra nscr i p t i on in HPVI B- immor talized human ke r a tinor ryr.en
res ults from inactivat ion of E2 an d addi t i onal ca l Lu Lar
events . Virology 189: 448 - 4 55 .
19 7
Sasson, I . f-l., xarey , N.J., Ho f f mann , D. and Wynde r , E .L.( 1985)
Cigarette s moking and neoplas ia of t he u te r i ne c e r v i x s moke
constituents in cervica l mucus. N . Engl . J . Med. 312 :315-316.
Saxon, P . J . , Srivatsan, E.S . a nd Stanbridge, E . (1986)
Introduct ion of huma n chromosome 11 via mi crocell trans fer
con t.ro l s tumor igenic expression o f He l a cel ls. EMBO J. 5:3461-
3166 .
Sch effner, M. , we r ne su , B .A ., Hui b r e g t s e , J.M. , Le vine, A .J.
an d Ilowl ey , P . M. (1 9 90) The E6 oncoprotein e nc o d e d b y huma n
pap Lj Lomav i ru s t y pe s 16 and 18 promotes the degrad ation of
p53. Ce ll 63:1129 -113 6 .
scner rner, M., Romanca uk , H., Mu nge r , K., Hribregtse, J . M.,
Mietz, J.A . and nowrev , P.M. {1 9 9 4 ) Functions of h uma n
pa pillomavirus p ro t.e ins. Curr o Top . Mi crob i a l . Immunol .
18 6 , 8 3- 9 9.
Sc hegget , J . T . and van cer Noo r daa, J. (1 9 9 4 ) Protein
phosphatase 2A and t he regu lation of human papillo mav i rus ge ne
activity. Cur r o Top. Micr obial . I mmunol . 186:12 1 -129 .
Schwe infest, C .w.and Pa pas , T. S (1 9 9 2 ) Subtractive hybridi zation:
approach t o the isolation of genes dif ferentially expres s e d i n
cancer an d other b iolog ical system (Review). I n t . J . Oneal.
1 : 4 9 9~ 5 0 6. .
Shah , K. Y . an d Howl ey, P . M. (1990) Condyloma acuminat a a nd
h uman genital cancer . Can c e r Res . 36:530 -534.
Shay, J . W., Wrig h t , W.E . and We r b i n , H.(1991 } Defini ng t he
mo l e cu l a r mechan isms of h uman c e ll inunortal i zat ion. Bioch.
Biophys. Acta 1072 :1 - 7 .
Sheikh , M.S" Li , X-S ., Che n, J-C ., snao. Z-M., Ordone z, J .V .
a nd Fo n t a na , J.A. (1994 ) Me c ha n i s ms of regulation of wafl / Ci p 1
gent" e xp ression in hu man breas t ca rcinoma: role of p 5 3 -
depe nd ent a nd Independent s i g na l transduction pat h ways .
Oncogene 9 :3407 - 3415 .
198
Shin, K-H . , Mi n, B-":. Cerric k , H. M. and Pa rk , N-H . (1994 1
Combined effects o f hu ma n pe p Lt J ornavd rua -La a nd N-methyl - N' -
nit ro-N-nitrosoguanid i ne on the t r a ns f o rma t i o n o f uo rme L human
oral keratinocytes . Mo l . Carcinog . 9 : 76 -86 .
Sh ioha ra, M. , EI -De i lY , W. S . , Wada, M_ Na ka mak i . '1'. , Tak eu chi .
S. Yang, R. , Chen , D- L. , vogelste in , B. a nd xoett j e r, P. (199 41
Absence of Wa f 1 rout a t i ons i n a variety of human nvi Li q na nc i es .
Blood 84: 3 7 81 - 37 84 .
Sillman , F. , St anek , A. , Sed I i s , A., Rosentha l, J. , La nka ,
K.W. , Buchhagen, D. , Nicast ri, A . and Boy ce , J . ( 1984) The
relationship be t we e n human papil lomav i r u s and r owe r- qen Lta l
intraepithe lia l ne o p l as ia in immunosupp ressed wome n . Am. J.
Obs tet . Gynecol. 15 0 : 300-308 .
Simon s, A.M . , va n Ile r c ke n r o de, C . M. , zod r Lquc a, J . A.,
Maitland, N., Ande rs o n. M. . Phi llips, D. H. and Co l e ma n ,
D.V.(1995 ) Demon st r at i on of s mok i ng - r e l a t e d DNA dnmaqe i n
cervica l epithe lium an d correlation with human pap i llomavi r us
t yp e 16 , us ing ext oliated c e r v i cal ce l ls. Br. J. Cancer
71 :2 46 -2 49.
Size mo r e , N. and zort:e . E .A. (1993) Human pa rd t tomv t rus 16
it nrnor tal ization o f nor mal human eccocerv i caj e pfthe l i a L c ello
a l t ers ret inoic ac i d regu l a t i o n o f cell growt h <1 11e! e p i de rmal
growth factor recep t o r expression. Cancer Res . ')3: 451 1- 45 17 .
Slebos, R.J ., Lee, M. H. , Plunket t, B.S. and Ke s u i n , 1'.D.(1994)
p 53 -depe nde n t GI ar r e s t involves pRB-related pro t e i ns a nd i s
d i srupted b y the human papillomavirus 16 E7 cncoprotern . Froe .
NatI. Ac a d . Sei. USA . 91 : 5320 -5324.
Smith , J. R. a nd Pe r i r a- Smi t h , O.M. (19 90) c ene t t c and
molecular studies o f cel l u l a r irrrnorta lization. Adv. ion cancer
Res . 54 : 63-77 .
Smith, M. L . , Che n. L T . , Zhan , Q. , aae , 1., e be n . C- Y. ,
Gi l me r, T . M., xaec e n. M. B., O' Co n nor , P.M . a nd Pornace ,
A. J. (1994 ) Interac t i o n of the p53 -regulated prote in Gadd45
wi t h p r o l i f e r a t i ng c e LL n uc l e a r antigen . Science 266:1376 -
199
13BO.
Smith, P.P., Brya nt , E.M ., xau . P . and McDouga l l , J. K.(1 9B9)
Cytogenetic ana Lys I s of eight human p api lloma v i r us
i nvnortali zed human k e z-atLnocv t ea . Inc . J . Can cer 44 : 112 4 · 1131 .
So k.olov, B. P . a nd p r oc kop , D.J . (1 994 ) A rapid and simp l e PCR-
b ased me t hod f o r iso l a t i on of cDNAs from d i f fere ntially
e xpressed genes . Nucl e ic: . Ac i d s Res . 22:4009 -4015 .
Solomon, E . Vorrow, .J an d Godda rd, A.D. (1991 ) Chromoso me
ab erra t i on s and ca ncer. Science 254: 1153 - 11 60 .
So us a, R., Dos t.a tn i , N. an d yan Lv , M.(1990 ) Control of
papi1lomavirus gen e ex pre s s i on. Bi o cb . Biop ll y s . Ac ta 1 032 :1 9-
37.
Sp r uck II I, C.H . , Rideout II I , W.M ., Olum i, A .~ ., Ohneseit.
P.F . , Yang, 11. . 5 . , Ts a i , Y,C . , Nichols, P.W . , Horn , T .,
he nn a nn , G .G . , Ste ven , K., Ross, R .K ., Yu , M. C . and J on e s ,
P. A. (1993) Dis tinc t pattern o f p53 mutat ions in b ladder
ca ncer: rel ationsh i p to tobacco usage . Cancer Re s . 53: 1162-
1 166 .
Srivasta va, S ., Tong, 'l . A. , Deva das , K., Zou, Z-Q. , Chen, Y. ,
Pirollo, K.lo'. and Cll1'l II(J, E.H . (1 992 ) The status o f the p5 3 gene
in human p apd Ll.oma vi r us pos i tive or ne gative cervica l
c a r c i noma ce l l l i ne s . Car c i n og en e s i s 13 :127 3- 1275 .
Stamp s, A.C., cua t e rson. B .A. a nd O'Hare, M. J . (1) 92) Are
t umours i mmortal? z vv. J. Cancer 2B1>. : 1495-1500 .
S t a nl e y , M. I>. . 11994 1 Rep l ication of human pap illomav irus in
cell cultu r e . Antiviral Re s . 24: 1 - 15.
Ste i nman , R.A. , Hor Ima u , 8 ., r ro, A. , Guil l oUf , C., Lieb e rma n ,
0 . 1>. . a nd El - Housenin i, M.E. (1994) In d uc t ion of p21 (Waf l!Cip1)
d uri ng d f f Ee rent i a t i on . Oncogene 9 : 3389 -3396 .
Stern , R.S. an d Lan rje , R. (1988) Non - melanoma skin c an cer
occurring in pa c r e ucn treated with pUVA five to ten years
2 00
a f te r f i r st t r ee t me nt . J . Invest. Derma t ol . 9 1 :1~O -124.
Storey, A. , Gr een f i e l d , I . , Banks, L., Pim , D., Cr o ok , T.,
Cr awfor d, L. a nd Stan l e y , M. (19 92 1 Lack of i mmor t a li z i ng
activity of a human pa p il l oma v i r u s type 16 var iant DNA wi t h a
mutat ion i n the E2 gene isolat ed f rom norma l human cervica l
keratinocytes. On cog en e 7:4 59 · 465 .
Sto r ey, A. and Bank s, L . (1 993) Human papi llorna v i rus type 16 E6
g ene co op e r ates with Ej· ras to i mmortalize prima ry mou s e
ce lls . O'1cogenes 8: 91 9 ·924 .
Sun, Q . , Tsutsumi, K. Kellehe r . M. B . , Pa ter, A . and Pater,
M.M . (1 9 92) Squamous metaplasia of normal and ce r c Luome in
situ o f HPV 16 - i mmo r t tlli ze d human endocervica l cells . Can cer
Res . 5 2 :4 2 S 4 ~ 4 2 60 .
Sun , 'i . , Heg a mye r , G . an d Col burn , N .H . ( 1 99 ,1) Molecul ar
c loning of five meas cuqe r RNAs dif ferent ially e xp r e s s e d i n
preneopla s tic or neop lastic JB6 mouse e p i de r ma l cells : one i s
homo l og o u s to human ti s s ue i nhi b i t o r of met et i.op rocetneses -a .
Cancer Res . 54 : 11 3 9 -1 144.
Te y s s i e r, J .R. (1989 ) The ch romosomal analysis of human no t Ld
t umor s : a t riple challenge. Can cer Genet . Cytoge ne t . 37: 103 -
125 .
Thomas, M., Mas s i mi , r. , Jerk ins, J . and Ba nks, 1., . (1 99 5) HPV ~
18 E6 mediate d i nhibi t i on of pS3 DNA bi nding cc t Ivt cv i s
i nd e pe nd e n t of E6 i nd uced degradation. Oncogene 10 :261-268.
Tho mps o n, A.M., Mor ris , R.G . , Wal l a c e , M., Wyll ie, A, H. ,
St eel , C. M. and Cart er , D.C . (1 993 ) Allele Lou s from Sq2 1
(APe/Mcel a nd 18q21 (De C) a nd DeC rnRNA e xp resn ton in b r eas t
c a nce r . Sr . J . Can c e r 69 : 64 - 68 .
Timmers, H. T. M., va n Dam, H. , Pronk, G.J., Bas, J. L. and Va n
de r EB, ' A. J . (1989 ) Adenovi rus ElA r e pr e s s e s t r-ans.c r i p t.Lon o f
t he cellula r JE gene . J . Viral . 63:1470 -1473 .
20 1
Tommasino, M. , Adam cze·"ski, J . P . , Carlot ti , F . , Barth, C . F .,
Ma ne t t i , R. , Con t o r-n i , M., Cavalier, F., Hunt, T. a nd
Cr a wfo r d, L. (1991 / I/PV16 E7 p rotein assoc i a t e d wi t h the
pro t e i n kinase p3 3' "' ' e nd cyct t.n . On cogen e 8: 195 -202.
Tr ush i n, N. , Rive ns on , A , and He cht , 5 . 5.( 1994 ) Ev idence
s upporting the ro l e o f DNA pyridyloxobutylat ion i n rat n a s a l
c a rcinogenesis by cococco -epec t eIc n i t r os a mi n e s . Cancer Res .
54 :1205-1211.
'reur.suuu , K. , 8e lagu U, N., Sun , Q .. Michal ak , T.!., Gul l i ver,
W. P ., Pa t er , A. and Pate r , M. (1992) Human pap illomav irus 16
DNA i rernort .af t aes tw o t yp e s of normal human epi thelial ce l l s of
the u t e r ine c e r v i.x . Am. J . PathCJl . 140 : 255-261.
va n de r Eb , A. , Ot f r i nq a , R. , TimmeI:s, H . T . , van Da m, H. ,
Mei jer , I " van d en Heu vel, J .L ., Kas t , W.M. , Me l i e t, J.M.,
Herr lich, P., zan t eme , A. a nd 80S, J .L . (1990) Inhibi t ion s of
cel lular gene exp. r-eus i on in ad e noviru s - t r a n s f o r me d cell s. I n
Pap illomaviruses , pp. 425-44 4 . Wil ey - Li s s, Inc.
Vernon , S. D., Ha r t , C. E. , Reeves, w. e . and Icenogle, J.P .A.
(19 931 The HIV-1 tat protein e nh ance E2 - de pe nden t hu ma n
pa p i l l oma v i r us 16 t rans cz-Lpt.Lon . Vi r us Res . 2 7 : 133 ·1 45 .
Vil l a, L .L . , Vieira, K.S.L ., Pei, X- F . an d Sch legel, R. (1992 )
Di fferential effec t of tumor nec ro s is f actor on prolifer a tion
of p rimary human ke rnr i nccyt ee and cell line s containi ng human
papi llomav iru s type 16 and 1 8. Mol. carci nog . 0: 5-9.
Vou s d e n, K.H . a nd rar re t , P.J.( 1994) Virus e s and human cancer.
Br. Med . Bull. 50: 500- 581.
Wag a , S . , Ha nnon . J .. Beach, D. a nd Stillman, 8 .(1994) Th e p2 1
i nhibi tor of cyclin -dependent kinase s c ontrols DNA replic a tion
by int era ction with r eNA. Nature 369: 574 - 578 .
Wa t a nabe , S., Kand a , T . and Yo s h iike , K. (1989) Human
pa pillomav i r u s type 16 transforma t ion of primary human
embryoni c fibrob l a s ts requi res ex p ress ion o f op en readi ng
f rames E6 and E7. J . Vi r o l . 63 :965 -969.
202
Wat s on , M. A. an d Fl eming , T . P . 11994 ) r so t .rt Lon o f
d ifferent i a l l y expre ssed sequence t a g s from huma n b r ea s t
can ce r. Can c er Res . '; 01:4 598 - 4602.
We inbe r g, R .A .11989 1 Oncogenes , enc t ou ccq e ue s , and t he
mol ecular bases o t nUl t i s t e p carc inogenesis . Cancer Res .
49 : 171 3-3721.
Werness , B .A ., tevt ue . A . J . an d Howl e y . P .M. 119 90 1 xeeocret. ton
of human p a p il l omav i r us t ype 16 and 18 E6 prote tuo wit h p53 .
Science 24 8: 76-79 .
Will e y, J .e., a r e t sc rcm, R. e . , Mo s e r , C. B.. Ouaune , C.,
Sundqv i st , K . and Ha r r is , e .c . (1987 ) atocnemtc ar an d
morphologi c a l e f fec t s o f c igarette s moke co ndc uc a ue a nd ita
frac t ions on norma l human b ro nc h ia l ep Lt he Lia I en 11s in v i ere .
Can ce r Res . 4 7 :2 04 5 · 2049 .
Winke l ste in , W. , J r . 11977 1 Smok i ng an d ca ncer o f t he uteri ne
cervix: hypo thesi s . Am . J . Epi demi ol . 106 : 257 - 259 .
Wi nkelscein, W. 11g e 6 1 Ciga r et t e smoking an d canc e r- o f t he
ut e rine cervi x . I n Mechan isms i n Toba cco Carcinogen e sis .
Boffmann, p p . 329 - 34 1. D. and Ha r ris. C. C. tees j . Co l d s p ring
Ha r bo r Lab . , USA.
Wi nk-elste i n , W. (1990 1 Smoking a nd cervical cancer -current
e ee eu e • a rev iew . Am. J . Epi demiol. 131 :945 -95"1.
Woodworth , C . D. , Bowden P .E. , Donigec , J ., Pi r isi , I, . • Barnes.
W. , La ncas t e r , W.D. a nd DiPaolo. J . A. (1988 1 Cha ra c ter izat ion
of no rmal human exoc e r v t ca f ep i thelial ce lls Inenort .al Laed in
vi t ro b y p apillomav i r u s type s 16 a nd 18 DNA . Canc er Res . 48 :
4620 - 4 628.
Wood worth , C .L ., Do ni ge r , J . and Di Pao l o,.J. A . 119 89 1
IIl\Illorta l iza t i on of huma n foresk i ke ra t illocyte :..; by var ious
human p ep d Lkomav dr-u n DNAG c orre s pon ds to t he ir uuuocfa t Ion
wi th cervi c al ca r c tnom .. . J . virol . 63: l59 ·l64
2 03
Woodwo r t h . C.D . • Wil'Jgoner, S ., Barnes , W. • Stoler, M.H . a nd
DiPaolo, J . A. (1990 ) Human cervical and foreskin epithelial
cell s immortal ized b y human papillomavirus DNAs exhibit
dysplas t ic differenLi a t.ion i n vivo . Cancer Res . 50 :3709-3715.
Woodwort.h, C ,D. , Li ch t.Lm, U . , Simpson , S., Evans, e .H. and
DiPaolo. J .A . (1992 1 Le ukor e gu lin and y-inte rferon inhibit
human papd Lj.cma v dr u s t ype 16 gene transcrip tion i n human
papillomavirus-immort al ized human cervical cells . Cancer Res .
52 : 456 -4 63 .
Xiong. 'I . , Ha nn on, G.J ., Zhang, H . , Cas s o . D. . Kobayashi , R.
an d Beach, D. (1993 ) P2 1 i s a universal inhibitor of cyclin
xtnaees . Nature 36 6 : 701 - 707.
Xu, F . , Meek , J .M. , Gr ee nha l g h , D . and Schlegel, R. (1993)
Cot r a ns f e c tion o f HPV- 1 8 and v-fos DNA i ndu ce s t umor i g e n i c i t y
of primary human kera t i nocy t e s . Vi r ol ogy 196: 855-860 .
vc xcy a . J . and 'sllg i mur a , T. (1 993 ) Mult ipl e steps in
carcinogenesis involvi ng al ternations of mul t i p l e t umor
suppressor genes . FAS EB J . 7 : 920 ·925 .
Yokoyama , M. , Yoah .i f umi , N., Yang. X. , Sun, Q . • Tsu tsumi, K. ,
Pater, A. and Pate r , M,M. (l995 ) Alterations in physical state
and expression of huma n papillomavirus type I S DNA following
c r i s i s and eetetn r s nment of i mmor t al i zed ectoce rviea l cells .
Virus Res . l i n press ) .
Ze ng , X-R . • Jiang , Y.• Zhang . S-J .• Hao H. a nd Lee,
M. Y. W.T. (1994 l DNA polyme r a s e ~ is involved i n t he c ellular
response t.o UV damaqe i n hu man cells . J . BioI. Chem .
269 : 137 4 8 - 13751 .
Zha n, Q., Carrier, F . and s c m a c e , A.J. (1993 ) Induction of
cellu lar p 53 act i v t ry by DNA-damaging agents a nd growt h
arrest. Mol. Cell. BioI. 13,4 242 -42 50.
Zha n, Q .• Lord, K.A . , Alamo , I . , Ho l l a nde r , M.e . , Carrier, F .,
Ron, D., Kahn , K.W. , Hoffman, B . , Liebermann, D .A. and
Fornace, A.J . (1994 l The ga dd and MyD genes define a novel set
204
o f mammalian ge nes encoding acidic proteins that
synerg i stically su ppress cell growth . Mol. Ce l l . tuoi •
14 : 2361-2371.
Zhang , L . a nd Medin a . D. (19 93) Gene express ion screening for
specific genes a s so ciated wi th mouse ruamrnary tumor
dev el op men t . Mol . Ca rc: i nog . 8:12 3- 12 6 .
Zimmerman n , J .W. and Sc hultz, R. M. (1994) Analys is of ge ne
e xp re s sion in t he p re i mplantation mou se emb r yo : use of mRNA
di f ferent ia l d i s p l ay . zec c . N~tl . Acad . S ci . USA 91: 54 56- 54 60 .
zu r Hau s e n , H. (19 76) Condyloma acum i nata and human ge n ital
cancer. Cancer Res . 36:5 30 -53 4.
zu r Hausen, H. (1 99 1 ) Human pept i rcmev t ruues i n t he
pa t hoge n esis of a noqen i t.a I c anc e r. Virology H I ·I : 9 -13 .
zu r Haus e n , H. ( 1~9 4) Disrupted dic ho tomous i ntracel l ular
contro l of human pap i Ll.omav i r u a i nf ection i ll cancer or t he
cervix . Lancet 343 : 95 5-9 57.
zu r Hausen, H. and Vill iers, E-M. (1 994 <1 ) Human
papillomaviruses. Ann u . Rev. Microbial . 48: 427- '147.
zu r Hausen, H. an d Vi ll iers, E-M. (19 941l) Molecular
p a t hogenesis o f ca ncer of the cervix and i ts ca us a t i o n by
specific human pap i ll omav i rus types . Curro Top . Microbia l .
zeauncz • 1 8 6 : 83 ~ 9 9 .
20 S
Ap pend ix I, Cumpnstrien of Media
Kera tinncytc G ro wth Mediu m (J{{ ;,\fJ :
[Ca2'1 O. I:'imM
Lcglu tamin e 500 mM
EG f , human, recomb inant :2~tglL
Bovine Pituita ry EXlract( Il IJ E) 50 mg!l.
Penicilli n-Streptomycinc 50,000 I II IL
Ullbecco' li Motli fied t:llJtll' Med iulII ( I):\ II:M):
jell! 'J I.5 mM
Deghrcose 4,500 1llgiL
I.-g lutam ine 5H.l mglL
I.-methionine Jum g/t.
l.-lcuciuc 105 mg/ L
Pyru vate 110 mgl L.
Phenol red 15 mg/ L
Sodium phospharc 125 mg/L
Calcium chlor ide 200 mg/l,
Pyridm:al .HCI -10mglL
res 10°....
l'enici l"" ,S lrCIl[Omycin 50,nn OIU/1.
Hydrocortisone -mumglL




